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Abstract 
The work carried out in this thesis initially involved the testing of the 'De Wit PCR 
protocol' in the detection of Mycobacterium tuberculosis from pericardia! fluids taken 
from suspected cases of tuberculous pericarditis. The scope of the thesis broadened to 
include the testing of the protocol in the identification of M tuberculosis from 
mycobacterial and BACTEC® (Becton Dickenson) cultures from clinical specimens 
received in the clinical laboratory. 
For the pericarditis study, a pilot sample of pericardia! fluids was processed and tested 
using the 'De Wit protocol'. This pilot sample of 54 specimens was part of a large trial 
which was instituted to compare and evaluate the efficacy of culture and DNA 
amplification techniques in the diagnosis of tuberculous pericarditis. 
The results of the pilot sample showed that the sensitivity of culture was appreciably 
superior to that of PCR, using this protocol. The reasons for this finding were sought. 
It was found that with the application of the commonly used DNA extraction methods, 
which included the 'De Wit extraction method', considerably less DNA was recovered 
in the final extraction product than had been expected. The use of multi-manipulation 
techniques in this context also increased the risk of DNA contamination arising from 
clinical specimens or from previous amplifications. This led to the testing of simpler 
methods of DNA recovery in order to i), avoid 'DNA target' contamination and ii), 
conserve the relatively small amounts of target DNA that are normally present in the 
relevant pericardia} fluids. Other simplified DNA recovery methods, namely 
commercially available 'rapid' DNA recovery packages were also assessed. It was 
found that all simple methods tested failed to recover sufficient quantities of DNA for 
our purposes. This was probably due, in part, to the properties of the M tuberculosis 
bacillus cell wall which is known to resist attempts at lysis. Another factor of 
importance in using the simpler DNA recovery methods was that these were not 
suitable for removing protein from pericardia! fluids . As a result, protein that was 
potentially inhibitory to PCR remained present in the final DNA extraction product. 
The use of re-amplification protocols was also tested in an attempt to increase the 
sensitivity of the protocol. A successful re-amplification protocol would enhance the 
detection of small amounts of target DNA obtained from recovery products and would 
obviate the need for the use of technically demanding and time-consuming 
hybridization detection techniques. While the use of this protocol did increase the 
sensitivity of detection, it was also evident that interference from contaminating target 
DNA sources compromised the usefulness of the method. Despite the use of a 
vigorous anti-contamination strategy, which included physical containment measures, 
the use of UV irradiation and of bio-chemical techniques, the problem of 
contamination was never entirely resolved. 
The problem of PCR inhibition, the factors involved and the experiments conducted 
regarding this problem are discussed. It appears that, in the PCR assay of the 
pericardia! fluids, inhibition did not play a role in the poor sensitivity of the PCR 
protocol. 
Another factor of importance in the sensitivity of a protocol is the validity and 
reliability of the thermocycler used. A chapter is devoted to tests conducted on four 
thermocyclers. 'Across-the block' temperature variation was present in at least one 
case. The implications of this and other variables of the thermocycle protocol for 
diagnostic PCR are discussed. 
The 'De Wit protocol' is proving useful in identifying mycobacterial cultures as being 
specifically that of M tuberculosis. This is in contrast to the more commonly used 
protocol where the 'M tuberculosis complex' IS6 J JO is used as a target for 
amplification. The 'De Wit protocol' is being routinely employed in our laboratory on 
both mycobacterial colony cultures from clinical specimens and on aliquots taken from 
BACTEC® cultures to confirm the isolation of M tuberculosis. 
A modification to the standard 0.75ml PCR tube was devised to allow for the 
sequential addition of reagents during the amplification process without the need to 
open the tube. The use of this strategy lessens the risk of DNA contamination of the 
contents of the tube. This concept and its application have been published. 
The thesis ends with a general conclusion. 
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1.1. Historical background. 
Tuberculosis (TB) is a disease of great antiquity. Lesions suggestive of tuberculosis 
have been found in the bones of Neolithic man (4000 BC) and also in mummies of 
Egyptian origin (Morse et al, 1964). There are reports of the infection among the 
indigenous peoples of North America (Maher, 1929) and evidence of its occurrence 
among the South American Indians (Morse et al., 1961. Archeological examination of 
human bones in burial sites show that the disease affected Pre-Columbian America, 
with epidemics raging through the Huron Indian population of pre-historic Ontario and 
the native Indians ofNew York state (Ryan, 1992a). 
It has been suggested that tuberculosis was spread from animals to man at the 
time when the former were first domesticated in Neolithic times. Taking into 
consideration the broad host range of Mycobacterium tuberculosis, which 
includes many different types of wild and domesticated animals, this is a fair 
postulate (Morse et al., 1964). The human type of tubercle bacillus has been 
found in natural tuberculosis of monkeys, cattle, pigs and dogs (Cruickshank, 
1969). 
The cause of tuberculosis remained a mystery until fairly recently. It was 
originally thought that the aetiology of tuberculosis was rooted in heredity and 
constitutional factors. In 1868, however, a French military surgeon, Jean Antoine 
Villemin (1868), showed empirically that tuberculosis was caused by a 
transmissable agent. In 1882, Robert Koch provided definitive evidence with his 
discovery of the causative organism of tuberculosis in man. He had both 
observed and cultured the organism now known as M tuberculosis (Grange, 1989). 
Characteristic pathological lesions are produced during tuberculosis. Known as 
tubercles, these are filled with a substance with the consistency of cheese and are, in 
fact, discrete areas of dead cells and bacilli (Grange, 1988e). Koch therefore 
called the causative agent Bacillus tuberculosis. It was later found that B. 
tuberculosis had the ability to produce a fungus-like pellicle in liquid cultures. 
'Mycobacteria' therefore became the collective term for the genus. The genus also 
has, in common with some bacterial spores and also with Nocardia species, the ability 
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to resist decolouration with weak mineral acids after staining with an 
arylmethane dye; hence the term 'acid-fast' (Grange, 1988a). 
1.2. World-wide phenomenon of tuberculosis. 
Accurate figures of the incidence and prevalence of tuberculosis are difficult to 
estimate (Grange, 1989) but the disease is a world-wide phenomenon (Cruikshank, 
1969). It is estimated that 1000 million people have died of the disease in this and the 
previous century (Ryan, 1992a). The risk of infection differs widely across the 
globe. For instance, annual infection rates are at least twenty times greater in 
developing nations than in Western European countries. Various surveys have 
indicated an annual infection rate of 2-5% for the populations of developing 
countries. In terms of absolute numbers, this suggests that 100 million individuals 
from these countries are infected annually, with approximately 10-20 million cases 
progressing from infection to disease. Of this latter group between 2-3 million 
people die per year (Grange, 1989). 
Developed countries show a much lower annual incidence rate on average. 
Health authorities in developed countries, however, have not maintained the necessary 
vigilence with regard to tuberculosis (Grange, 1989). For instance, it was believed 
in the United States that, due to the introduction of anti-tuberculous chemotherapy, 
tuberculosis would be eliminated by the turn of the twenty first century. This led to a 
decline in resources devoted to epidemiological surveillence and tuberculosis 
research funding (Collins, 1991). During 1986, an increase of 3% in notified cases 
of tuberculosis in the USA was recorded (Barnes, 1991). This represented a 
reversal of a declining trend in a developed country (Grange, 1989) and can be 
explained partially by the influx of infected persons from areas of the world such as 
South-East Asia, Central America and Mexico where tuberculosis rates are higher. In 
the United States during 1989 the increase was 4% over the previous year and in 1990, 
it was 9.4%. This pattern of an increase in cases was also recorded in Britain and 
Western Europe (Ryan, 1992b). 
In developing countries rates of incidence and prevalence show little or no 
decline. The impact of Acquired immune deficiency syndrome (AIDS) on the 
incidence of tuberculosis in developing countries remains to be determined but it has 
been estimated that a person with AIDS has a 100 times greater chance of developing 
tuberculosis than do members of the general population (Grange, 1989). 
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With regard to AIDS in Africa, Schulzer et al., (1992) developed a mathematical 
model using four scenarios based on HIV prevalence rates. The intention was to give a 
range of predictions, for the period 1980-2000, of the expected increase of smear-
positive tuberculosis rates in sub-Saharan Africa in the sub-population of 15-45 years 
old. At best, the increase is predicted to be 50-60% by the year 2000. The worst-case 
scenario predicts a 10-fold increase in smear positive rates. Clearly, Southern African 
tuberculosis rates, already high at present, will follow any AIDS-tuberculosis 
trends prevailing in developing countries. 
On average 15 people die of tuberculosis each day in South Africa . The estimated 
incidence of tuberculosis in the Coloured and Black population groups in the 
Western Cape is thought to be 600/100,000 annually (Steyn, 1992). Tuberculous 
meningitis, because it always requires hospitalisation, can be used as an indicator of 
the extent of the infection in the community. Berman et al., (1992) showed that high 
incidence rates of tuberculous meningitis were found in the Western Cape ( for 
example: age-specific rates, 1985-1987: 31.5/100,000 for the 0-1 year old group). 
W odd-wide, the overall financial cost of the identification and treatment of 
tuberculosis cases, together with the concomitant loss in productivity incurs costs 
in excess of $500 million annually (Collins, 1989). 
To place tuberculosis in some sort of perspective, malarial parasites cause infections 
in an estimated 150 million previously uninfected individuals each year. Malaria 
is an important cause of childhood mortality; indeed malaria kills over a million 
children each year in Africa alone and this number is increasing (Grange, 1989). 
Disease due to schistosomal infections has a prevalence of 200 million cases. 
However, schistosomiasis is a disease of low mortality. Also, the population at 
risk is much lower with malaria (1800 million) and schistosomiasis (600 million) 
and the impact of these infections is geographically more localized. With 
tuberculosis, the disease is not geographically confined and the population at 
risk (3000 million) is much higher (Samsarrica, 1982). 
Table 1 illustrates some of the demographic aspects of the morbidity and mortality of 
infectious diseases in developing countries. High birth rates, high infant mortality 
rates and dependency ratios, coupled with a low literacy rate, low per capita income, 
low productivity, a low life-expectancy and low food-to-population and physician-to-
population ratios are features of developing countries which contribute to the fact that 
infectious diseases in general and tuberculosis in particular are more prevalent in 
these regions. 
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Table 1. Comparison of some major demographic and economic characteristics of 
developing and developed countries. 
high (50-80/1000) live 
births 
low 
Phy~~~~tt9EP~P\iltl§rt low (1:10000-15000) 




low ( 45-65 years) 
low (10-18/1000) live 
births 




high (65-78 years) 
Source: Mausner J.S. and Kramer S. (1985). Table 10.2., Population dynamics and health In 
Epidemiology, an Introductory Text, 239-262. W.B. Saunders Company, Philadelphia, USA. 
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Probable factors that may influence the infection and development of disease in 
susceptible hosts by M. tuberculosis are portrayed in figure 1. These factors exist 







Risk Factors for Tuberculosis 
~-----(Distant from Outcome) ---1 .. 
Tissue Invasion 
and Reaction 
Mechanism of Tuberculosis 
(Proximal to Outcome)---t~ 
Figure 1. Factors in the development of tuberculosis . Source : Fletcher R.H. , Fletcher 
S.W. and Wagner E.H. (1982) . Figure 11.4., Cause In Clinical epidemiology-the essentials, 
185-202. Williams and Wilkins, Baltimore, Maryland, USA. 
( 
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1.3. Epidemiology, pathology and pathogenesis of tuberculosis. 
1.3 .1. Epidemiology of tuberculosis. 
Infection is primarily spread from cases of open pulmonary tuberculosis (Cruikshank, 
1969). Tuberculosis infection and disease are more likely among contacts of smear-
positive than smear-negative tuberculosis cases. Airborne spread from droplet 
nuclei is considered to be the major mode of transmission from person to 
person (Mausner and Kramer, 1985b). Spread via airborne droplets formed during 
coughing or sneezing is a function of droplet size. Heavier droplets do not 
remain airborne for long periods but are deposited on the nearest surface. In these 
cases tubercle bacilli might survive drying for some weeks if protected from 
the germicidal effects of direct/indirect sunlight. These might eventually infect 
susceptible hosts as a result of the inhaling of dust or fomites under overcrowded 
conditions (Cruikshank, 1969). Droplet nuclei might also be formed. These are 
small air-borne particles, 1-4µm in diameter, that are the remains of larger droplets 
which have evaporated. The viability of M tuberculosis within these droplets is 
dependant on the relative atmospheric humidity and temperature, and the size of the 
droplet nuclei. These droplets can remain airborne for hours, or even days, and can 
travel long distances. 
After inhalation, particles or droplets which are over 5 nncrons m diameter, are 
trapped and removed from the upper respiratory passages and do not reach the 
alveoli. With a decrease in particle size however, more particles are inhaled and 
reach the lungs. Approximately 50% are deposited in the lungs when their size 
reaches a diameter of 1-2µm (Mausner and Kramer, 1985b). 
1.3.2. Pathology and pathogenesis of pulmonary tuberculosis. 
Infection can be divided into primary and post-primary (secondary) stages. 
Primary infection can occur at any age but is more likely to be manifested as 
clinical disease during adolescence, young adulthood and in immunocompromised 
individuals. As has been stated, various factors preceding infection may influence 
the manifestation of clinical disease, for example, adverse social and 
constitutional factors. This applies to both primary and post-primary infections. 
Primary infection appears most commonly as a pulmonary infection. After 
gaining access to the alveoli, the bacteria are engulfed by the alveolar macrophages 
which are equipped with multiple microbiocidal mechanisms (McDonough et al., 
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1993). These include phagolysosome fusion and respiratory burst. In order to 
proliferate and to spread via the bloodstream, the bacillus must be able to elude these 
defense mechanisms. There is some evidence that virulent strains of M tuberculosis 
are able to escape from the fused phagolysosome into the surrounding cytoplasm or 
into non-fused vesicles. Virulence has also been correlated with the ability to multiply 
intracellularly in a variety of cell lines (McDonough et al., 1993). Thus, because 
tubercle bacilli produce no recognized toxins, the disease results from the 
establishment and proliferation of the bacillus in the host tissue. 
Host resistance and the hypersensitivity of the host greatly influences disease 
development (Jawetz et al., 1972). The primary tissue lesion or 'Ghon focus', 
which is usually found on the periphery of the lung, is an acute exudative lesion 
that spreads rapidly to the local lymph nodes. Macrophage induced granulomas 
form in both sites. Enlargement of the granulomas, although rare in primary lesions, 
might occur. These may eventually caseate and calcify. Early patterns of primary 
infection may be asymptomatic and can resolve completely. However, in a 
minority of cases, more generalised infection can follow. Wallgren (1948) stated that 
bacillaemia almost always occurs with primary infection, and that only with a 
high bacterial load does the infection become wide-spread via the blood or 
bronchi. Miliary tuberculosis can result, with spread particularly evident in the 
liver, lungs and meninges (Lucas, 1989). 
The term 'post-primary' refers to an infection occurring five or more years after 
a primary infection. Also known as 'adult' or 'secondary' infection, this is the 
most frequently occurring form of clinical tuberculosis in which, for example, 
one or more lung lesions progress to caseation and cavitation, with further 
spread of infection by way of the larynx and intestines. The infected person's 
sputum is the vehicle of transmission in these instances. Post-primary infection 
can be caused by reactivation of the dormant infections of a primary site 
(endogenous re-infection) or a challenge from a new (exogenous) infection 
(Cruikshank, 1969 and Jawetz, 1972). Primary pulmonary infections often manifest 
at the base of the lung whereas post-primary infections almost always occur at 
the lung's apex (Jawetz, 1972). Chronic tissue lesions with a productive tissue 
response and little regional lymph-node involvement is a feature of a secondary 
infection. While pulmonary infection is the most common manifestation of 
tuberculosis invasion and the only really contagious form, many other sites in 
the body can be affected. 
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As regards the histology of tuberculosis, the development and the production of lesions 
and their healing or progression are determined by the number of infecting tubercle 
bacilli in the inoculum and their subsequent multiplication. The resistance and 
hypersensitivity of the host are a determining factor as well. Two main lesions are 
found: (i) the exudative type, which consists of an inflammatory reaction with oedemal 
fluid, polymorphonuclear leukocytes and later monocytes congregating around the 
tubercle bacilli. This type is typically found in lung tissue. It may heal or become 
necrotic, or it may result in the second, 'productive' type of lesion. (ii) the second type 
of lesion, when fully developed, consists of three zones: a central area of large multi-
nucleated cells containing tubercle bacilli, a midzone area of epithelioid cells and an 
outer zone of fibroblasts, lymphocytes and monocytes. This may lead to the eventual 
development of peripheral fibrous tissue and the caseative necrosis discussed earlier. 
1.3.3. Pathology and pathogenesis of extra-pulmonary tuberculosis. 
The site of tuberculous infection is a function of a combination of factors which 
includes race, age, sex, portal of entry and also other pre-disposing factors such as 
alcoholism, peptic ulcers, immunosuppression, neoplasia, and cytotoxic chemotherapy. 
Clinical disease due to this form of tuberculosis might be localised to certain organs or 
areas of the body but can also manifest as a generalised infection. At times, extra-
pulmonary tuberculosis can even remain cryptic. Extra-pulmonary tuberculosis is 
essentially similar to the pulmonary condition with regard to histology and 
pathogenesis but the clinical features and management are somewhat different; with 
treatment often involving surgical intervention as well as the administration of anti-
tuberculous drugs (Grange, 1988e). Most cases can be traced to haematogenous 
dissemination from a primary pulmonary focus. 
It is noteworthy that, while rates of pulmonary tuberculosis in the developed world are 
decreasing, this decline is being offset by an increase in extra-pulmonary tuberculosis. 
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1.3.3.1. Disseminated tuberculosis. 
There are two main forms of disseminated tuberculosis: miliary tuberculosis and 
cryptic disseminated tuberculosis. The miliary form is usually a consequence of 
primary tuberculosis and, typically, the macroscopic picture is the generalised 
occurrence of discrete granulomas which look like millet seeds. The disease can 
advance rapidly but may take a chronic form. 
Cryptic disseminated tuberculosis usually occurs in elderly and immuno-suppressed 
individuals. In contrast to miliary tuberculosis, there is very little cellular infiltration; 
the typical picture being one of very small necrotic foci filled with acid-fast bacilli. 
Chest X-ray does not always show lesions and the tuberculin test is commonly 
negative. Patients usually show non-specific features such as fever and weight loss 
(Grange 1988e and Kennedy, 1989). Biopsy of the lung, liver or bone-marrow might 
be necessary for diagnosis. 
1.3.3.2. Localised extra-pulmonary tuberculosis. 
1.3.3.2.a. Lymph node infection. 
This is also known as scrofula or as TB lymphadenitis of the neck. The aetiology was 
firmly established by Villenin during his classical studies on the transmissibility of 
tuberculosis. Scrofula tends to occur more frequently in females of all ethnic groups. 
When, in past times, cow's milk was frequently contaminated with the bovine tubercle 
bacillus, lymphadenitis often resulted from a primary tonsillar lesion and the cervical 
glands were often involved. In regions where milk-borne tuberculosis is not common, 
cervical lymphadenitis is commonly due to the human tubercle bacillus and 
supraclavicular node infection is often involved (Grange, 1988e). Tuberculous 
lymphadenitis responds to standard chemotherapy. Relapses can occur more 
frequently than with pulmonary disease, therefore treatment is continued for longer 
periods. 
1.3.3.2.b. Bone and joint tuberculosis. 
Bone and joint tuberculosis is usually the result of haematogenous spread of the 
infection from primary foci situated elsewhere, commonly the lung. Bone and joint 
tuberculosis is one of the most important crippling diseases world-wide. The 
symptoms might mimic other conditions, especially arthritis (Grange, 1988e). 
Disseminated tuberculosis may present with accompanying multiple cysts. In 
comparison with other bone and joint sites, the spine is the most frequent site of 
infection, followed by the large joints of the lower limbs, and then the upper limbs. 
11 
Spinal lesions may cause severe deformities with serious complications for the patient. 
The diagnosis of spinal tuberculosis is not always easy as specimens are not easily 
obtained and the numbers of bacilli are extremely low. Chemotherapy is particularly 
helpful in treating this form of the disease. 
1.3.3.2.c. Tuberculous meningitis. 
This is a serious, although fairly rare condition which might occur in any age group 
and at any time after the initial infection. It is the result of the rupture of a meningeal 
or subcortical lesion. Tubercle bacilli can then enter freely into the cerebrospinal fluid. 
The clinical disease can present in three stages: where the patient is at first compos 
mentis, with little evidence of meningitis, followed by a mentally confused state, 
followed in turn by unconciousness. Typically, tuberculous meningitis profiles an 
increase in lymphocytes and protein and a decrease in glucose levels, although this 
clinical picture is not always evident. Definitive diagnosis is made by way of 
microscopic evidence of acid-fast bacilli in the centrifuged deposit of the cerebrospinal 
fluid (CSF) or by the culture of M tuberculosis. Computerised tomography is very 
helpful in diagnosis as characteristic tuberculomas usually occur in the brain and 
spinal cord ( Tandon and Bhargava, 1985). 
1.3.3.2.d. Urinary and male genital tracts. 
Renal lesions are as a result of haematogenous spread of the disease and can appear 
some years after the initial infection. The renal cortex is favoured and infection might 
progress from here into the medulla and the renal pelvis. Leakage into the urine might 
result in secondary spread to the ureters, bladder, epididymis and testis. Symptoms 
can be vague; in which case a delay in the diagnosis might result. Definite symptoms 
include dysuria, haematuria and renal colic. Treatment involves chemotherapy and in 
some cases, surgery (Gow and Barbos, 1984). 
1.3.3.2.e. The female genital tract. 
The female genital tract can also be infected although spread is nearly always directly 
from the blood. Sexual transmission is rare. The disease usually starts in the 
epithelium of the fallopian tubes and spreads to the endometrium. Infertility, pain in 
the pelvic area and excessive menstrual bleeding are common symptoms. The use of 
chemotherapy has reduced the need for surgical intervention (Sutherland 1981 ). 
12 
1.3.3.2.f. Abdominal tuberculosis. 
This form of the disease can be divided into intestinal and peritoneal tuberculosis. The 
intestinal form was prevalent in Europe when milk-borne bovine tuberculosis was 
common. Today it is still encountered even where milk-borne bovine infection has 
been eradicated. Lesions in the stomach and the small intestine can be due to the 
swallowing of the bacilli during post-primary pulmonary tuberculosis. Intestinal 
tuberculosis occurs most frequently in the ileocaecal region and results in mucosa! 
hypertrophy. Patients might present with problems such as intestinal obstruction, 
malabsorption and peritonitis. Tuberculous peritonitis is found in two main groups of 
people, namely young women and older alcoholic males. The prognosis is poor 
especially in older alcoholics, even with chemotherapeutic intervention (Grange, 
1988e). 
1.3.3.2.g. Cardio-vascular tuberculosis. 
Tuberculous infection of the cardio-vascular system is particularly relevant to this 
study for at least two reasons: (i) certain areas of South Africa have an uncommonly 
high rate of tuberculous pericarditis, for example the Transkei. One study revealed 
that 3 83 cases were diagnosed during a four year period in a total population of about 
3 million people (Girling et al., 1988). (ii) This thesis focuses on the evaluation of the 
De Wit PCR protocol which was designed to be used as an aid in the diagnosis of 
pericarditis associated with M. tuberculosis infection. 
Before the advent of anti-tuberculosis chemotherapy, tuberculous pericarditis was 
almost always fatal ; at present the mortality rate is still over 30%. The mode of 
infection of the pericardium is probably blood-borne or derives from the mediastinal 
lymph nodes and lung. In a study of cases from the Transkei, only a small proportion 
of patients show an accompanying active tuberculous lung infection. Clinical signs 
and symptoms are variable, and the progression of the disease unpredictable (Girling et 
al., 1988; Kennedy 1989). Positive identification of M tuberculosis can only be 
obtained by the culture of the organism from pericardia! fluid and membrane, or by the 
histological examination of pericardia! tissue. In one study, a biopsy at the time of 
diagnosis produced definitive tuberculous histological lesions in about 70% of cases. 
Culture of the organism in suspected tuberculous pericardia! fluids was positive in 
about 59% of the 189 cases tested in another study (Girling et al. , 1988). 
The culture and identification of M tuberculosis is a lengthy procedure. Compared to 
the numbers of bacilli found in florid cases of pulmonary tuberculosis, pericardia! fluid 
contains relatively few tubercle bacilli. Thus large amounts of pericardia! fluid have to 
be used for microscopy (Kennedy, 1989) and culture purposes. A laboratory test that 
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identifies cases of M tuberculosis pericardia! infections in a short time would be an 
advantage from the clinical and diagnostic point of view. 
1.4. AIDS and tuberculosis. 
Aids and tuberculosis are clearly associated (Nunn et al., 1988). This is evident in 
certain risk groups which include homosexuals and intravenous (IV) drug abusers. In 
the United States it is postulated that the increase in the number of reported cases of 
tuberculosis is because of the AIDS epidemic in that country (Nunn et al., 1988). Of 
the estimated four million people who were infected with both during 1992, 95% of 
these were in developing countries (Narain et al., 1992). In South Africa, because of 
the human immunodeficiency syndrome (HIV) epidemic, an upsurge in the number of 
cases of tuberculosis can be expected (Ktistner, 1993). 
After a primary infection with tuberculosis, tubercle bacilli can lodge in many organs 
as a result of haematogenous dissemination. These bacilli may lie dormant for decades 
before reactivating as post-primary tuberculosis. One factor known to be associated 
with reactivation is a state of immunosuppression, which can in turn be the result of 
HIV infection. AIDS patients are also susceptible to repeated infection with tubercle 
organisms from other patients because of their immunosuppressed state. TB diagnosis 
frequently precedes that of AIDS. As with other mycobacterial disease, tuberculosis 
may be a presenting feature of the predisposing disorder (Grange, 1988e; Sunderam et 
al., 1988). M tuberculosis bacilli recovered from HIV positive individuals should 
classify the person as suffering from AIDS (Collins, 1989). In addition, people who 
are infected with M tuberculosis and HIV develop overt tuberculosis more rapidly 
(Harries, 1990). 
Clinically, HIV-associated tuberculosis differs in certain respects from non-HIV 
associated tuberculosis with a number of studies commenting on the clinical features 
and management of tuberculosis in AIDS. For instance, there is a greater chance of 
tuberculosis being extra-pulmonary (Barnes et al., 1991 ), lymphatic or disseminated if 
associated with AIDS (Nunn et al., 1988). Pulmonary tuberculosis is less of a feature 
in AIDS related tuberculosis compared to those patients with tuberculosis alone: the 
figures are 30% as compared to 80%, respectively (Nunn et al., 1988). Hence bacilli 
can be cultured from many sites including the lymphatic system, blood and faeces . 
Pericardia! involvement also occurs frequently in AIDS-associated tuberculosis with 
the pericardia! fluid often containing large numbers of acid-fast bacilli (Nunn et al. , 
1988); as opposed to the small numbers associated with tuberculous pericarditis in an 
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HIV-negative individual. Central nervous system involvement with HIV infection has 
also been reported (Bishberg et al., 1986). 
The diagnosis of AIDS-associated tuberculosis poses problems. The results of sputum 
and tuberculin tests are often inconclusive. 
1.5. Immunity and hypersensitivity. 
Resistance to tuberculosis is acquired during the first infection. This means that the 
patient acquires an increased ability to localize the bacilli, preventing further spread 
and retarding their multiplication. 
This contrast between first infection and re-infection is shown experimentally in the 
'Koch phenomenon.' The guinea-pig, when inoculated subcutaneously with virulent 
tubercle bacilli, develops a rapid immune response at the site of inoculation. This 
heals quickly. This is followed later by an ulcerating nodule at this same site which 
does not appear to heal. Regional lymph glands are affected, developing 'tubercles' 
which caseate. If the same animal is inoculated at a different site some weeks after the 
initial inoculation, a different response is elicited. The inoculation site does not heal 
but ulcerates due to tissue necrosis. Following this, the site heals rapidly. Regional 
lymph nodes either do not become infected or become infected after a delay. This is 
known as the 'Koch phenomenon' (Jawetz, 1972). 
Likewise humans, after the first challenge by tubercle bacilli, acquire an increasing 
ability to resist haematogenous and lymphatic spread of infection, although spread 
from active pulmonary sites via the sputum seems to continue unhindered. The 
hypersensitivity reaction displayed by the guinea-pig on re-inoculation with tubercle 
bacilli at a site away from the first area of inoculation is the basis of the tuberculin test. 
This test becomes positive if a sensitized person is deliberately exposed to tuberculo-
protein. A positive test suggests that the person has experienced immunologically 
effective contact with a mycobacterial species. It then follows that the positive status 
could be due to active infection with M tuberculosis. It could, however, indicate a 
pastM tuberculosis infection or a past challenge with BCG vaccine which might elicit 
a positive tuberculin test 3-7 years after vaccination. A tuberculin test becomes 
positive 4-6 weeks after challenge with tubercle bacilli or BCG vaccine; hence it 
merely indicates past contact and not necessarily current infection. A negative result 
does not exclude tuberculosis. Under certain conditions 'anergy' may develop due to 
overwhelming tuberculosis or measles infection, Hodgkin's disease, sarcoidosis and 
15 
treatment with immuno-suppressive drugs. Under these circumstances the tuberculin 
test will remain negative (Jawetz, 1972). 
1.6. Control measures. 
The purpose of control measures is to prevent the spread of infection from person to 
person. Control measures involve the tracing of infected individuals, treating 
tuberculous patients with chemotherapy to render them uninfectious, the active and 
effective immunization of the susceptible non-infected population to raise immunity 
and lastly, the prophylactic treatment of high risk susceptibles with chemotherapy. 
Early diagnosis and effective treatment of the disease reduces the infection risk in the 
community more rapidly than an effective vaccination campaign (Sutherland, 1988). 
This is especially important in developing countries where infection rates are high and 
the disease is mainly progressive-primary, exogenous tuberculosis (Sutherland, 1988). 
Because pulmonary tuberculosis is clinically a difficult infection to detect unless the 
disease is advanced, tracing infected individuals involves both 'active' and 'passive' 
case-finding: 
(i) Active case-finding involves large-scale screening programmes of susceptible 
populations with procedures such as chest radiography and sputum microscopy. 
Chest radiography as a means of detecting smear-positive cases in accessible 
populations has proved disappointing (Sutherland, 1988). Active case-finding also 
involves seeking out contacts of known infectious cases of tuberculosis and treating 
these if this is indicated. This is important to the control of the disease. 
(ii) Passive case-finding relies on individuals with symptoms seeking professional 
help at a health clinic on their own initiative. 
Chemotherapeutic intervention in the treatment of infected individuals is effective as it 
reduces the period during which the patient is infected (Sutherland, 1988), but its 
success depends on patient compliance, the effectiveness of the treatment regimen, the 
number of infected people in a community that are detected and the interval between 
the onset of infectivity and the diagnosis. Control through herd immunity is dependent 
on the socio-economic status of the community and the efficacy of the 'Bacille 
Calmette-Guerin' (BCG) vaccination campaign (Grange, 1988d. 
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1. 7. Mycobacterial classification. 
The mycobacteria are Gram-positive, aerobic bacilli which appear to have evolved 
from genera which include Corynebacteria and Nocardia. They are non-sporulating 
and non-motile. The properties of members of the genus vary greatly, and this is 
evidenced by the range of virulence and antigenic properties found. Different 
rates of growth occur and there is a range of nutritional requirements. Unique 
qualities identifying members of this genus are found in its complex, lipid-rich 
cell walls (Grange, 1988a). 
The boundaries of the species within the genus Mycobacterium are well defined 
compared to other bacterial genera. Taxonomic divisions separate mycobacteria 
into rapid-growers, slow-growers, and those that remain as yet not cultured. 
Mycobacteria can also be classified into pathogens, those that frequently cause 
opportunistic infections, and those that rarely do so (Grange, 1988b ). Most 
mycobacterial species, according to their importance as human pathogens, are 
merely grouped into taxa or clusters of shared features while pathogens are 
exhaustively subjected to speciation, especially when these are suspected of being 
clinically implicated. Therefore, the major human pathogens are M tuberculosis 
· and Mycobacterium leprae while the remaining mycobacterial species are generally 
referred to as environmental mycobacteria or 'mycobacteria other than tuberculosis' 
(MOTTS). 
1. 7 .1. Classification according to biochemical characteristics. 
In the 'approved lists of bacterial names' 41 species of mycobacteria are listed, 
although some species have been omitted and some have been described subsequently. 
In addition, some of the listed species are considered to be variants of other species 
1. 7.1.1. The M tuberculosis group. 
This group includes M tuberculosis, Mycobacterium bovis, Mycobacterium 
africanum and Mycobacterium microti. The first two listed are the human and 
bovine types respectively while M africanum has properties common to both of 
these. All three have clinical significance for man. M microti is the vole tubercle 
bacillus (Reed, 1957). 
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The human tubercle bacillus is divided into two major types: Koch's 'classical' 
type, and the Asian type. Low virulence for the guinea pig separates the Asian 
type from its counterpart although both are virulent for and cause similar 
disease in man. Growth features separate the bovine from the human strain, 
while the African strain exhibits some growth characteristics of both. M microti 
is not naturally virulent for man and is in fact rarely found even as a pathogen 
of voles. BCG is the vaccine strain and was reputedly derived from M bovis 
(Sakula, 1983). BCG vaccines owe their origin to in vitro attenuation by Calmette 
and Guerin. The strains resulting from this attenuation have since been maintained by 
many different laboratories, using different methods. These strains, although 
marketed under the generic name 'BCG', are not bacteriologically identical (Smith, 
1988). Attenuated strains have been grown by using different methods, thus resulting 
in different strains, and the collective term 'BCG vaccines' (Smith, 1988). 
1.7.1.2. M /eprae. 
The other major pathogen besides members of the M tuberculosis group is the 
causative organism of leprosy, M leprae. This is non-cultivable except in live 
armadillos. No extensive animal reservoir exists and it seems to be an obligate 
pathogen of man only (Grange, 1988b). Taxonomic studies have not been able to 
relate it to any known cultivable mycobacterium. The diagnosis of leprosy is based 
on clinical manifestations and the demonstration of acid-fast bacilli in tissue. 
1.7.1.3 . Slow growing photochromogens. 
Mycobacterium kansasii, Mycobacterium marinum, Mycobacterium simiae and 
Mycobacterium asiaticum are all opportunistic human pathogens. M kansasii is one 
of the faster growing of the slow-growers ( substantial growth can be obtained from 
sub-culture on Lowenstein and Jensen slopes (L&J) in 14 days) and it is commonly 
implicated in opportunistic infections. It is rarely encountered in the natural 
environment but has been cultured on occasion from piped water supplies (Collins et 
al., 1984). M marinum, the cause of 'swimming pool' granuloma and 'fish-fancier's 
finger', was first isolated from diseased fish . Similar to M kansasii in growth features 
and colonial morphology, it is nevertheless distinguishable by its poor tolerance of 
higher temperatures (it grows poorly or not at all at 370C). M simiae was, as the name 
implies, originally isolated from monkeys, whereas M asiaticum, also isolated from 
monkeys, was later identified as a different species. The latter is a very rare cause of 
human lung disease. 
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1.7.1.4. Slow growing scotochromogens. 
Mycobacterium gordonae, Mycobacterium scrofulaceum, Mycobacterium szulgai 
and some strains of Mycobacterium avium are members of this group. These can 
sometimes cause disease in man (Grange, 1988b) 
1.7.1.5. Slow growing non-chromogens. 
This group includes the M avium and Mycobacterium intracellulare species which 
are among the most prevalent causes of opportunistic mycobacterial disease in 
immunocompromised patients. Their importance as causes of disease has therefore 
increased with the advent of AIDS. They are not readily subdivided into two distinct 
species by standard biochemical tests and are often reported as 'M avium-
intracel/u/are' (Grange, 1988b). Other members of this group cause disease in 
animals. For example Mycobacterium paratuberculosis causes hypertropic enteritis 
in cattle and less frequently in other ruminants. Mycobacterium haemophilum has 
been described as a human pathogen (Sompolinsky et al., 1978). 
1.7.1.6. Rapidly growing mycobacteria. 
There are 17 species in this group and they rarely cause disease in man, with the 
exception of Mycobacterium chelonei and Mycobacterium fortuitum which have 
been implicated as causative agents of disease (Grange, 1988c). 
1. 7 .2. Classification according to DNA hybridisation and restriction analysis. 
The extent of hybridisation between DNA fragments from different species or strains 
of mycobacteria shows the extent to which they are related. These studies have 
confirmed the species classification as shown by other methods. Restriction analysis 
of DNA and ribosomal RNA can even reveal differences between closely related 
strains. Sequence analysis of 16S RNA from mycobacteria have revealed areas of 
conservation and areas of variability. Polymerase chain reaction (PCR) based 
sequencing strategies were used by Rogall et al., (1990a,b) to demonstrate that rRNA 
sequences can be used for the rapid identification of mycobacterial isolates. 
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1.8. Laboratory diagnosis. 
1.8.1. Biological properties of M tuberculosis. 
1.8.1.1. Morphology and staining. 
The tubercle bacillus is a straight or slightly curved rod of 0.25-0.35µ in length. In 
tissue, the bacillus can appear singly, in pairs or even in small parallel bundles. M 
tuberculosis is non-motile, non-sporulating, non-capsulated and is resistant to drying. 
It is Gram-positive although it does not stain effectively with this stain. It has the 
ability, along with other mycobacterial species, nocardiae and some corynebacteria, to 
resist decolourisation after treatment with weak solutions of sulphuric and nitric acid 
and also after alcohol treatment; hence the term 'acid and 
alcohol fast' bacillus (AFB) (Cruickshank, 1972). 
1.8.1.2. Cultural characteristics and viability. 
M tuberculosis is an obligate aerobe and grows optimally at 35_37oc. Primary culture 
on L&J slopes with the addition of glycerol and sodium pyruvate is recommended 
although after repeated sub-culture the bacillus will grow in a simple salt solution with 
only glycerol and asparagine added. A feature of M tuberculosis in culture, and a 
decided disadvantage as regards a definitive diagnosis, is its slow growth. At 3 70c on 
L&J slopes, colonies appear after 2-3 weeks while a provisionally negative slope has 
to be incubated for up to 6-8 weeks to ensure that no growth has taken place. The 
colonial morphology on L&J slopes is characterised by rough, buff-yellow colonies 
that are difficult to break up ( eugonic growth). 
M tuberculosis is not heat resistant, and is usually inactivated at 600C within 15-20 
minutes. It will survive for many weeks in moist, darkened conditions. Bacilli can 
also survive for several days in sputum even though the sample might have dried. 
Tubercle bacilli exposed to sunlight, or even daylight are rapidly killed, although they 
are fairly resistant to chemical disinfection. Phenol (5%w/v) treatment of several 
hours is required to disinfect sputa. Glutaraldehyde and glutaraldehyde-phenate are 
effective in inactivating M tuberculosis but the concentration of these disinfectants, 
the time of exposure of M tuberculosis to these and the total organic load present in a 
sample are variables that can influence the efficacy of the disinfecting agent. 
(Cruickshank, 1972 and Best et al. , 1990). 
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1.8.1.3. Animal pathogenicity. 
Guinea-pigs, and to a lesser degree mice, are susceptible to experimental infection 
with M tuberculosis. Animal inoculation is, however, rarely used today to identify M 
tuberculosis. Monkeys, dogs and cats (Laidlaw, 1989), as well as cattle (Cruickshank, 
1969) may be infected naturally with the human strain of tuberculosis. 
1.8.2. Laboratory diagnosis. 
The clinical diagnosis of tuberculosis can be difficult. Patients are often placed on 
treatment without a conclusive diagnosis Laboratory diagnosis is definitive but can be 
a lengthy process (up to 11 weeks) if drug susceptibility testing of cultures is required 
(Laidlaw, 1989). Specimens for examination include sputa (pulmonary tuberculosis) 
cerebro-spinal fluid (meningitis), gastric aspirates, urine, stool, pus and tissues, as well 
as pleural and pericardia! fluids . 
1.8.2.1. Microscopy. 
Microscopic examination of a stained specimen for the presence of acid-fast bacilli is 
a valuable presumptive diagnostic tool. Although not a definitive test, it is an 
invaluable precursor of the later confirmation of disease, especially when used to 
indicate the presence of an 'open' or infectious case. This method is not specific for 
M tuberculosis as saprophytic acid-fast bacilli might be present in some specimens . 
Also important to remember is that a negative result does not exclude the presence of 
M tuberculosis. Some 10,000 bacilli/ml of sputum must be present to yield a 
positive result. This problem is compounded in specimens where the expected 
concentration of bacilli is far less. This is so with infected pleural and pericardia! 
fluids. Fluorescent microscopy, after staining the material with auramine dyes, can 
substitute for the Ziehl-Neelsen stain (Cruickshank, 1972 and Grange, 1988c). 
1.8.2.2. Culture. 
Because M. tuberculosis 1s slow-growing, specimens for culture are first 
decontaminated to prevent overgrowth by the less hardy and rapidly growing 
bacteria. Decontamination agents range from the use of the milder tri-sodium 
phosphate and benzalkonium chloride through to the harsher sodium hydroxide and 
oxalic acid. Selective antimicrobial agents can also be added to culture media to kill 
organisms other than mycobacteria. 
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Culture media include L&J medium. This contains egg, asparagine, glycerol and 
mineral salts. Malachite green is added for two reasons: to selectively inhibit 
overgrowth by non-mycobacterial bacteria and to provide a suitably coloured 
contrast during examination for mycobacterial growth. Other culture media 
available include Middlebrook-Dubos 7H9 broth, Sauton's medium and Kirchner's 
broth ( Grange, 1988c and Laidlaw, 1989). Inoculated culture media are usually 
incubated at between 35-370C under aerobic conditions. Growth is enhanced by the 
addition of 5-10% CO2 in air. Culture media are examined weekly for growth for up 
to 8 weeks. Although costly, radiometry (BACTEC®, ie., a commercially available 
radiometry system from Becton Dickenson) can be used to detect the release of 
radioactive carbon dioxide during mycobacterial metabolism. With this method, 
growth of mycobacteria may be detectable in 2 to 3 days (Grange, 1988c). Following 
successful culture, M. tuberculosis has to be distinguished from other mycobacteria 
using various culture and biochemical tests. Two distinguishing tests are: (i) the 
addition of theophen-2-carboxylic acid hydrazide to culture media which does not 
inhibit M. tuberculosis; (ii) the detection of niacin which is almost exclusively 
produced by the human tubercle bacillus among the mycobacteria. 
Culture identification, while definitive, is laborious and time-consuming and cannot 
have an immediate impact on the clinical options open to the physician. Bacterial 
cultures are required, however, for antibiotic sensitivity profiles (Grange 1988c and 
Laidlaw, 1989). In addition, the culture of clinical specimens is reputed to have a 
sensitivity of as low as 50% in the case of M tuberculosis (Daniel, 1990). 
1.8.2.3. Immunodiagnosis. 
Antimicrobial antibodies do not as yet appear to have any protective function. 
However, the humoral response to infection has been tested as an alternative to culture 
in the diagnosis of tuberculosis, especially as culture of the organism is not always a 
routine diagnostic procedure in developing countries where the prevalence of 
tuberculosis is high. Also, culture specimens from extra-pulmonary sites of the disease 
and sputum culture specimens from suspected cases of pulmonary tuberculosis in 
children are not easily obtained. 
As a result, much work has gone into developing a viable diagnostic alternative using 
serology rather than bacterial culture. Serodiagnosis does however, present certain 
problems. Most of the immune response is directed toward shared mycobacterial 
antigens The discrimination between levels of response in those patients with 
tuberculosis as compared to healthy individuals who have antibodies against 
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environmental mycobacteria is such that the interpretation of results is difficult. This 
lack of specificity has led to the search for species-specific serodiagnostic tests using 
antibodies to epitopes and not to whole antigens. An antibody competitive assay, 
using monoclonal antibodies, allows the measurement of antibody titres directed 
against single epitopes. A differential enzyme-linked immunosorbent assay (ELISA) 
using antigens from different mycobacterial species has also been tested. 
Overall, 'ELISA' serodiagnosis is most useful where the expected prevalence of 
tuberculosis is high. The specificity of the test increases with the use of purified 
species-specific antigens. As a rapid technique, it is also useful when presenting cases 
are extra-pulmonary as in tuberculous meningitis. Some authors feel that 'ELISA' 
serology has a value similar to that of a direct sputum smear (Daniel, 1990) although 
recent findings in Uganda suggest, however, that the 'ELISA' technique, while useful 
in a developing country as a quick low-cost testing system falls short in that patients 
infected with both AIDS and tuberculosis give tuberculosis antibody titres which 
collectively, and incorrectly, show a bias toward a low tuberculosis prevalence 
(Daniel, 1990). There is an urgent need for a test which is simple, sensitive, specific 
and reliable in the diagnosis of tuberculosis. While some aspects of tuberculous 
serology do show some promise, current serology does not give the required sensitivity 
and specificity needed to show that it improves upon and does not merely match the 
usefulness of other current tuberculous diagnostic techniques. 
A screening test based on the detection of anti-tuberculoidphospholipid antibodies is 
the kaolin agglutination test which is, according to a report by Sarnaik et al (1993), 
economical, rapid and useful in countries where the prevalence of tuberculosis is high. 
1.8.2.4. Tuberculostearic acid detection. 
This method which makes use of gas chromatography/mass spectrometry (Brooks et 
al., 1990), has also yielded mixed results. Tuberculostearic acid (Minnikin, 1982), a 
broken chain fatty acid common to the mycobacteria but not to other genera, has been 
found in the sputa of patients with pulmonary tuberculosis and in the CSF from 
patients with tuberculous meningitis. A degree of cross-reactivity with other 
mycobacteria and the appearance of false positive results following treatment with 
amikacin has been reported (Ivanyi et al., 1988.). Savic et al., (1992) found that the 
test for the detection of tuberculostearic acid in sputum samples was unsatisfactory due 
to its lack of sensitivity and specificity. Other authors disputed this conclusion based 
on their own work (Daniel, 1990); finding that TSA detection was probably the best 
approach in the rapid diagnosis of tuberculous meningitis. The main disadvantage of 
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the ISA detection was found to be the sophisticiated equipment necessary and the 
complexity involved in conducting the test. This automatically diminishes its 
usefulness as a diagnostic test in developing countries. 
1.8.2.5 . Nucleic acid probes. 
Several probes have been developed for the detection of M tuberculosis ( Pao et al., 
1988; Petersen et al., 1989; Hermans et al. , 1990 and Engelberg et al. , 1991). DNA or 
RNA hybridization tests with labelled specific probes are an additional method to 
detect the presence of M. tuberculosis, either directly from the clinical specimen or 
indirectly from culture isolates. With a detection limit of about 50pg of DNA being 
required for reliable identification, the sensitivity of probes used to detect M 
tuberculosis directly from clinical specimens has not been better that of a direct smear 
examination. The probing of cultures of clinical isolates rather than direct probing of 
clinical material has shown more promise as a test. 
1.8.3. Polymerase Chain Reaction. 
The use of the polymerase chain reaction as a diagnostic procedure represents a natural 
progression in the application of nucleic acid technology. PCR has provided the 
means to explore many areas of molecular biology without resorting to laborious 
cloning techniques. Some areas of application for this useful technique include the 
diagnosis of pathogenic and genetic disorders, the construction of genetic maps, 
forensic and agricultural applications, environmental monitoring and phylogenetic 
studies ( Erlich et al. , 1989 and Ramesar, 1992). 
Oligonucleotide primers, specific for a selected target DNA sequence at the correct 
annealing temperature, anneal to denatured target DNA and are extended using a heat-
stable DNA polymerase. The PCR cycle, made up of denaturing, annealing and 
extension 'steps', is repeated 30-35 times during which, theoretically, millions of 
copies of DNA sequences, identical to the original target sequences, are produced. 
Pathogenic organisms present in clinical material can thus be identified in a short 
period of time. This, in turn, is based entirely on the identification of selected DNA 
sequences unique to a particular organism. 
Numerous papers have been published concerning PCR protocols tested in the 
diagnosis of AIDS (Loche et al. , 1988), hepatitis B (Larzul et al., 1988), herpes 
(Rowley et al., 1990) and tuberculosis infections ( Brisson-Noel et al., 1989; De Wit 
et al., 1990; Sjobring et al., 1990; Shankar et al., 1990 and Pao et al. , 1990), to cite but 
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a few of the many. However salutary warnings regarding the use of PCR in its role as 
a detection system for pathogenic organisms are also appearing in the literature (Farrell 
and Tidy, 1989; Persing, 1991 and Steyn, 1993). Despite a period of 10 years since its 
inception as a technique, it is 'in fact an array of clinical problems, some created by the 
technique itself, that have prevented it from becoming a clinical laboratory bench 
procedure' (Persing, 1991 ). 
1.8.4. Conclusion. 
The specific aim of this thesis was to evaluate the practicability of using the 'De Wit 
PCR protocol' as an aid in the diagnosis of M tuberculosis in the clinical laboratory. 
More specifically, this entailed a comparison between the results obtained after both 
culture and PCR techniques were applied to pericardia! fluids taken from suspected 
cases of tuberculosis pericarditis. This was in order to establish whether the 'De Wit 
PCR' techniques had a useful role to play in the diagnosis of tuberculous infections in 
general and tuberculous pericarditis in particular. This was done according to the 
guidelines listed below: 
(i) A review of the 'De Wit PCR protocol' is given as it was applied by De Wit et al. , 
(1990) to clinical specimens (mainly pleural fluids) from suspected cases of 
tuberculosis. This is followed by the methods used and results obtained by myself on 
applying the 'De Wit PCR protocol' to pericardia! fluids from suspected cases of 
tuberculous pericarditis ( chapter 2) 
(ii) Chapter 3 examines the 'De Wit PCR protocol' as a DNA extraction and recovery 
method. This is followed by a literature review of M tuberculosis DNA isolation 
methods (chapter 4) and empirical attempts to use commercially available rapid DNA 
isolation methods in order to process pericardia! fluids ( chapter 5). Chapter 6 deals 
with empirical attempts to evaluate DNA isolation techniques. 
(iii) The limitations of certain thermocycler formats to provide reliable and accurate 
modes of operation for successful PCR is examined in chapter 7. Documentation of 
the results after testing is provided. 
(iv) Chapter 8 deals with attempts to introduce a sensitive nested amplification 
protocol in order to reduce the labour input and time expended between receipt of the 
specimen and assay result. 
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(v) Chapter 9 deals with the question of PCR inhibitors which might have influenced 
the PCR results given in this thesis. 
(vi) Chapter 10 studies the role played by DNA contamination in producing false 
positive results. Remedial actions to avoid or eliminate the contamination of clinical 
specimens with target DNA are given. 
(vii) The 'De Wit PCR protocol', because it is specific for M tuberculosis, plays a 
useful and reliable role in the identification of mycobacteria cultured from clinical 
specimens. This is discussed in chapter 11. 
(viii). Chapter 12 gives details of a modification carried out to a PCR reaction tube. 
Arising from an idea conceived of in the Department of Medical Microbiology, this 
modification has proved useful in allowing the addition of extra reagents during PCR 
without the need to open the tube, thus lessening the risks of contamination. 
(ix). The thesis is concluded with a general discussion. 
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PCR ON PERICARDIAL FLUIDS. 
2.1. Introduction. 
De Wit et al., (1990)developed a PCR assay for the amplification of a 336bp repetitive 
fragment present in the chromosome of M tuberculosis. The lack of sensitivity and 
specificity of the Ziehl Neelsen stain and the long culture period required to isolate the 
human tubercle bacillus provided the impetus in the search for more efficient methods 
of diagnosing tuberculosis. The traditional methods used to identify an M 
tuberculosis-related infection, together with their relative advantages and 
disadvantages, have been listed in section 1.8. of this thesis. Latterly, molecular 
biological techniques have been used to identify the presence of the human tubercle 
bacillus in clinical specimens. Various papers have been published listing different 
DNA sequences, present in the genome of M tuberculosis, which have been used as 
the target for amplification (Brisson-Noel et al., 1991; Cormican et al., 1992; Cousins 
et al., 1992; Clarridge et al., 1993; Folgueira et al., 1993 and Forbes and Hicks, 1993). 
However, most protocols are not able to distinguish members of the M tuberculosis 
complex. The assay developed by De Wit et al., (1990) on the other hand, is specific 
for M tuberculosis. 
In order to provide the necessary background for the work in this thesis, the PCR 
technique as described by De Wit et al., (1990) is summarised in section 2.2. This is 
followed by a description of the application of the 'De Wit PCR protocol' to pericardia! 
fluids and the results obtained from this pilot study. 
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2.2. Summary of PCR on Pleural fluids: De Wit et al, (1990). 
2.2.1. Materials and methods. 
(i) DNA extraction from mycobacterial strains. 
The DNA from various mycobacterial strains was isolated in order to test the 
specificity of the 'De Wit PCR protocol'. Strains of M tuberculosis (H37Rv), M 
avium, M fortuitum, M gordonae, M kansasii, M marinum and M scrofulaceum 
were cultured on L&J medium M bovis!BCG was cultured on Sauton's broth 
(Laidlaw, 1989). The cultures were harvested and the DNA was extracted using the 
'De Wit PCR protocol', namely, phenoVSDS and chloroform/isoamyl alcohol to lyse 
the bacilli and to separate the bacterial DNA from protein content. The DNA was 
precipitated using polyethylene glycol, washed twice with ethanol, dried in a 'Speed-
Vac' concentrator and rehydrated in sterile distilled water to a final concentration of 
0.1-0.3µg per µ1. 
(ii) DNA extraction from clinical specimens. 
Pleural fluids were obtained from patients with pleural effusions in the medical wards 
of Groote Schuur Hospital. These samples were sent for routine culture and were also 
made available for PCR testing. The pleural fluids were mixed with an equal volume 
(2mls) of 20% polyethylene glycol (PEG 6000; Sigma) in 2.5M NaCl for between 10 
and 30 minutes at 'room' temperature (20-25°C) and the precipitate dissolved in 500µ1 
of TES buffer (Velan, 1989) followed by a phenoVSDS, chloroform/isoamyl alcohol 
extraction. A second PEG precipitation was performed. The DNA was washed, dried 
in a concentrator, and rehydrated in 30µ1 of distilled water. Cerebrospinal fluids and 
pericardia! fluids were treated .in the same way as the pleural fluids. A lung biopsy 
sample was cut into small fragments before extraction with 10% SDS and buffered 
phenol. 
2.2.2. DNA amplification. 
A 336bp fragment in the M tuberculosis genome was the target for amplification. 
This sequence is part of a 5.5kbp Mbol, cloned DNA fragment (p36) from the 
organism which in previous experiments had hybridized to multiple bands of the 
restricted chromosomal DNA of M tuberculosis. The 336bp fragment was further 
characterised as part of a 375 bp Kpnl-Smal fragment contained in the original clone. 
Two 25mer oligonucleotide primers were synthesized by Beckman (SA); one 
hybridised adjacent to the Smal site and the other 39bp from the Kpnl site within the 
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target DNA (fig 2.1). These pnmers had the following sequences: 5'-
gcggctcgggcggcgtcggtggctt-3'; 5-gccagaaccgaccaacccgccgata-3 '. 
Mycobacterial chromosomal DNA (l0-14 to 10-1s gram) or DNA extracted from the 
clinical specimens was added (15µ1) to a PCR mixture (final volume 100µ1) which 
included 10% dimethyl sulphoxide and 1-2 µmol of each of the primers. The reaction 
mixtures were pre-heated at 950c before adding Taq polymerase. Thermal cycling 
(30-40 cycles) followed: 950c for 60 seconds and 700c for 2 minutes using a custom-
built thermal cycling machine. Amplification was followed by alcohol precipitation of 
the amplification products. After drying and rehydration, the products of amplification 
(20µ1) were separated by electrophoresis in a 3% agarose gel. Southern blotting 
(Sambrook et al., 1989) to a Hybond-N membrane (Amersham) was followed by 
hybridisation to a probe radio-labelled by nick-translation (Sambrook et al., 1989). 
This probe was obtained from the restriction profile when p36 was digested with KpnI 
and Smal. 
Tl l y - -
Figure 2.1. Restriction enzyme map of the KpnI-SmaI subclone of the Mtuberculosis 
recombinant, p36. The target DNA fragment for amplification by PCR is 336bp, and is flanked 
by KpnI-SmaI restriction sites. Symbols: 0, Aval; V, Kpnl; •. Smal; primer binding 
sites (De Wit et al, 1990). 
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2.2.3 . The results of amplification. 
(i) The detection of DNA from cultures of M tuberculosis. 
Upon hybridization, the amplified product of Ing of purified M tuberculosis DNA 
gave a 336bp fragment signal. This contained an Aval site as predicted by the 
restriction map (figure 2.1.) and also hybridized to the radiolabelled DNA probe, 
confirming that the amplified product was the target DNA fragment. Several bands 
were present after cycling protocols which specified a 550c annealing step. However, 
at an annealing temperature of 700c, the primers were specific for M tuberculosis 
among the mycobacterial species tested. Only M tuberculosis gave a 336bp fragment 
signal. Further, no other mycobacterial species tested gave an amplification signal of 
any size at this annealing temperature apart from BCG, which gave a 260bp fragment 
signal. The amplification product of chromosomal DNA (lpg) from the M 
tuberculosis culture could be detected by electrophoresing and staining the products of 
amplification in agarose gel while a PCR product of the amplification of 1 Ofg was 
detectable after hybridization and autoradiography. 
(ii) The detection of M tuberculosis DNA in clinical specimens. 
Of the 26 specimens cultured, 14 were positive for M tuberculosis. When the 
amplification protocol was applied to the same 26 specimens, the assay correctly 
identified all 14 culture positive specimens. Of the 26 examined, Ziehl N eelsen 
analysis correctly identified 3 of the 14 as positive. 
2.2.4. Conclusions. 
This preliminary study showed promise that the 'De Wit PCR protocol' could be used 
as an aid in the diagnosis of tuberculosis. Furthermore, the assay was specific for M 
tuberculosis. When chromosomal DNA from other members of the Mycobacteriaceae 
family were tested, the 336bp band was not synthesized. The BCG strain did produce 
a 260bp band which could be used to distinguish between these two members of the 
M tuberculosis complex. This distinction is not possible with DNA probes directed 
against the 16S ribosomal sequences of these organisms, or with the many other PCR 
assays for M tuberculosis described. With regard to tuberculous pleural effusions, it 
would appear that PCR of the pleural fluid has a detection limit for M tuberculosis 
that is greater than bacterial culture of the fluid alone. 
In view of the results obtained with this and a subsequent study (De Wit et al., 1992), 
it was decided to test this protocol in the detection of M tuberculosis from pericardia! 
fluids from cases of pericarditis. To this end, numbers of pericardial fluids were 
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collected from suspected cases of tuberculosis pericarditis. As part of a pilot study, 54 
of these were tested for the presence of M tuberculosis using traditional culture 
methods as the 'gold standard' assay, and the De Wit PCR protocol described above as 
the test assay. 
2.3. Isolation of DNA from pericardial fluids. 
Pericardial fluids were obtained from patients with suspected tuberculous pericarditis 
in the medical wards of Groote Schuur Hospital and from hospitals in the Transkei. 
This was in preparation for a large trial involving culture techniques for the isolation 
of M tuberculosis. A second aim of the trial was to test the efficacy of PCR 
techniques as regards the detection of M tuberculosis DNA in the fluids. Separate 
portions of the pericardia! fluids were (i), sent for routine microscopy and culture, and 
(ii), made available for the PCR assay. Upon receipt in the Medical Microbiology 
laboratory, pericardia! fluids were processed as follows: the presence of red blood cells 
or haemolysis was noted in view of the implication of blood products in the inhibition 
of PCR ( chapter 9). Pericardia! fluids that had a high red blood cell load were 
centrifuged briefly at 200xg for 4 minutes to remove most of the cells from the fluid. 
Thereafter, the clarified fluid was centrifuged at 2500xg for 25 minutes. The pellet 
and the pericardia! fluid directly above it (some 6 mis), were stored at -2ooc. As noted 
above, a portion (54) of the total number of pericardia! fluids were treated to isolate 
DNA for PCR. The remainder were stored pending the outcome of the pilot study. 
2.4. DNA extraction technique on pericardial fluids. 
Buffered phenol (2mls), made up according to the method of Maniatis (1982), and 
10% SDS (2mls) were added to 2mls of pericardia! fluid. The mixture was agitated for 
3hrs at 370c on a mechanical shaker to disrupt tubercle bacilli and to extract proteins 
and lipids. Following centrifugation (2000xg for 15 minutes), the aqueous supernatant 
fluids were further extracted with an equal volume of phenol/chlorofonn/isoamyl 
alcohol (25:24: 1/vol:vol:vol). This extraction was repeated at least once. The 
maximum volume of supernatant fluid recoverable ( approximately 2mls) was added to 
an equal volume of polyethylene glycol (20% PEG 6000 Sigma in 2.5M NaCl), mixed 
well, and allowed to stand for 20 minutes. The mixtures were aliquoted into 1.5ml 
microfuge tubes and centrifuged at 14000xg for 15 minutes (Eppendorf centrifuge 
model 5415C). The DNA pellets were washed 3 times with ethanol (70%v/v) and 
allowed to air-dry in an enclosed space to avoid exposure to air currents. The latter 
strategy was to reduce the possibility of DNA contamination. The dry pellet was 
dissolved in 40µ1 of pure water. 
2.5. DNA amplification, gel electrophoresis and hybridisation on pericardia) 
fluids. 
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The De Wit PCR protocol was used and thermocycling was at first conducted in a 
custom-built thermocycler used in the pleural effusion assays (section 2.2.2). This was 
later replaced by another local commercial machine, the JDI Temperature Profiler (JDI 
Instruments, Noordhoek, Cape Town). The latter was designed to accommodate the 
0.5ml tube and not the 1.5ml previously used. For this reason, the volume of the 
reaction mixtures was halved and only 1 Oµl of DNA extracted material was added. 
Cycling times and temperatures remained essentially the same. Following 
amplification, the products of amplification (20µ1) were separated by electrophoresis 
in a 3% agarose gel, stained with ethidium bromide and photographed by UV trans-
illumination. The gel was then Southern-blotted and subjected to hybridisation, using 
a 105bp 32p probe specific for M tuberculosis. This probe was obtained by restricting 
the M tuberculosis specific 336bp fragment (section 2.2.2), with Bani restriction 
enzyme (it is standard practice to use an internal fragment for probing). Radiolabelling 
was by nick translation in the presence of 32p, Autoradiography of the hybridisation 
products was for 2 to 72 hours. 
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2.6. Results of the PCR of the pericardial fluids. 
The initial specimen number of cultured fluids tested totalled 54. The PCR assay gave 
a total of 10 positives, while culture methods for M tuberculosis gave a total of 20 
positives. Table 2.1. provides explanatory definitions relevant to tables 2.2. and 2.3. 
which in turn summarise the pilot study data. 
Table 2.1. 
Source: Fletcher, R.H., Fletcher, S.W. and Wagner, E.H. (1982). Diagnostic test In Clinical 
Epidemiology- the essentials, 41-55. Williams and Williams, Baltimore, Maryland, USA. 
Table 2.2. presents a comparison of PCR and culture results of M tuberculosis from 
pericardia! fluids obtained from cases of tuberculous pericarditis. This is presented in a 






Table 2.3. The relationship between PCR (test assay) and culture (gold standard) for 
M tuberculosis in 54 pericardia! fluids from cases of suspected tuberculous 
pericarditis. 
Table 2.3 . 
= 5/20 = 25% 
= 34/54 = 63% 
A cursory examination of the results of the pilot study reveal that the PCR assay gives 
fewer positive results when compared to the 'gold standard' test of the culture of the 
organism. In a number of other reports on TB PCR, the sensitivity of PCR exceeded 
that of culture (Brisson-Noel et al., 1991; Manjunath et al. , 1991). Other investigators 
report sensitivities which compare less favorably with culture, for example, Sjobring et 
al., 1990 and Pierre et al., 1991. The probable reasons for the findings of the pilot 
study as well as attempts to address the situation will be discussed in the ensuing 
chapters. 
CHAPTER 3. 
DNA ISOLATION METHODS: the 'De Wit PCR Protocol'. 
3.1. Introduction. 
3.2. Examination of certain aspects of the DNA isolation method used in the 
'De Wit PCR protocol'. 
3.3. DNA recovery techniques and the 'De Wit PCR protocol'; a comparison. 
3. 3 .1. Introduction. 
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DNA ISOLATION METHODS: The 'De Wit PCR protocol'. 
3.1. Introduction. 
DNA isolation involves the lysis of the bacterial cells and the separation ( extraction) of 
DNA from other cellular material. For successful diagnostic PCR, certain 
requirements with regard to DNA recovery have to be met. For example, the 
mechanical rupture (Folgueira et al., 1993) as well as the loss of DNA during the 
procedure must be minimised, so as to aid in the maximisation of the amplification of 
the target sequence. Furthermore, the final product of recovery must be free of all 
PCR inhibitors. In diagnostic PCR there is no universal DNA recovery procedure; the 
choice of method is dependent on the specimen and on the nature and the numbers of 
the target organism present in the specimen. Table 3 .1. lists factors to be considered in 
the selection of a DNA recovery procedure. 
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Table 3.1. Factors to be considered in the selection of a DNA recovery procedure. 
3.2. Examination of certain aspects of the DNA isolation method used in the 'De 
Wit PCR protocol'. 
With the 'De Wit PCR protocol' (Chapter 2), phenol/SDS and PEG are used in the 
recovery of M tuberculosis DNA from pleural and pericardia! fluids . Several 
'cleaning' steps are needed to free the final extraction product of phenol, SDS, PEG 
and denatured protein; all of which can inhibit PCR. The result of the cleaning 
process is that extraction material is progressively transferred through succeeding 
tubes with an accumulating loss of DNA. Specimens of pericardia! fluid taken from 
cases of tuberculous pericarditis do not usually contain great numbers of M 
tuberculosis bacilli (Kennedy, 1989) and since a positive PCR assay is based on the 
amplification of DNA from infecting organisms, the sensitivity of the test will be 
compromised if the loss of target DNA is too great. 
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To illustrate the number of manipulations required during this protocol, the extraction 
procedure as applied to 1ml of pericardia! fluid is used as an example (table 3.2). 
Table 3.2. 
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* The number of tubes used depends on the volume of pericardia! fluid processed 
initially. 
During the ethanol wash (table 3.2, stage v), the DNA pellets are pooled and the tubes 
used in the previous step are washed out twice with ethanol (70% v/v) in order to 
harvest all DNA precipitate which might have collected on the sides of the tube during 
centrifugation. However, the ethanol washing procedure needs fairly vigorous 
manipulation with a plastic pipette and one result is that aerosolisation can occur, with 
the risk of cross-contaminating specimens. 
With the completion of the recovery procedure, the DNA material has, in this example, 
passed through 15 tubes. The processing of larger sample volumes would mean an 
increase in the total number of tubes used. 
Because the extracted material passes through a number of transfer tubes during this 
protocol, an experiment was conducted to establish how much DNA is recovered 
during this and other DNA recovery procedures, compared to a control sample (section 
3.3). 
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3.3. DNA recovery techniques and the 'De Wit PCR protocol'; a comparison. 
3.3.1. Introduction. 
Freeze-dried M bovis/BCG (as vaccine material) was used as an extraction source to 
compare the efficiencies of different DNA recovery methods. It had been established 
before-hand that DNA from lyophilysed M bovis/BCG was readily recoverable 
because of the nature of the vaccine material. During vaccine production, M 
bovis/BCG pellicle grown cells are processed by grinding and freeze-drying 
procedures. These methods result in the break-up of individual bacteria. Upon 
rehydration, mild lysing procedures were therefore adequate to recover enough DNA 
for the purposes of this experiment (figure 3.1. lanes 1 and 2 respectively). 
Aliquots (0.5ml) of rehydrated M bovis/BCG were subjected to four extraction 
protocols (including the 'De Wit PCR Protocol') in order to provide a comparative 
profile of the amounts and quality of the DNA recovered. A fifth aliquot, which was 
subjected to rehydration and centrifugation, followed by the precipitation of free DNA, 
was used as the control specimen. Analysis was by electrophoresis in agarose gels. 
The DNA was stained with ethidium bromide and photographed with UV trans-
illumination. Visual examination was used to gauge the amounts and quality of the 
DNA remaining after recovery procedures had been completed. 
3.3.2. Recovery methods. 
Five vials of freeze-dried M bovis/BCG were re-hydrated, each with 0.5ml ultra-pure 
water, and pooled. After thorough mixing, five aliquots were taken from the pool and 
each was subjected to a different DNA recovery method, namely: 
(i) An aliquot was centrifuged at 14,000g for 3 minutes. The supernatant fluid was 
removed. Lithium chloride solution (4M, 1/10,v/v) followed by isopropanol (6/10,v/v) 
was added to the mixture. After centrifugation at 14000xg for ten minutes, the pellet 
was washed with ethanol (70%,v/v) and allowed to air-dry overnight before 
rehydrating with 100µ1 of pure water. This 'unextracted' aliquot served as the control 
sample. 
(ii) A second aliquot was boiled and frozen alternately (5x) and further treated as in 
(i). 
(iii) The DNA isolation method used in the 'De Wit PCR' protocol was used to 
extract DNA from this aliquot. Lithium chloride/isopropanol substituted for sodium 
acetate/ethanol in the precipitation of DNA. The pellet was washed, dried and 
rehydrated as in (i). 
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(iv) Using the method based on that of Thieny et al., (1990), the suspension was 
heated in a solution of O. lN NaOH/SDS (0.5%w/v) at 950c for 15 minutes. After 
centrifugation at 10,000xg for 3 minutes, the supernatant fluid was mixed with an 
equal quantity of phenol/chloroform to remove the remaining impurities. Lithium 
chloride/ isopropanol precipitation (i above) was followed by ethanol (70%, v/v) 
washing. The pellet was dried and rehydrated as in (i). 
(v) The fifth aliquot was incubated at 370c for one hour in a solution of SDS 
(0.5%,w/v) and proteinase K (lOOµg/ml) . Cell debris, polysaccharides and the 
remaining proteins were removed by precipitation with cetyltrimethyl-ammonium 
bromide (CT AB) This was followed by extraction with chloroform/isoamyl alcohol 
(24: 1) (Sjobring et al., 1990).. Lithium chloride/isopropanol (i above) was used to 
precipitate the DNA. The pellet was washed, dried and rehydrated as in (i). 
The results of the extraction procedures are shown in figure 3 .1. 
3.3.3. Results and discussion. 
The amount of DNA recovered by each recovery method was determined by 
comparing the results of each with the amount obtained by the rehydration/ 
precipitation treatment of the 'unextracted' control (lane 1 ). 
(i) The boiling and freezing method (lane 2) presented comparable quantities of high 
molecular weight DNA compared to the control lane. 
(iii) The 'De Wit PCR protocol' method (lane 4) yielded high molecular weight but 
little low molecular weight DNA compared to the control. Overall, despite a 
substantial DNA loss compared to the result in lane 1, the quality of the extracted 
product was good (that is: the DNA was unsheared). 
(iv) The sodium hydroxide method (lane 6): it was apparent that considerable 
amounts of DNA were lost during this recovery method after comparing the results 
with the control lane. 
(iv) The 'CTAB' method (lane 7) the yield of low molecular weight (sheared DNA) 
was comparable to that of the control specimen. However, considerably less high 
molecular weight DNA was evident in this lane. 
These extractions were repeated to confirm the results. 
While M bovis/BCG material was used as a substitute source of recoverable DNA (in 
the place of an M tuberculosis source of DNA), the object of the experiment was to 
show how much DNA was lost to attrition during the recovery methods used. For this 
reason, any easily extractable DNA source would have been suitable. 
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A high recovery rate of high molecular weight DNA of sufficient purity is an important 
characteristic of a good extraction method (Wilson, 1987). Not unexpectedly, the 
greatest amount of DNA (both high and low molecular weight) recovered was from the 
control (section 3.3.2.i.) as the M bovis/BCG DNA was easily extracted for reasons 
mentioned in section 3 .3 .1 and little manipulation of the specimen was needed. 
Although the method of DNA quantitation (visual) is crude, all recovery methods 
showed varying degrees of DNA loss compared to the control. However, methods 
which were most successful in the recovery of DNA in the above experiment, might 
fail to extract adequate amounts of amplifiable DNA from a clinical specimen 
containing an organism from which DNA is difficult to extract (for example M 
tuberculosis from pericardia! fluids) . The experiment shown in this section however, 
does provide valuable information on the amount of DNA lost where the source DNA 
is readily available to extraction and isolation. 
Because of the expected low count of infecting orgamsms from tuberculous 
pericarditis cases (Kennedy, 1989), a sine qua non of DNA extraction involving these 
specimens is that, apart from other factors such as PCR inhibitors ( chapter 9), the loss 
of DNA during the procedure should be kept to a minimum if amplification of target 
DNA is to be maximized. Ideally, this implies the use of an isolation technique which 
requires few manipulations of the clinical specimen. 
Alternative methods of M tuberculosis DNA isolation that were assessed will be dealt 
with in the following three chapters. 
42 
Lane 1 2 3 4 5 6 7 8 
Figure 3.1. A comparison of the efficiency of DNA recovery by four different procedures on 
freeze-dried M bovis/BCG cells. 
Lane 1, 'untreated' control aliquot; lane 2, 'boiled' aliquot; lane 4, 'De Wit PCR protocol' 
treated aliquot; lane 6, a 'sodium hydroxide' treated aliquot; lane 7, 'CT AB' treated aliquot; 
lane 8, molecular weight marker; lanes 3 and 5, no sample added. 
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4.4. Multi-step methods for the recovery of M. tuberculosis DNA from clinical 
specimens: a review of chemical agents used and their mode of action. 
CHAPTER 4. 
M. tuberculosis DNA RECOVERY METHODS: 
a review of methods and chemical agents. 
4 1. Introduction. 
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This chapter is composed of two sections. The first is a review of direct methods used 
in the isolation of DNA from M tuberculosis cell suspensions and bacterial cultures. 
By definition these methods require little manipulation of the specimen and minimal 
use is made of chemical agents. This is followed by a review and mode of action of 
chemical agents found in the variety of multi-step or indirect methods which have been 
used in the isolation of M tuberculosis DNA from clinical specimens. 
4.2. Direct methods of DNA isolation from M. tuberculosis. 
Mycobacteria are resistant to lysis (Patel et al., 1990). The extraction of DNA from 
M tuberculosis is complicated by the physical and chemical make-up of the cell 
envelope surrounding the organism. Not only is this waxy envelope thicker than in 
other bacteria (Wilson et al., 1993) but it also has a high lipid content (Prescott et al., 
1990b ); a property which makes it hydrophobic. These features of the external barrier 
and the tendency of the organism to clump in growth provide for the relative resistance 
of M tuberculosis to the effects of less stringent cell lysis techniques. Because of 
these characteristics and the nature of the clinical specimens in which the organism 
can be found, DNA isolation procedures are often elaborate and require the use of 
corrosive chemical agents. Nevertheless, direct isolation procedures have been used 
for recovery purposes where maximum yields of DNA are not required. 
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4.2.1. Direct methods to isolate DNA from M tuberculosis. 
4.2.1.a. Freeze/thaw method 
Fries et al., (1991) reported that a PCR procedure was used specifically for the 
identification of mycobacteria. The organisms tested were taken from liquid cultures, 
frozen cultures of mycobacteria and from colonies grown on L&J slopes. PCR was 
done directly on a washed aliquots of the specimen. Reaction products were detected 
by analysis with electrophoresis followed, where necessary, by specific hybridization 
to increase specificity. Patel et al., (1990) also reported the successful PCR of M 
tuberculosis sequences, using thawed, but otherwise untreated specimens of TB 
cultures 
4.2.1.b. Other simplified methods. 
Buck et al., (1992) investigated several simplified methods for the treatment of M 
tuberculosis cell suspensions in order to release mycobacterial DNA for PCR. The 
extraction techniques involved the following: 
(i) Treatment with proteinase K and non-ionic detergents. 
(ii) Boiling in non-ionic detergents. 
(iii) Freezing/thawing in pure water or 2% Triton X in PCR buffer. 
(iv) Sonication and boiling. 
The suspensions were subjected to the above extraction methods ( one aliquot from 
each suspension per method), all subsequent extracts were subjected to a PCR protocol 
described by Eisenach et al., (1990 and 1991) and the reaction products were detected 
by separation in 12% polyacrylamide gels photographed under UV illumination. This 
data is summarised in table 4.1 (Buck et al., 1992). 
Table 4.1. 
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One clear message from table 4.1. is that the efficiency of DNA amplification from M 
tuberculosis in a non-biological fluid suspension is a function of the extraction method 
used. These results do confirm that simplified cell-lysis techniques can be used in 
protocols for the isolation of M tuberculosis DNA. However, aside from the 
sonication and boiling technique, the lowest number of organisms that could be 
detected after using these methods was approximately 1000. There are other reports 
that suggest that boiling on its own as a method of lysing cells to release DNA was 
shown to be less effective (Forbes et al., 1993). Nevertheless, this technique is a 
useful means of lysing mycobacterial cells for certain purposes. In the department of 
Medical Microbiology UCT, PCR identification of mycobacterial cultures is done on 
cell suspensions which have been boiled to lyse mycobacterial cells. Using this 
method, enough DNA from M tuberculosis cultures is released for identification by 
PCR (chapter 11). Cousins et al., (1992) also report the use of PCR to identify 
mycobacterial cultures using PCR. However, we have found that despite testing 
suspensions with a moderate bacterial load ( approximately 1 colony per ml of TE), 
there are occasions when niacin-producing culture specimens give a negative PCR 
result using the electrophoresis detection method (section 11.3). This phenomenon is 
probably due to insufficient bacterial lysis and therefore the inadequate release of 
DNA by the boiling method, although other factors such as inhibition of PCR and the 
sensitivity of the amplification protocol might also play a role. 
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4.3. Microwave treatment. 
Background. 
The advantage of this method is its simplicity. It has been used to extract HBV DNA 
from serum aliquots (Cheyrou et al., 1991 and Yi Kun Lou et al., 1993), where serum 
(10µ1 quantities) was distributed in 0.5ml PCR tubes. In the Cheyrou et al., (1991) 
study, tubes were closed and arranged radially on the rotating dish of a 850 watt 
microwave oven. The aliquots were subjected to radiation at maximum power until the 
serum water content had boiled off (about two to four minutes was required). After 
centrifugation of the tubes for 20 seconds at 14000xg, the supernatant condensates 
were collected and subjected to PCR. The results in this study indicated an improved 
PCR sensitivity after microwave treatment. 
Evaluation. 
The pericardia! fluid 'micro-wave' protocol was as follows: pericardia! fluid was 
centrifuged ( 6000xg for 20 minutes) and the deposit resuspended in normal saline. A 
volume was removed for 'microwaving' before PCR. However, the amounts 
'microwaved' in the Cherou et al., (1991) protocol were 10µ1 volumes. Because of this 
limitation, it was intended to apply the method to volumes of pericardia! fluid no larger 
than 50-100µ1. 
For safety reasons, the initial tests were frrst conducted on 50µ1 aliquots of M bovis 
BCG suspension. The 'microwave' boiling of the BCG suspension proved difficult to 
achieve, even after 10 minutes of microwave exposure. A subsequent and frequent 
problem was that a proportion of the tubes used (20% initially; after 10 minutes, 50%) 
ruptured explosively during microwave treatment, spraying the BCG contents over the 
inner surface of the oven. 
No further testing of this method took place because of the associated hazards. 
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4.4. Multi-step methods for the recovery of M. tuberculosis DNA from clinical 
specimens: a review of chemical agents used and their mode of action. 
4.4.1. Introduction. 
Rather than review the many multi-step methods used in the extraction of M. 
tuberculosis DNA from clinical specimens, a review of some of the chemical agents 
which are common to several of these methods and the mode of action of these agents 
follows. Also given are references to methods where these agents are used. 
4.4.2. NaOH. 
Although M tuberculosis is resistant to chemical agents because of its hydrophobic 
nature and its tendency to clump in growth (Jawetz et al., 1972), this resistance is 
relative. Treatment with acids and alkalis has been used effectively to lyse 
mycobacterial cells. Thus a NaOH treatment step forms part of the procedure in many 
isolation protocols (Pierre et al., 1991; Buck et al., 1992 and Walker et al., 1992), 
often in conjunction with the use Qf Proteinase K, lysozyme and phenol/SOS and a 
boiling step. 
4.4.3. Phenolic compounds/SOS. 
The release of DNA from M tuberculosis is facilitated by the use of phenol. Phenol, 
equilibrated with a buffer to pH >7.8 (0.5M Tris Cl pH 8.0) and used in conjunction 
with chloroform, is effective in denaturing proteins, disrupting cell membranes 
(Prescott, 1990a) and probably in dissolving denatured protein (Treco, 1989). 
Phenolics as a group are tuberculocidal and are effective in the presence of organic 
matter. Thus, phenol has been used to isolate M tuberculosis DNA from diverse 
clinical specimens; namely blood, CSF, pus, sputa and other body fluids as well as 
from histological specimens (Hermans et al., 1990; De Wit et al., 1990; Brisson-Noel 
et al., 1991 and Manjunath et al., 1991). Another advantage of the use of phenol is the 
relative purity of the extracted product; a feature which helps to optimize 
amplification. Disadvantages include the highly corrosive nature of phenol and the 
safety precautions required with its use and disposal (Maniatis et al., 1982). In 
addition, methods which include phenol are often labour intensive. 
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SDS, frequently used in conjunction with phenol (Sjobring et al., 1990), is an anionic 
detergent which disrupts non-covalent bonds in native protein (Stryer, 1988a) and thus 
aids in cell lysis. Like phenol it is a potent inhibitor of PCR and must be removed 
from the products of DNA extraction. 
4.4.4. CT AB /Chlorofonn/isoamyl-alcohol solution. 
CTAB is used in protocols (Sjobring et al., 1990) for the preparation of genomic DNA. 
This is because it complexes with the polysaccharides and residual proteins remaining 
after preliminary extraction treatment of the specimen with a protease. Both kinds of 
contaminating molecules can then ·be effectively removed by subsequent emulsification 
and extraction with chloroform and iso-amyl alcohol. Chloroform also denatures 
protein and provides a clear boundary between the organic and aqueous phases after 
treatment with phenol. Iso-amyl alcohol prevents foaming of the extract solution and 
aids in the separation of the phases and the removal of protein at the interface between 
the phases (Treco, 1989). 
4.4.5. Proteinase K. 
This enzyme is used to cleave native proteins and has the advantage of being active in 
the presence of SDS (Boehringer Mannheim Catalogue, 1994). It is commonly used to 
digest proteins after the initial denaturation step with NaOH has taken place. After 
protein digestion is complete, a boiling step is required to denature Proteinase K. 
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CHAPTER 5. 
RAPID DNA RECOVERY METHODS. 
Attempts to adapt commercially available protocols for the isolation 








RAPID DNA RECOVERY METHODS. 
Attempts to adapt commercially available protocols for the isolation 
of M. tuberculosis DNA from pericardial fluids. 
5.1. Introduction. 
Protocols discussed in this chapter are commercially available and have been used for 
the rapid recovery of DNA in solution. As M tuberculosis is resistant to lysis, the 
pericardia! fluids tested by these methods had to be boiled beforehand to release cell-
bound DNA and to denature the protein component. This was followed by a simple 
centrifugation step to separate the denatured protein from the de-proteinised aqueous 
component. Following on this, the commercially available kits were used to attempt to 
recover DNA from the aqueous component of the treated pericardia! fluid. 
With all of the methods discussed, the background to each protocol is given first ( 5 .2. ), 
and this is followed by the respective methods where applicable (5.3). The next 
section gives the results obtained with regard to the recovery of DNA from pericardia! 
fluids (5.4) and the chapter ends with the conclusion (5.5). 
5.2. Background. 
5 .2.1. 'Fast Magnetic Particle'. 
The FMP technique was developed to provide a rapid method of separating single 
stranded DNA from M13 recombinants (package insert: Fast Magnetic Purification for 
M13 single-stranded DNA minipreps; RPN 1690, Amersham; appendix 4). DNA in 
solution is first precipitated. Small, superparamagnetic particles are used as a solid 
phase around which the precipitate can form. A magnetic field is used to attract the 
particles, which take the precipitate with them. This permits easy removal of the 
solution fluid together with impurities. With the removal of the magnetic field, the 
particles redisperse, allowing the precipitate to be recovered in a suitable solvent. 
5.2.2. 'Isogene'. 
Based on the principles of Vogelstein and Gillespie (1979: IsoGene Kit: L228-0440, 
Perkin Elmer Cetus; appendix 4), DNA is extracted from the specimen onto a finely 
particulate binder in the presence of sodium iodide. Solubilization of protein is 
favoured under these conditions thereby facilitating the isolation of DNA from cell 
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lysates. The binder is reputed to have a high affinity for DNA. Overall, its binding 
capacity is greater than binders of the 'glass milk' variety ((package insert 
GENECLEAN II: GLASSMILK' is the registered trade name for a silica matrix 
product obtainable from BIO 101 Inc. that binds DNA without binding contaminants.). 
Bound DNA is separated from enzyme inhibiting impurities and from phenol and other 
organic solvents and is recovered by elution in distilled water. 
5.2.3. 'EnZap'. 
A simple alternative to the DNA capture protocols is the use of a capture filter with a 
resin component. This resin has a high affinity for proteins in solution while allowing 
the free passage of nucleic acids. After the addition of a specimen sample to a resin-
containing tube-like insert, the latter is fitted into a 1.5ml centrifuge tube. The system 
is subjected to centrifugation, allowing the free passage of nucleic acids which can 
then be recovered in the centrifugate tube by means of precipitation. The 'EnZap' 
(package insert: Enzap, Bio Ventures Inc.; appendix 4)) method is used for the recovery 
of nucleic acid from solution after the application of techniques such as restriction 
digests, ligation sequencing and amplification. The 'EnZap' system is reputed to 
capture 98% of proteins while allowing the recovery of greater than 90% of the 
available DNA from a solution. The procedure is also simple and can be rapidly 
executed. 
5.3. Methods. 
5.3.1. 'Fast Magnetic Particle'. 
It was decided to test this method on the supernatant from boiled ( therefore largely de-
proteinised) pericardia! fluid. The method is given in appendix 4. 
5.3.2. 'Isogene'. 
This method is usually used for the recovery of DNA from agarose gels, PCR post-
amplification mixes and from mixtures following the completion of techniques such as 
nick-translation and end-labelling. The method can be found in the package insert 
(appendix 4). Briefly, three (M tuberculosis) culture positive and one culture 
negative pericardia! fluids were boiled, centrifuged and 500µ1 of the supernatant fluid 
subjected to the IsoGene protocol. The eluted fraction was subjected to the sensitive 




This method was tested on pericardia! fluids ( after boiling treatment and 
centrifugation) which were culture positive for M tuberculosis (see chapter 6 for a 
detailed evaluation). The assay method consisted of PCR, followed by Southern 
blotting and hybridisation with a radio-labelled (32p) probe. The results were analysed 
by autoradiography. 
5.4. Results and Discussion. 
5.4.1. 'Fast Magnetic Particle'. 
A problem encountered was that trace amounts of protein remaining caused adhesion 
between the DNA-attracting 'FMP' particles. The combined surface area of the 
attracting particles was thus reduced, compromising DNA-capture ability. The results 
of PCR on M tuberculosis culture positive pericardia! fluids using this method (results 
not shown, but all were negative ) indicated that the technique had a poor capacity to 
extract the necessary DNA from pericardia! fluids. 
5.4.2. 'IsoGene'. 
The positive controls ( 45fg-45pg M tuberculosis DNA) registered positive. All three 
culture positive tests gave a negative result (not shown) using the IsoGene DNA 
isolation method. 
5.4.3. 'Enzap'. 
Of the four culture fluids assayed, only two tested positive (figure 6.3). The PCR 
sensitivity of this DNA recovery method when tested under these specific conditions 
was less than satisfactory ( chapter 6). 
5.5. Conclusion. 
While commercially available methods for the isolation of DNA from solutions have 
the advantage of allowing rapid processing yet simultaneously requiring few 
manipulations, they were unsuitable for recovering DNA from pericardia! fluid mainly 
because of the problem of residual protein content ( after boiling) and because the 
volume processing capacity per unit was small (equal to/less than 500µ1). 
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CHAPTER 6. 
DNA RECOVERY METHODS. 
An empirical assessment of the recovery of DNA from non-biological 
and biological fluids. 
6.1. Introduction. 
6.2. Methods. 




DNA RECOVERY METHODS. 
An empirical assessment of the recovery of DNA from non-biological 
and biological fluids. 
6.1. Introduction. 
This chapter further discusses recovery methods. All involve the empirical testing of 
methods reviewed in previous chapters. Firstly, attempts (by electrophoresis) are 
recorded to recover DNA from pericardia! fluids using the heating method discussed in 
chapter 4. The results of this method provide for an indication of the amount of DNA 
recovered. This is followed by the method and assessment of the PCR results 
obtained following the use of combinations of DNA recovery methods and 
amplification protocols on dilutions of M tuberculosis DNA in TE buffer. PCR was 
further tested on the DNA extraction products of M tuberculosis culture positive 
pericardia! fluids using a rapid DNA recovery method discussed in chapter 5 namely, 
the 'Enzap' method of rapid DNA recovery. Finally, the use of NaOH and CT AB in 
the recovery of DNA from pericardia! fluid is discussed briefly. 
6.1. 1. Recovery of DNA from pericardia! fluids by heating in boiling water. 
As with other multi-step recovery techniques, the 'De Wit DNA recovery procedure' 
( chapters 2 and 3) requires the manipulation of specimens to a degree which risks 
specimen contamination and results in a cumulative loss of DNA (chapter 3). In an 
attempt to avoid these problems in the recovery of DNA from pericardia! fluids, the 
'boiling' method of protein removal and DNA extraction was assessed. 
6.1.2. Differences in the amount of DNA target detected when using different DNA 
extraction and different amplification protocols. 
It has been clearly shown that the recovery procedure chosen can affect the amount of 
DNA recovered (chapter 3). The small amounts of DNA recovered after extraction is 
one explanation for false negative PCR results . However, the amplification procedure 
chosen (which includes the primers used) can also have a substantial influence on the 
sensitivity of a PCR protocol (Forbes et al., 1993). 
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6.1.3. DNA recovery fromM.tuberculosis culture positive pericardia! fluid: the 'Enzap' 
DNA capture recovery method ( chapter 5), employing a radio labelled probe to detect 
PCR amplification after Southern blotting is discussed. 
6.1.4. DNA recovery from pericardia! fluid using NaOH and CTAB. 
The use of multi-manipulation DNA recovery techniques involving NaOH (chapters 3 
and 4 and a method based on that according to Thierry et al., 1990) and CTAB 
(chapters 3 and 4 and a method based on that according to Sjobring et al. , 1990) on 
pericardia! fluids was attempted. 
6.2. Methods. 
6.2.1. Recovery of DNA from pericardia! fluids by heating in boiling water. 
To determine the effects of the 'boiling' protocol on the quality and quantity of DNA in 
pericardia! fluids, the following experiment was carried out: aliquots (0.5ml) of 
rehydrated M bovis BCG were added to equal quantities of water ( specimens 1 and 2) 
and pericardia! fluids (specimens 3 and 4). After heating for 5 minutes in boiling 
water, the contents of the tubes were centrifuged at 6000xg for 10 minutes and the 
supernatant fluids mixed with lithium chloride/isopropanol (section 3.3.2.i.) to 
precipitate DNA. The effects of the 'boiling' protocol on the amount and quality of 
DNA can be seen in figure 6.1. The products of extraction (20µ1) were separated by 
electrophoresis in agarose gel, stained with ethidium bromide and photographed with 
UV trans-illumination. 
6.2.2. Differences in the amount of DNA target detected when using different DNA 
extraction and different amplification protocols. 
Aliquots of TE (1ml) were spiked with different concentrations of M tuberculosis 
DNA (2.5pg, 25pg, 250pg, 2.5ng and 25ng) and subjected to a DNA recovery 
procedure ('De Wit PCR protocol', chapters 2 and 3). A further set of similarly spiked 
aliquots were subjected to the 'CTAB/prot.K' DNA recovery method (section 3.3.2.v). 
The products of each recovery procedure, as well as positive PCR controls ( 1 OOpg M 
tuberculosis DNA) were subjected to two different PCR amplification procedures 
namely i), the De Wit and ii), the protocol based on the amplification of a sequence 
found in the p23 gene of M bovis (appendix 1). The PCR products were separated by 
electrophoresis in agarose gels and photographed with UV trans-illumination. 
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6.2.3. DNA recovery from M tuberculosis culture positive pericardia} fluid: the 'Enzap' 
DNA capture recovery method, using a radio labelled probe to detect PCR 
amplification after Southern blotting. 
The principle of this method was summarised in chapter 5. Four M tuberculosis 
culture positive and one M tuberculosis culture negative pericardia! fluids were 
treated using this DNA recovery system. 'Boiled' pericardia! fluid supernatant fluid 
was added to the resin containing tube. After centrifugation, difficulties were 
experienced in that, compared to the amount of supernatant fluid added to the resin-
containing tube (300µ1), sub-optimal amounts of filtrate were obtained (50-80µ1) after 
passage through the resin layer. This was because the resin layer became blocked with 
pericardia! fluid protein, despite the removal of most of the protein during the heating 
procedure. The supernatant-resin mixture was re-centrifuged for a further five minutes 
(counter to the manufacturer's recommendation) to obtain enough DNA-containing 
filtrate (200µ1) . 
PCR amplification was carried out on the extracted material using the 'M bovis PCR 
protocol' ( appendix 1 ). This protocol was used because (i) preliminary investigations 
show that it is specific for the 'TB Complex' group of mycobacteria and (ii) because it 
is sensitive enough to show the amplification of sub-picogram amounts of DNA on 
gel-electrophoresis. Anti-contamination precautions were taken namely: the use of 
aerosol resistant tips, UV irradiation and the Ava II protocol (sections 10.3.1-2. and 
10.3.4. respectively). Positive amplification controls (1 and lOpg of genomic M 
tuberculosis DNA) and a negative control were included. 
6.2.4. DNA recovery from pericardia} fluid using NaOH and CT AB. 
Both of these compounds have been used in the extraction of DNA from mycobacterial 
cultures. 
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6.3. Results and discussion. 
6.3.1. Recovery of DNA from pericardia! fluids by heating in boiling water.. 
When evaluating the results in figure 6.1., it must be remembered that the 'pericardia! 
fluid' lanes contain M bovis BCG and native (pericardial-fluid-contained) DNA 
whereas the 'water control' lanes contain DNA recovered from M bovis BCG only. A 
visual comparison (figure 6.1.) of the amounts of DNA remaining after the completion 
of recovery procedures has to take this fact into account. After boiling, less DNA was 
observed in the 'pericardial fluid' as compared to the 'water control' lanes, even though 
greater amounts of DNA were initially present in the pericardia! fluid aliquots. In 
addition, more low molecular weight DNA is present in the 'pericardia! fluid' lanes, 
showing that shearing of the DNA had taken place. The 'boiling' of mycobacterial 
suspensions in non-biological fluids has been shown to be a relatively inefficient 
method of releasing DNA for use in PCR (chapter 4). However, the heating of 
pericardia! fluids in boiling water as a method of separating DNA from other 
components has appeal because of the speed and simplicity of the technique. In 
addition, the boiling method has been reported as a cell lysis technique in certain PCR 
protocols (Cheyrou et al., 1991; Buck et al., 1992; and Forbes et al., 1993). 
Preliminary investigation in the department of Medical Microbiology suggested that 
this method was ideal for removing proteins from pericardial fluids. This is because 
the protein component of pericardia! fluid denatures when boiled. The denatured 
material, if loosened and centrifuged at 6000xg for 10 minutes, separates into a 
denatured protein pellet and supernatant fluid. What was unknown were the effects (if 
any) of the use of heating technique on the quality of the DNA component derived 
from the lysis of mycobacterial cells present in pericardia! fluid. The experiment in 
this section was carried out to give an indication of the possible effects. 
Richards (1989) states that the aim of any genomic DNA preparation is to recover 
DNA of high molecular weight and purity. Whether the shearing of DNA in this 
instance is a disadvantage (Folgueira et al., 1993) for the purposes of PCR is 
debatable; it may even be an advantage. Notwithstanding, because of the ease with 
which protein is removed from pericardia! fluid by this method, it was decided to 
assess the method further by using it in conjunction with the 'Enzap' protocol. 
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Lane 1 2 3 4 
Figure 6.1. Comparative amounts of M bovis BCG DNA recovered after 'boiling' treatments 
of equal quantities of pericardial fluid . Water controls are included. 
Lanes 1-2, re-hydrated M bovis BCG (vaccine) cells (0.5ml) added to pericardial fluid; lanes 
3-4, an equal quantity of M bovis BCG cells added to water controls. These specimens were 
treated with RNAse before electrophoresis. 
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6.3 .2. Differences in the amount of DNA target detected when using different DNA 
extraction and different amplification protocols. 
The results are shown in figure 6.2. The positive PCR control tested positive with the 
'De Wit amplification protocol' (lane 1 ). A second similar positive PCR control tested 
positive using the 'M bovis' PCR amplification procedure (lane 15). Using the 'De Wit 
PCR protocol' (DNA recovery and amplification) on DNA-spiked aliquots of TE, no 
amplified product was observed (lanes 3-7). By contrast, using the 'CTAB' DNA 
recovery method and 'De Wit amplification procedures' (lanes 9-13), a product was 
amplified from 25ng of DNA (lane 9). Using the 'De Wit DNA recovery' and the 'M 
bovis amplification' procedures, no amplified product was observed (lanes 17-21). 
Using the 'CTAB' extraction and the 'M bovis amplification' procedures (lanes 23-27), 
a product was amplified from the extraction of the lowest concentration (2.5pg) of 
DNA (lane 27). Lane 24 represents the products of the PCR of 2.5ng of DNA (no 
product visible; possibly due to technical difficulties). 
In a discussion of these results, it is clear that: 
(i) The 'CT AB/prot.K DNA recovery' procedure is superior to the 'De Wit DNA 
recovery' procedure as regards the amounts of DNA isolated. However, it must be 
remembered that in this instance the extractions were carried out on DNA dilutions in 
non-biological fluid (TE buffer; ref: Maniatis et al, 1982). The 'De Wit extraction' 
procedure might well be a superior technique as regards the lysis and release of DNA 
from mycobacterial cells present in biological fluids. It might also be more effective in 
removing PCR inhibitors from extractions done on biological fluids. However, a 
relatively high rate of DNA loss did occur during this protocol in this instance, thus 
agreeing with the result obtained in section 3.3. 
(ii) The 'M bovis amplification' procedure is more sensitive than the amplification 
procedure of the 'De Wit PCR protocol'. Contrasts in the sensitivity of different 
protocols was also noted in a report by Forbes et al. (1993) where one set of primers 
detected a single M tuberculosis organism while the other primer set could only detect 
about 100 similar organisms. 
(iii) The 'M bovis amplification'/CT AB/Prot.K extraction' procedure is more 





Figure 6.2. The results of PCR after the recovery of M tuberculosis DNA from TE. Two 
different DNA recovery procedures were used and the products of these were each subjected 
to different amplification procedures. 
Lanes 1-13 : 'De Wit PCR amplification' procedure; lanes 3-7: 'De Wit PCR extraction' 
procedure; lanes 9-13 : 'CTAB/prot.K extraction' procedure; lanes 3-7 and 9-13 : 25ng, 2.5ng, 
250pg, 25pg and 2.5pg genomic M tuberculosis DNA respectively. Lane 1: IOOpg genomic 
M tuberculosis DNA amplified directly as the positive control. Lanes 2, 8, and 14 contained 
no sample. 
Lanes 15-27: 'M bovis amplification' procedure; lanes 17-21: 'De Wit PCR extraction' 
procedure; lanes 23-27: 'CT AB/prot.K extraction' procedure; lanes 17-21 and 23-27: 25ng, 
2.5ng, 250pg, 25pg and 2.5pg genomic M tuberculosis DNA respectively. Lane 15 : lOOpg 
genomic M tuberculosis DNA amplified directly as the positive control. Lanes 16 and 22 
contained no sample. 
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6.3 .3. DNA recovery from Mtubercu/osis culture positive pericardia! fluid: the 'Enzap' 
DNA capture recovery method, using a radio labelled probe to detect PCR 
amplification after Southern blotting. 
The positive controls were positive on agarose gel electrophoresis. In contrast to these 
results, none of the culture-positive specimens were positive. Detection of the 
amplified product required specific hybridization. Table 6.1 . shows a comparison of 
the culture and PCR results of the four culture positive specimens obtained after 
hybridization and autoradiography. 
Table 6.1. 
ositive ne ative 
ositive ositive 
ositive ne ative 
ositive ositive 
Figure 6.3. shows these results after hybridization and autoradiography. Lanes 10 and 
11 represent the two positive control PCR amplifications on 1 Opg and I pg genomic M 
tuberculosis DNA. Lane 5 represents a negative fluid culture; this is PCR negative. 
No specific amplification is present in lanes 1 and 3 but lanes 2 and 4 are giving 
positive results. All specimens in lanes 1-4 were culture positive. 
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Lane kb 1 2 3 4 5 6 7 8 9 10 11 12 
Figure 6.3. Southern blotting hybridization results of the PCR of M tuberculosis culture 
positive pericardial fluids, using the 'Enzap DNA extraction' protocol. 
Lanes 1-4, 'Enzap' extractions of M tuberculosis culture positive pericardial fluids; lane 5, 
'Enzap' extractions of an M tuberculosis culture negative pericardial fluid; lanes 10-11, lOpg 
and lpg respectively of genomicM tuberculosis DNA; lane 12, negative control. 
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In a discussion of these results, it is clear that the four 'culture positive' specimens did 
not give positive amplification results upon electrophoresis whereas the positive 
amplification controls tested positive. After Southern blotting, hybridization and 
autoradiography, only two out of the four culture positive specimens tested positive. It 
is apparent that the 'Enzap DNA recovery protocol on boiled pericardia! fluid together 
with the 'M bovis PCR protocol' used ( appendix 1) are not as sensitive as the culture 
assay for the organism in detecting the presence of M tuberculosis in pericardia! fluids 
In a paper by Hermans et al., (1990), the resolving power of a PCR protocol to detect 
quantifiable numbers of M tuberculosis bacilli, using hybridization as the detection 
method, was studied. Ten fold serial dilutions of M tuberculosis cells were made in 
buffer solution or in sputum taken from a non-tuberculous person. DNA extractions 
were canied out using a proteinase K/SDS/phenol/chloroform method. PCR was done 
using the Eisenach et al., (1990 and 1991) protocol followed by Southern blotting, 
hybridization and autoradiography. The following contrasts were noted: 
(a) The detection limit for this protocol amounted to 200 bacteria for cells suspended 
in buff er and 1000 bacteria for cells suspended in sputum. 
(b) The detection limit for genomic M tuberculosis DNA (added directly to the PCR 
mixture) was 1 OOfg~ a quantity theoretically corresponding to about 20 bacteria. 
Further, a study by Shawar et al., (1993) showed that the sensitivity of detection in 
sputum samples seeded with M tuberculosis was 5 times lower than that obtained in 
the testing of a similar culture suspension of the organism. This finding agrees with 
(a) above. 
The results in this and the Hermans et al., (1990) study, confmn that in many recovery 
procedures the attrition of target DNA during the recovery procedure occurs to a 
degree which is unacceptable in diagnostic PCR. Added to this are the presence of 
unknown factors, possibly inhibitors of PCR ( chapter 9) which often compound the 
problem of false negative results (Shawar et al., 1993). Clearly, the quantity and 
quality of DNA isolated is dependent on a number of parameters, for example: the 
number of organisms present in the specimen, the type of specimen for extraction and 
the extraction procedure. Consequently, the effects of these parameters on the 
sensitivity of a PCR assay can be cumulative. 
Thus, for DNA isolation procedures where the loss of DNA occurs: 
(a) it might not be possible to detect target DNA from the small amounts of infecting 
organisms present in the pre-extraction material; 
(b) it might be possible to detect target DNA but not to be able to distinguish 
between low levels of contaminating target and 'specimen' target sequences. To quote 
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from a reference: 'Regardless of the conditions used for PCR, the limiting factor for the 
detection of organisms will undoubtedly be the technique used for the processing of 
the clinical sample, lysis of the mycobacteria, and purification of the DNA' (Eisenach 
et al., 1990). 
6.3.4. DNA recovery from pericardia! fluid using NaOH and CTAB. 
Attempts to extract DNA from pericardia! fluid using protocols incorporating NaOH 
and CT AB yielded a recovery product which was not suitable for use in routine, 
diagnostic PCR. This is because the products of DNA recovery contained relatively 
large amounts of residual 'detritus' which was probably proteinaceous material. 
The 'De Wit DNA recovery protocol', by contrast, yields a final DNA recovery product 
which is free from unwanted extraction material. 
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6.4. Conclusions. 
Several conclusions can be drawn from the data found in the chapters on recovery 
methods and in the publications referred to: 
(i) The bacillus M tuberculosis and pericardia! fluids (as opposed to the pericardia! 
fluid centrifuged deposit) are examples of material from which the extraction of DNA 
for diagnostic PCR poses difficulties. 
(ii) The DNA extraction and the amplification procedures used influence the 
sensitivity of a PCR assay. The relative insensitivity of the amplification primed by 
the De Wit PCR primers (Kl and S2) help to explain why the sensitivity of the PCR 
on the pericardia! fluids tested compared unfavorably with other PCR protocols cited 
(section 2.6 and De Lassence et al., 1992). Detection methods also play an important 
role in the final result of an assay. Shawar et al., (1993) showed that as few as 50, or 
as few as 5 M tuberculosis cells can be detected by agarose gel electrophoresis and 
subsequent hybridisation, respectively. Hance et al., (1990) showed PCR detection 
limits of 1000 cells by agarose gel electrophoresis and 100 cells by hybridisation. 
(iii) In diagnostic PCR, a recovery technique should allow for the recovery as much 
DNA as possible in order to expedite the amplification of DNA from infecting 
organisms. Multi-manipulation techniques are not suitable for the reasons mentioned 
in chapter 3 namely, that the loss of DNA during the extraction procedure and the risk 
of exposing the specimen to potential contamination can affect the results in diagnostic 
PCR. 
(iv) On the other hand, the use of simpler methods of DNA recovery which are 
conducted with fewer manipulations of the specimen (for example boiling) avoid 
exposing the specimens to the risk of contamination but these fail to extract DNA in 
toto (chapter 4). The 'FMP', 'Isogene' and 'Enzap' techniques (chapter 5) meet some of 
the important criteria of DNA extraction for diagnostic PCR, namely speed and ease of 
use. Multi-manipulation of the specimens, with concomitant loss of DNA, is also 
avoided in such methods. However, simple methods of extraction are not always 
suitable for the lysis of cells and the release of DNA for recovery. They are not 
suitable for removing protein and, by implication, possible inhibitors of PCR from 
pericardia! fluids. Until such time as these problems are overcome, these theoretically 
attractive systems will remain unsuitable for the purposes of DNA extraction from 
pericardia! fluids. 
(v) Special emphasis has been placed on DNA recovery methods in this and in 
preceeding chapters. While DNA recovery methods are an important cause of false 
negative results, other factors, such as the limitations of instrumentation, the PCR 
amplification protocol used and possible PCR inhibitors (chapters 7, 8 and 9 
respectively) play an equally important role in false negative results. However, it is 
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important not to underestimate the fmdings in this chapter as regards the effective use 
of the PCR assay in the diagnostic laboratory. 
CHAPTER 7. 
PCR PARAMETERS 
AND CHOICE OF INSTRUMENTATION. 
7.1. General introduction. 
7 .1.1. Definitions. 
7 .1.2. The characteristics of the 'ideal' thermocycler. 
7.1.3. The importance of correct denaturing and annealing 
temperatures. 
7.2. Materials and methods. 
7.2.1. Introduction. 
7.2.2. Commercial thermocyclers tested. 
7.2.3. Thermocycle parameters and the aims of this study. 
7.2.4. Measuring equipment. 
7.3. Results. 
7.3.1. Introduction. 
7.3.2. Machine A. 
7.3.3. Machine B. 
7.3.4. Machine C. 
7.3.5. Machine D. 
7.3.6. Photographic results (after electrophoresis) obtained after the test 
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AND CHOICE OF INSTRUMENTATION. 
7.1. General introduction. 
Two critical requirements of thermocyclers are the accuracy and reliability of 
the temperatures achieved. This chapter is devoted to defining temperature 
accuracy and reliability and to giving reasons as to why these are important 
with regard to the denaturation and annealing aspects of the 'De Wit PCR 
protocol'. The concept of the 'ideal thermocycler' is also introduced. An 
empirical evaluation of the temperature accuracy and reliability of 
commercially available thermocycle machines follows. This evaluation was 
done in two ways: (i) by means of temperature measurement, using calibrated 
monitoring systems, and (ii) by comparing (photographically) the final yield of 
DNA product amplified using different thermocyclers and different block 
positions. 
7 .1.1. Definitions. 
Laboratory data can be considered as 'hard' data, that is as measurements that 
can be described as being objective, reliable and dimensional (Feinstein, 1967). 
One major kind of error in measurement is that known as systematic error. 
This type can be formally defined as 'any difference between the true value and 
that actually obtained that is the result of all causes other than sampling 
variability' (Mausner and Bahn, 1985a). The only method of detecting such 
error is by comparing the results of a measurement with a correctly calibrated 
instrument (Mausner and Bahn, 1985a). Two concepts are used to describe the 
quality of measurements namely, accuracy and reliability. The accuracy and 
reliability of measurement in any scientific discipline is important if the results 
are to be used to extrapolate from a specific situation to the general, and if 
strategies for the future are to be based on these measurements. Pivotal to the 
evaluation of thermocyclers is the accuracy and reliability that can be obtained 
at critical points during thermocycling. In formal terms, accuracy ( or validity) 
is the degree to which the results of a measurement correspond to the true 
situation. Reliability is the extent to which repeated measurements of a 
reasonably stable phenomenon fall closely to each other. Repeatability, 
70 
reproducibility and precision are other terms for this property (Fletcher et al, 
1982). 
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Figure 7.1. Accuracy and Reliability. A is accurate and reliable; B is accurate but not 
reliable; C is not accurate but is reliable; D is neither accurate nor reliable. 
Source: Fletcher, R.H., Fletcher, S.W. and Wagner, E.H. (1982). Abnormality, In 
Clinical Epidemiology-the essentials, 18-40. Williams and Wilkins, Baltimore, 
Maryland., USA. 
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7 .1.2. The characteristics of the 'ideal' thermocycler. 
This machine possesses both obligatory 'essential' and optional 'desirable' 
features. 
7.1.2.1. Essential features. 
Certain features are essential to optimal thermocycler performance and these 
are all related to accuracy and reliability: 
(i) The thermal performance of the machine must be accurate and reliable 
(Oste, 1989). This applies to intracycle performance within individual block 
positions as well as to intercycle performance across the entire block. A 
temperature monitoring system that conveys accurate specimen temperatures to 
the software of the thermocycler is needed. This is effectively catered for by 
using a Type K thermocouple wire immersed in a mock specimen (Watson, 
1990). 
(ii) Accurate and reliable expression of the programmed temperatures 
depends on the physical contact between the reaction tube and the heating 
system. The reaction tube walls must therefore be in intimate contact with the 
heat transfer system (Oste, 1989). In the case of 'solid block' specimen holders 
in particular, standardization of the specimen tube configuration ( a consistent 
shape) is important for accurate and reliable incubation of the contained 
specrmen. 
(iii) Also related to accurate and reliable performance is automation of 
operation. This allows for the standardization of cycling parameters and avoids 
labour intensive manipulations. 
7 .1.2.2. Desirable features . 
The following list of desirable features is by no means exhaustive, and depends 
in many instances on the function and the cost of the thermocycler: 
(i) a large programme-function capacity which supplies adequate memory 
storage and the ability to link different programmes; 
(ii) interchangable blocks to cater for different types of reaction tubes; 
(iii) a light portable machine that occupies a small bench-area and that 
depends on standard power sources; 
(iv) a refrigeration-storage mode; 
(v) an energy efficient and reasonably priced machine; 
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(vi) an independent temperature-monitoring system, supplied as an accessory, 
to enable the periodic checking of temperature profiles. 
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7 .1.3. The importance of conect denaturing and annealing temperatures in PCR 
amplification. 
7.1.3.1. Introduction. 
Optimal denaturing and annealing temperatures require accurate and reliable 
heating cycles. Other important factors, directly related to the accuracy and 
reliability of thermocyclers, are the efficiency of heat transfer to the specimen 
tube and the uniformity of temperatures across the sampling block of 
thermocycler. 
7.1.3.2. The importance of the correct denaturing temperature. 
Denaturing temperatures are critical for several reasons: 
(i) Exposure to an excessively high temperature for extended periods can 
result in the premature inactivation of the Taq polymerase. The half-life of Taq 
polymerase activity at different temperatures is shown in table 7 .1. 
Table 7.1. 
. ··.· ··.·•·· l~o mwrtfis ~ 9is?d · x ·. 
· 4Q tiiiAutes@95?C 
·• .... ··.. > s2§ mmµt~~ @9J.1??c 
Source: Gelfand, D.H. (1989). Taq DNA Polymerase In PCR Technology, Principles 
and Applications for DNA Amplification, 17-22. Edited by Erlich, H.A. Stockton 
Press, New York, USA. 
The Taq polymerase enzyme, despite its relative resistance to heat, is 
substantially affected by a soc difference in temperature in this temperature 
range. The problem is compounded if, as in the De Wit PCR protocol, the 
target template is G+C rich, as higher temperatures are required to denature 
G+C rich templates. The problems associated with the inactivation of the Taq 
polymerase has to a certain extent been overcome with the use of more heat-
resistant polymerases (package insert: Vent technical data sheet, DNA 
Polymerase, New England Biolabs, Beverley, Massachusetts, USA). 
(ii) A denaturing temperature that is too low will not ensure that adequate 
denaturation of G+C rich sequences takes place. Although denaturation takes 
74 
only a few seconds; 'snap-back' or re-annealing of denatured DNA can occur if 
incubations at a particular temperature are too short (Innes and Gelfand, 1990). 
(iii) Some PCR protocols incorporate anti-contamination features; for 
example the use of UNG (section 10.3), which is denatured at high 
temperatures. A temperature which is too low for the adequate denaturation of 
the UNG enzyme could result in a situation where UNG would begin to 
degrade DNA amplified from true target sequences. 
7.1.3.3. The importance of the conect annealing temperature. 
A lower than optimal annealing temperature can result in mispriming (Innes, 
and Gelfand, 1990 and Rybicki, 1992), with the amplification of non-target 
DNA and a lower yields of target DNA. However, the success of PCR 
amplification is subject to many other variables: sub-optimal MgS04 
concentration, dNTP depletion, excessive amounts of DNA polymerase and 
excessive primer extension time can also cause a high background 
amplification product (package insert: Vent technical data sheet). In general 
though, the higher the annealing temperature, the greater the stringency of 
hybridization, the lower the background and the lower the yield of the desired 
product (Komer, 1990). However, where product purity is essential, then 
product yield is of secondary importance. 
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7.2. Materials and methods. 
7.2.1. Introduction. 
The Department of Medical Microbiology had been using (1989-1992) a 
custom built automatic thermocycler which heated and cooled reaction tubes 
with water. Tubes were placed into a central chamber. Three water baths, 
each providing heated water of differing temperatures, were linked to the 
central chamber. Switching valves controlled the entry and exit of water from 
these baths. This machine, while reliable, proved to have a limited application, 
mainly because it was not designed to allow for different temperature-and-time 
settings. It was therefore decided to evaluate the performance of four different 
commercial systems. 
7.2.2. Commercial thermocyclers tested. 
Three of the models tested were fitted with a solid metal sample block to 
transfer heat energy from the heat source to the sample tube. These machines 
used different methods to generate the required temperatures. These methods 
were: 
for heating: semi-conductors (Peltier devices) or a light-bulb heat source; 
for cooling: semi-conductors or a fan system. 
A pe1ipheral temperature probe, placed into a 0.5ml reaction tube containing a 
solid specimen 'sample' (volume displaced by the solid sample: 500µ1), was 
used in two of the metal block machines to monitor the temperature and to 
relay this data to the software. 
A fourth machine, designed and manufactured locally, made use of rapidly 
flushing water (heated by a high-watt element) to transfer heat energy to the 
specimen tubes. Cooling of the specimens was achieved by rapid flushing and 
mixing with tap-water which was at ambient temperature. In contrast to the 
'metal block' machines, the probe on this machine consisted of metal 
the1mocouple immersed into a reaction tube containing a mock liquid sample 
(50µ1) . 
All four machines used a micro-processor to regulate the cyclic temperature 
changes. 
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7.2.3. Thermocycler parameters and the aims of this study. 
The aim of this study was not to compare directly the performance of each of 
the machines tested but rather to highlight specific shortcomings which might 
be present when evaluating thermocyclers. The following parameters were 
tested: 
(a) The variations between the programmed machine settings and the 
temperatures obtained empirically. 
(b) The presence of cycle to cycle temperature variations in the same block 
position. 
(c) Temperature variations present across the heating block. 
The four thermocyclers were evaluated according to one or more of these 
parameters. 
7.2.4. Measuring equipment. 
(i) A thermo-couple, identical to that found in the 'metal block' machines, and 
connected to a digital thermometer was used to measure temperatures. The 
calibration of the digital thermometers used (Gondo, TK70I) was verified 
across a range of temperatures by comparison with a range of temperature 
readings obtained from two mercury thermometers. 
(ii) Where the products of the amplification of standard amounts of DNA 
were used as an empirical measure of the efficacy of temperature profiles 
(Polaroid photographs, section 7.3.6), the amounts of specific product produced 
were assessed by visual inspection namely, by UV trans-illumination after the 




Table 7.2. defines the statistical measures used to provide a summruy of the 
raw data. These measures will be used where necessruy. The raw data can be 
viewed in appendix 2. With regard to the manufacturers and model numbers of 
each machine, anonimity is maintained as the objective of these evaluations is 
to reveal the disparity (if any) between the ideal and the evident; as well as the 
implications of the various findings for diagnostic PCR. 
Table 7.2. 
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Source: Daniel, W.W. (1974). Organizing and Summarizing Data In: Biostatistics: a 
foundation for analysis in the health sciences, 1-29. John Wiley and Sons, Inc. New 
York, USA. 
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7.3.2. Machine A. 
Machine A was evaluated to gauge the extent of variation present between 
cycles in the same block position. Thus, all readings were taken with the 
temperature recording probe measuring temperatures in one block position. 
Temperature readings were recorded for the first ten cycles of a thirty five 
cycle protocol. The thermocycler sensor probe and the temperature recording 
probe were placed into adjacent block positions to exclude the effects of 
potential 'across the block' variation in temperatures. The results are 
summarized in table 7.3 . 
Prdgrartuned}·· 
tenf e.ra.ttm~J · 
Prggt"~~4\·.· 
tetri e:r:hkes · ·. ··· 
rewheta,nn.-eIJ · 




Table 7.3 . 
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The mean and median of the recorded values showed a marked disparity 
between the programmed and the actual denaturing temperatures indicating 
that, overall, there was a lack of accuracy in this block position. The range and 
standard deviation values showed dispersion among the readings. This 




The mean and median results showed a 2-30C difference between the 
programmed and actual annealing temperatures in this block position, 
indicating a lack of accuracy at this temperature setting. The range and 
standard deviation showed minimal dispersion among the readings; so while the 
machine was inaccurate at this setting in this particular block position, it was 
nevertheless reliable. 
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7.3 .3. Machine B. 
This machine was tested for 'across the block' temperature variation. The 
implications of this form of variation are discussed in section 7.3.4. Readings 
were recorded in five block positions: four were situated in the corners and one 
in the centre of the block. Either three or four readings were taken at each 
position. The results are summarized in table 7.4. 
Table 7.4. 





There was little disparity between the programmed setting and the recorded 
'across the block' and 'in any one block' denaturing temperatures. The range 
values showed little difference over all readings. Machine B therefore 
displayed both accuracy and reliability. 
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Annealing temperature: 
There was, once more, little disparity between the programmed settings and all 
recorded annealing temperatures. Range values showed little difference, 
showing that this thermocycler was accurate and reliable at the annealing step. 
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7.3.4. Machine C. 
Because of the implications of 'across the block' variation, machine C was also 
tested for this type of variation. Temperature readings were taken in five block 
positions: four were in the comers and one in the centre of the block. Either 
four or five denaturing and annealing readings were taken at each position 
(appendix). The mean values of the four/five readings taken at each block 
position were calculated and, after a comparison of these values, the mean and 
the range of all values over the 5 block positions was calculated. This 
information is summmarized in table 7.5. 
Table 7.5. 
!!I 
< Jr bto6kt 93.1- 91.7- 93.4- 92.0- 92.2- 91.7-... . . .. 
> < 94.80C 92.10c 93.50C 92.20c 92.50C 94.80C 
·tooc:L ... . ...... . 
1 2 3 4 5 all 5 
68.90C 680C 68.70C 68.20c 68.20c 68.40C 
· .block 68.6- 68- 68.7- 68.1- 68.20c 68-
10.10c 6s.1oc 68.8oc 68.20c 10.10c 
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Denaturing temperature: 
With regard to the analysis of the mean readings obtained in each block 
position tested, the comparison of block positions one and three (93.6 and 
93.40C respectively) with positions two and four (91.9 and 92.IOC 
respectively) showed differences of 1. 7 and 1.30c. This is an important finding 
as positions one and two, as well as positions three and four were situated on 
opposing sides of the block. This indicated 'across the block' differences in 
temperature. The range values of the relevant individual positions confirmed 
this observation. Further, there was disparity between the programmed setting 
(940C) and the recorded denaturing temperatures. These findings can have 
implications for diagnostic PCR. 'Across the block' variation in denaturing 
temperatures can produce a bias toward obtaining negative results : denaturing 
temperatures that are too high on one side of the block could inactivate the Taq 
polymerase, with obvious implications. Conversely, if temperatures are too 
low, inadequate denaturation of G+C rich templates is a consequence. 
Annealing temperature: 
The mean values of individual block positions showed little differences 
between tested locations on the block. The range measures given also recorded 
little variation between and within block positions aside from block position 
one: (the value of 70. IOC). The mean annealing temperature recorded was 
lower than that programmed for (68.40C versus 700C). 
This machine, with regard to denaturing temperatures, showed 'across the 
block' variation. The denaturing and annealing temperatures were lower than 
the programmed values. 
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7.3.5. Machine D. 
A problem specific to at least one of the thermocyclers tested so far has been 
temperature variation across the sample holding block. Machine D heated the 
specimen tubes with water (an 'all-fluid' type of configuration). The thermal 
performance was measured using a thermocouple sensor-probe placed into a 
'mock' specimen similar in all respects to the assay specimens. Information 
from the sensor-probe viz a viz the temperature in sample specimens during 
amplification cycles was therefore precise. Temperature readings were taken in 
five sample positions; four in the comers and one in the centre of the grid. 
Three readings were taken at each position. The results are summarised in 
table 7. 6. 
.. ·.·,·.•.··.·.··.·.·.---.·. 
readw. ···· $. ·. 
. . . . 
· ann~illµig .. ···.··· 
re~~il1>$ ... ·.·.· 
Discussion: 
Table 7.6. 
iridividual.. ······ -0v~i:?··········· >••••••· 
•• <·····•wells ...• c<•·· th¢ bl66k ) 
This machine displayed complete reliability. The thermocycler was, at first 
glance, deficient as regards accuracy ( as shown by the difference between the 
programmed denaturing temperature, 950c, and the actual temperatures 
obtained, all 970c). This was explained by the thermal differences between the 
machine's temperature-reporter probe (the thermocouple probe in the 50µ1 
mock specimen) and that attatched to the digital thermometer used to test the 
denaturing and annealing temperatures (the monitor probe fixed into a tube 
containing solid material). That the machine was accurate was verified by 
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agreement between the temperature-reporter probe and two mercury 
thermometers used to monitor waterbath temperature independently. 
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7.3.6. Photographic results (after electrophoresis) obtained after the test 
amplification of standard amounts of DNA using different thermocyclers and 
sample positions. 
Figures 7.2.a. and b. show the results of the amplification of identical amounts 
of genomic DNA (lOOpg) in selected areas of the block, using two different 
'metal-block' machines. Figure 7.3 .a. shows the results of similar reactions 
using machine D, the 'water block' machine. The last photograph (figure 7.3.b.) 
shows the results of an amplification which was carried out by physically 
moving the PCR reaction tubes between appropriately heated waterbaths 
manually The 'De Wit amplification protocol' was used throughout. The 
products of amplification (20µ1) were separated by electrophoresis in 3% 
agarose gel, stained with ethidium bromide and photographed with UV trans-
illumination. It is noteworthy that, in these photographs, only the water based 
and one metal block machine gave reasonably consistent results. 
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Figure 7.2.a. and b. Results of the amplification of identical amounts of genomic 













Figure 7.3.a. and b. Results of the amplification of identical amounts of genomic 
DNA (lOOpg) employing (i) a machine which used water to heat the specimen tubes 
directly (7.3.a) and (ii) manual manipulations to physically move specimen tubes 
between two pre-heated waterbaths (7.3.b). 
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7.4. Conclusion. 
Of the four machines tested, only machines B and D produced acceptable levels 
of accuracy and reliability. Thus only two thermocyclers would produce 
temperature profiles which would avoid the systematic error ( section 7 .1.) that 
is one of the causes of false assay results. These results are to be compared 
with the following: in a report of a performance test of nine machines (Hoelzel, 
1990), where only one machine (a 'metal-block' machine) gave the same results 
in all wells and produced a sample tube temperature profile that was the same 
as the programmed temperature. 
For successful PCR, stress should be placed on parameters which directly 
involve sample preparation, the PCR reaction mix (for example: primer design 
and concentration) the cycling parameters (for example; the choice of cycling 
temperatures and 'times') and detection systems. However, other factors, such 
as the efficacy of the thermocycle profile, must not be taken for granted, 
despite the claims of manufacturers. Thus stress must also be placed on the 
accuracy and reliability of the 'workhorse' of PCR, namely the thermocycler, 
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The use of the one-set, two primer protocol described by De Wit et al., (1990) 
displayed certain practical disadvantages when used in a diagnostic laboratory 
setting. Firstly, the test results of pericardia! fluid PCR assays are, under ideal 
conditions, only available after 4-5 working days. Small batches (10-15) of 
specimens can take up to 10 days to assay. This time period is not unusual: the 
use of the one-set two primer protocol for hepatitis and HIV PCR requires 
similar assay times if hybridization forms part of the detection method 
(personal communication: Mrs J Kannemeyer and Dr Smuts, Dept. of Virology, 
Medical School, UCT). However, a shorter assay time would have distinct 
clinical and diagnostic advantages. Secondly, the 'De Wit protocol' uses 32P as 
the label for the probe in the detection of specific PCR product. While its use 
increases the sensitivity of the assay, it is potentially hazardous, costly and has 
a short half-life. Thirdly, the protocol involves numerous steps which increases 
the risk of specimen contamination with spurious target DNA. These factors 
make this protocol unsuitable for general use in the diagnostic laboratory. 
8.1.1. 'Nested' PCR. 
A simple and rapid method, based on that described by Plikaytis et al (1990), 
was therefore developed for testing. In nested amplificatiop, two sets of 
primers instead of one are used. The outer set of primers direct the 
amplification of specific DNA product. An internal fragment of the specific 
product is the target for amplification by a second set of primers which 
generates an internal 'nested' product (figure 8.1). The use of the two sets of 
primers has been shown to increase the specificity of amplification by reducing 
the possibility that non-target DNA is successfully primed (Bloch, 1991 ). 
Moreover, since the sensitivity of the reaction is increased, product detection 
does not require 32p. Rather, it relies on simpler, more practical, although less 
sensitive, methods such as that involving separation of the amplified product by 
electrophoresis. For these reasons, the one-set primer protocol was compared 





Figure 8.1. Representation of a nested reamplification system, showing the external 
primers ('A' and 'B' above) as a part of the first amplification product. The internal, 
'nested' primers ('C' and 'D' above) are used to detect the synthesis of the larger, 
specific PCR product. 
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8.1.2. Three-step 'nested' reaction. 
A three-step 'nested' amplification was attempted to see if the application of a 
third amplification step could increase the sensitivity of the protocol further 
without compromising the specificity of the assay (specificity here refers to the 
specificity of origin of the M tuberculosis target DNA; the 'De Wit PCR 
amplification protocol' is specific for M tuberculosis amongst the range of 
mycobacteria tested). 
8.1.3. Reproducibilty of the three-step 'nested' reaction. 
The reproducibility of the three-set amplification protocol was also tested as 
contamination with target sequences before, during or even after amplification 
(sections 8.4.3-8.4.4.) can give a false positive result. To examine the 
reproducibility of the three-set amplification protocol results, a batch of white 
blood cell DNA extracts were subjected to the three-set protocol on three 
different occasions. 
8.2. Materials and methods. 
8.2.1. Amplification pnmers used for the two-step and three-step 'nested' 
protocol. 
The PCR assay described by De Wit et al., (1990) uses two primers designated 
Kl and S2, which prime a fragment of 336bp. The abbreviations 'K' and 'S' 
refer to the primer position relative to the Kpnl and Smal restriction sites 
present in the target region. Using DNA sequencing data of this fragment and 
its flanking region, an additional set of primers (K2 and S 1) was synthesized. 
The two outer primers (Kl and SI) direct the amplification of product 489bp in 
length while the inner primers direct the amplification of a sequence 279bp in 
length (figure 8.2). 
The M tuberculosis p36 partial clone sequence (chapter 2) is shown to illustrate 
the sequence and location of the two sets of primers used in the nested 




Figure 8.2. Nested amplification in the modified 'De Wit PCR protocol' showing the 
relationship between the outer and inner primers .. The outer target DNA fragment 
(K 1 S 1) for amplification by PCR is 489bp ('A' to 'B' above) and the inner fragment 
(K2S2) 279bp in length ('C' to 'D' above). 
Table 8.1. Locations on clone p36. 
lo2;tion ~~i\·· 
5' gccagaaccgac caacccgccgata 3' K 1 · outer primer. 
location 411 
5' cgccggcc9caccggtgccgtatag·3.t • K2•1Ililer primer. 
!~¥atio1~~, ( ... \I{ . . , .. 
·5,' gcgg~t§.gggcig~gtcggtggct(~'S2 innyr primer. 
location 830 
5' caggccgccggtgcgaacggcggtg 3' S l outer primer. 
The outer primers KI and S 1 direct the amplification of a sequence 489 bp in 
length. The inner primers K2 and S2 direct a sequence 279 bp long. 
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8.2.2. The two-step and three-step 'nested' reactions. 
The thermocycler settings and the concentrations of PCR components in the 
two- and three-step nested reactions were identical to those used in the 'De Wit 
PCR protocol' (one-step). 
For the two-step 'nested' reaction, an aliquot (10µ1) of the reaction mixture 
obtained from the first or 'outer' reaction was transferred to the second PCR 
mixture containing the inner primers. The transfer was carried out after the 
PCR tubes from the first reaction were cooled on ice and centrifuged. This 
was necessary to avoid the dissemination of potentially contaminating 
amplicons with the opening of the first amplification reaction tubes. The 
detection of amplification was achieved by the separation of the PCR products 
by electrophoresis in agarose gel, followed by staining with ethidium bromide 
and analysis with UV trans-illumination. 
Primer components and conditions for the second and the third stages of the 
three-step 'nested' amplification assay were identical (the reaction mixtures for 
both contained the 'internal' primers). Amplified material (10µ1) from the 
second amplification product of the two-step protocol was re-amplified. The 
second set amplification tubes were centrifuged before opening to minimize the 
contamination risk. 
8.2.3. The reproducibilty of the three-step 'nested' reaction. 
Bloods, obtained from suspected cases of tuberculous pericarditis, were treated 
with an anti-coagulant (lithium chloride). White cells were extracted using a 
Ficoll separation protocol (Lymphocyte Separation Medium, Boehringer 
Mannheim, GmbH, Germany) and re-suspended in physiological saline. DNA 
was extracted from the white cells and subjected to three PCR assays, each 
using a modified De Wit PCR amplification protocol (three-primer-set; see 
above) All available precautions were taken to avoid contamination of the 
specimens before amplification ( at this point, only physical means were 
available: see chapter 10). Aliquots of the products of amplification were 
separated by electrophoresis in 3% agarose gel, stained with ethidium bromide 
and analysed with UV trans-illumination. 
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8.3. Results. 
8.3.1. One-step and two-step 'nested' reaction. 
Figure 8.3.a. shows the results of a 'one-step' nested reaction ('De Wit PCR 
protocol') and figure 8.3.b the results of the two-step 'nested' reaction. Using 
the De Wit one-set assay, lOpg of M tuberculosis DNA is required as starting 
template for the detection of the amplification product by the electrophoresis 
protocol. By contrast, in the two-step reaction, the target sequence was 
detected without the use of 32p, even though concentrations as low as lOfg of 
M tuberculosis DNA as starting material were used. The negative PCR control 
in this test was negative (result not shown). 
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a. 
Lane kb 1 2 
b. 
Lane kb 1 2 3 
.517-+ 
.234-+ 
Figure 8.3.a. and 8.3.b. The sensitivity of the 'De Wit' and the two set nested 
(modified 'De Wit') PCR protocols. 
Figure 8.3.a., lanes 1 and 2, genomic M tuberculosis DNA (20pg) amplified by the 'De 
Wit PCR protocol'. Figure 8.3.b., Lanes 1, 2 and 3. genomic M tuberculosis DNA; 
10pg, 100fg and 10 fg respectively, amplified by the modified 'De Wit PCR protocol'. 
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8.3.2. Three-step 'nested' reaction. 
The three-set protocol has increased the sensitivity of the amplification 
markedly. Lane 3 (lOfg DNA starting material, figure 8.4.) shows greatly 
increased levels of amplified product ( compared to lane 3, two-set protocol, 
figure 8.3.b.) using separation by electrophoresis to detect the product. Lane 4, 
however, which gave a positive signal, represents the PCR negative control. 
The positive result seen in this example was due to the observed 'carry-over', 
during the gel-loading stage, of a minute amount of reaction product from lane 
3. The implications of this result will be discussed in the next section. Figure 
8.4. shows the results of the three-set 'nested' reaction. 
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Lane kb 1 2 3 4 
.394~ 
.234~ 
Figure 8.4. The sensitivity of the modified 'De Wit' (three-set nested amplification) 
PCR protocol. 
Lanes 1, 2 and 3, genomic M tuberculosis DNA, lOpg, lOOfg and IOfg respectively, 
amplified using a modified 'De Wit PCR protocol'. Lane 4 represents the negative 
(water) control. 
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8.3.3 . Reproducibility of the three-set 'nested' reaction. 
The reproducibility test of the three-step 'nested' reaction gave equivocal results 
(table 8.2.): the 3 identical assays on each specimen were not consistent as no 
specimen tested gave uniformly positive or negative results, apart from the 
positive control specimen. 
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Table 8.2. Results obtained on specimens assayed on three occasions, using a 
three set 'nested' PCR. 
......... Three Set Amplification Results . 
ositive ne ative ositive 
ne ative ositive n/a* 
.4 _/_ .. -,- WBC extract ne ative ositive ositive 
II II ositive ne ative ositive 
" " ositive ositive ne ative 
" " ne ative ositive n/a* 
" " ne ative ne ative ositive 
* results not available. 
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8.4. Discussion. 
8.4.1. One-step and two-step 'nested' reactions. 
The two-set amplification assay was more sensitive than the one-set assay 
described by De Wit et al., (1990). The two-set assay sensitivity approaches 
the results obtained by Plikaytis et al (1990), where the resolving limit of a 
nested amplification PCR, using electrophoresis to detect the amplification 
product, was 3fg of starting material. Pierre et al., (1991) and Miyazaki et al., 
(1993) also report increased sensitivity using a nested reaction. Disadvantages 
of the nested reaction include the extra cost in terms of materials and reagents 
used. More importantly, the nested system where DNA is transferred from the 
first reaction to the second reaction does increase the chances of false positive 
results unless great care is exercised. 
8.4.2. Three-step 'nested' reaction. 
The three-step 'nested' reaction showed increased sensitivity. However, the 
positive result in lane four represents the accidental transfer of minute amounts 
of amplified material from a positive control lane to a negative control lane. 
This does illustrate the ease with which a negative result can read as a 'false' 
positive. As can be seen in this instance, not all false positive results are due to 
the contamination of the specimen during pre-treatment with genomic target 
DNA or amplicons from previous reactions. 'Spill-over' during the loading of 
the gel with the products of amplification prior to electrophoresis might be a 
cause (Noordhoek et al. , 1994). This was the case in this particular instance. 
The 'electrophoresis re-run' of the negative control reaction product gave a 
negative result, therefore the contamination of the negative control occurred 
after the completion of PCR amplification and not before. 
This finding is also relevant as regards results obtained using a one-set PCR 
protocol where the detection of amplified product includes Southern blotting 
and hybridization; an extra step which increases the sensitivity of detection by 
several orders of magnitude. In such instances, false positives results arising 
from the 'spill-over' might not be evident directly after electrophoresis but only 
at a much later stage, namely after hybridisation and autoradiography. Thus, 
because of a lack of 'immediacy' and because hybridisation and 
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autoradiography is a more sensitive detection method than gel electrophoresis 
false positives could result. 
8.4.3 .Reproducibility of the three-step 'nested' reaction. 
The results of the three-step 'nested' reproducibility tests show that the 
avoidance of DNA 'target' contamination during the testing of the protocol is 
very difficult. 
8.5. Conclusion. 
Nested protocols have the advantage of increasing the sensitivity of PCR, 
thereby increasing the probability of being able to read results off gel 
electrophoresis and thus reducing the assay time considerably. 
However, it is clear from the results in this chapter that there is always a strong 
possibility of contamination, and therefore of false positive results, during the 
application of nested amplification protocols where reaction tubes are of 
necessity opened during the procedure. 
A possible solution to this problem is that suggested by Wilson et al. , (1993), 
who made use of a nested system which took place in a single tube and which 
used primers with different annealing temperatures (namely: a high annealing 
phase protocol which used long outer primers, followed by a low annealing 
phase which used shorter inner primers). This is not possible with the 'De Wit' 
primer system evaluated in this chapter. 
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INHIBITION AND OPTIMISATION OF PCR 
with special reference to the De Wit et al., (1990) PCR protocol. 
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INHIBITION AND OPTIMISATION OF PCR: 
with special reference to the De Wit et al., (1990) PCR protocol. 
9.1. Introduction. 
A number of substances may either partially or completely inhibit PCR 
amplification. Primary ( or constitutive) inhibitors are components of the 
material which contains the target template. Inhibition can also be caused by 
the inappropriate presence or incorrect concentration of reagents which are 
used in the extraction and amplification of DNA. These can be termed 
secondary inhibitors. Further, sub-optimisation regarding certain parameters of 
the PCR thermocycle protocol can result in the non-detection of target. Lastly, 
PCR inhibition can arise from enviromental sources: pollen grains have been 
implicated as a cause (St. Pierre et al., 1994). 
In this chapter, secondary inhibition and sub-optimisation, with special 
reference to the extraction and amplification procedures used in the De Wit 
PCR protocol, will be reviewed first. This is followed by an examination of 
specimens from the diagnostic M tuberculosis laboratory at Groote Schuur 
Hospital (swabs from mycobacterial cultures, chapter 11) and from the 
pericardia} fluid trial ( chapter 2) for primary sources of inhibition. 
9.2. Potentially inhibitory reagents used in the extraction and amplification 
of sample DNA. 
(a) Sodium dodecyl sulphate. 
SDS is an anionic detergent commonly used in DNA extraction techniques, 
including the De Wit PCR protocol. Protein-protein and protein-lipid 
interactions are disrupted by SDS (Stryer, 1988a.b). While the presence of 
SDS facilitates the separation of DNA from proteins, trace amounts remaining 
after extraction can inhibit PCR amplification. Table 9.1. illustrates the effects 
of differing concentrations of SDS on Taq polymerase activity. 
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Table 9.1. The effects of certain components on Taq polymerase . 
. :.·>.··.·.·.·.·.·.·.·>.·.·.·> .. ·.·.·.·.· .. : : .. :·: :·::. 
·············••••c6hceritritidn•······· 
. . •······ .. /{{·.:··.··:-:· 















Source: Gelfand, D.H. (1989). Taq DNA Polymerase In: PCR Technology: Principles 
and Applications for DNA amplification, 17-22. Edited by Erlich, H.A. Stockton 
Press, New York. 
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(b) Ethanol. 
Ethanol (70%v/v) is used to remove trace impurities from extracted and 
precipitated DNA during the final washing procedure in the 'De Wit PCR 
protocol'. After polyethylene glycol precipitation, each specimen is washed 
successively (3x) with ethanol before allowing the precipitated DNA to air-dry. 
Drying was formerly done using a Speed-vac (Savant instruments Inc., New 
York, USA.) but, because of concerns about cross-contamination, an overnight 
air-drying step, with the specimens secured in a lockable drawer, to avoid air-
currents, was introduced. 
Table 9.1. illustrates the effects of differing concentrations of ethanol on Taq 
polymerase activity. To establish whether trace amounts of ethanol affect 
amplification using the 'De Wit PCR protocol', a PCR reagent mastermix was 
aliquoted (50µ1) into four reaction tubes. Ethanol (2µ1) was added to two of 
the four tubes ( 4% final concentration). M tuberculosis genomic DNA 
( 1 OOpg) was added to all of the tubes. All assays were carried out according to 
the 'De Wit PCR protocol'. The amplification products were separate~ by 
electrophoresis in 3% agarose gel, stained with ethidium bromide and analysed 
with UV trans-illumination. 
The results can be seen in figure 9 .1. Amplification of 1 OOpg of genomic M 
tuberculosis DNA was demonstrable by agarose gel electrophoresis in the 
absence of ethanol whereas it was completely inhibited by the addition of 4% 
ethanol. This experiment was repeated to confirm these findings . These 
findings are contrary to data presented in table 9.1. A colleague involved in 
papilloma virus DNA extractions has also found that trace amounts of ethanol 
do not interfere with her amplification protocol (Dr. A. Williamson, Dept. of 




1 2 3 4 
Figure 9.1. DNA amplification in the presence and absence of ethanol. 
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Lanes 1-2, amplification of I OOpg of M tuberculosis DNA using the 'De Wit PCR 
protocol'~ lanes 3-4, similar amplifications in the presence of 4% ethanol (v/v) . 
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( c) Magnesium chloride concentration. 
The concentration of MgC12 can influence primer annealing, the denaturing 
temperatures of both template and PCR product, the formation of primer-dimer 
as well as enzyme fidelity and activity. Taq polymerase needs free magnesium 
in addition to that bound by template DNA, primers and dNTP's (Innes et al., 
1990). Therefore, the concentration of MgC12 is important to the specificity 
and yield of amplification. Excess levels will result in non-specific 
amplification while too low a concentration reduces the yield of amplified 
product (Saiki, 1989). 
A concentration of l.5mM has been found to be optimal when using 200µM of 
each dNTP in the 'De Wit PCR protocol'. 
( d) Di-methyl sulphoxide. 
DMSO is an essential component of the 'De Wit' PCR reaction mix. It 
enhances amplification in certain protocols by aiding DNA denaturation and by 
moderating the Tm of the primers used. A lower annealing temperature can 
thus be used (Gelfand, 1989). To show that DMSO is essential to the 'De Wit 
PCR protocol', genomic M tuberculosis DNA (lOOpg) was amplified in the 
presence and absence of DMSO (10%v/v, figure 9.2.a). 
( e) F ormamide. 
A problem frequently encountered with DNA amplification is the appearance 
of additional amplification bands when agarose gel electrophoresis of the 
products of amplification are examined. Amplification of spurious product can 
occur at the expense of target sequence generation; hence the specificity of the 
amplification is influenced (Sakar, 1990). Increasing the annealing 
temperature, or the use of a nested protocol are two methods employed to avoid 
this problem. A third strategy involves the use of formamide ( or DMSO, see 
above) which is reputed to increase specificity of amplification without the 
need to resort to the expense of having primers synthesized for nested 
amplification (Bloch, 1991). Like DMSO, formamide aids in the process of 
DNA denaturation and moderates the Tm of the primers used, allowing the use 
of lower annealing temperatures. 
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As the target sequence in the 'De Wit PCR protocol' is G+C rich and therefore 
requires a higher denaturing temperature than is needed where sequences are 
A+ T rich, an experiment was conducted to test whether the addition of 
formamide affects amplification using this protocol. M tuberculosis genomic 
DNA (lOOpg) was amplified with and without the addition of formamide 
(figure 9.2.a. and 9.2.b). The products of amplification (20µ1) were separated 
by electrophoresis in 3% agarose gel, stained with ethidium bromide and 
photographed with UV trans-illumination. 
Formamide (2%v/v) adversely affects amplification using the 'De Wit PCR 
protocol'. Less product was produced with the inclusion of formamide at this 
concentration (figure 9.2.a). The addition of formamide (5% v/v) to the 
protocol inhibits visible amplification completely (figure 9.2.b). Further, the 
results also show that a concentration of 2% (v/v) formamide cannot substitute 
for 10% (v/v) DMSO (figure 9.2.a.). 
These results, when using the 'De Wit PCR protocol', are at variance with the 
findings of Sakar et al., (1990) where the addition of formamide at 
concentrations of 1.25%-10% (v/v) did not appreciably affect the generation of 
target DNA. DMSO was not used in the Sakar et al., (1990) study. 
Formamide, while i), aiding specific amplification in other PCR protocols and 
ii), not affecting polymerase activity at a concentration of 10% (v/v) (table 9.1), 
is inhibitory to amplification at lower levels of concentration (5%) with the 'De 
Wit PCR protocol'. In addition, it cannot, where it is used at a concentration of 
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Figures 9.2.a.· and 9.2.b. The effects of DMSO and formamide on the 
amplification by the 'De Wit PCR protocol'. 
Figure 9.2.a. Genomic M tuberculosis DNA (lOOpg) was amplified in the presence 
(lanes 1-2) or absence (lanes 5-8) of DMSO (10% v/v) and in the presence (lanes 3-4 
and 7-8) of formamide (2%). Figure 9.2.b. Genomic M tuberculosis DNA (lOOpg) 
was amplified in the absence (lanes 1 and 2) and presence of (lanes 3 and 4) formamide 
(5 %(v/v). 
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9.3. Causes of sub-optimal results with PCR. 
9.3 .1. Low stringency annealing conditions. 
The appearance of non-specific products during amplification can be due to the 
primer-template annealing and extension that occur under 'permissive' or low 
stringency conditions (Innes and Gelfand, 1990). The latter exist when 
reactants are mixed at room temperature and are allowed to stand for various 
intervals between mixing and the first amplification cycle. Initial mismatching 
between the template and the primer will lead to an extension product that may 
compete with matched primer-target annealing and extension, thereby 
inhibiting the amplification of the true target (Bloch, 1991). Amplification of 
non-target DNA proceeds at these lower temperatures because of partial 
denaturation of the genomic DNA containing the target DNA. This 
denaturation occurs spontaneously where extraction involves a heating step (Li 
et al., 1988) or where ethanol is used in precipitating DNA. Ethanol can aid in 
strand separation (Bloch, 1991 ). 
It has been reported that pre-amplification heating, namely, the addition of 
denatured samples to the reaction mix at 100c rather than at ambient or lower 
temperatures, results in a significant increase in the sensitivity and specificity, 
probably by promoting stringent primer annealing (D'Aquila et al. , 1991). 
Sensitivity and specificity are considerably enhanced when (i) the polymerase 
enzyme is the final component added to the reaction mixtures before 
amplification; (ii) this addition takes place only when these mixtures have 
reached 600C (Bloch, 1991). The 'hot start' technique has been shown to 
improve the sensitivity and specificity of PCR by reducing primer-dimer 
formation (Chou et al., 1992) 
Chapter 12 describes the use of the modified reaction tube conceived by myself 
and developed in this laboratory for the sequential addition of reagents in PCR. 
The use of this modified tube allows the simple addition of template and/or 
enzyme during a pre-amplification heating step without the opening of the tube 
and the potential introduction of contaminating DNA. 
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9 .3 .2. High stringency annealing conditions. 
An annealing temperature that is excessively high can also result in the non-
amplification of specific target. The following experiment shows the effects of 
a 20c increase in annealing temperature on amplification using the 'De Wit 
PCR protocol'. Genomic M tuberculosis DNA, at concentrations ranging from 
lOpg to lOOng, was added to 3 sets (50µ1 aliquots) of reaction mixtures. Each 
set was subjected to one of three amplification protocols. These protocols were 
modified slightly with regards to the annealing temperatures ( 68, 69 and 70°C 
respectively). The products of amplification (20µ1) were separated by 
electrophoresis in 3% agarose gel, stained with ethidium bromide and analysed 
by UV trans-illumination (figure 9.3). The results show that there is a 10 fold 
drop (judged by visual inspection) in sensitivity when the annealing 
temperature of 680C is raised to 700c. This once more illustrates the 
importance of precision as a feature of thermocyclers ( chapter 7). 
Before completing this section on priming annealing and inhibition, another 
factor to be considered in the inhibition of PCR is the primer design. Primer-
dimer formation can influence the amplification of target DNA adversely 
(Gelfand and White, 1990). The working concentration of the primers is also 
important (Vandenvelde et al., 1990). In the Dept. of Medical Microbiology all 
primers used in the 'De Wit PCR protocol' are titrated to establish optimal 
concentrations for use. 
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Lane kb 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
.336-+ 
Figure 9.3. The effect of an increase in annealing temperature on amplification using 
the 'De Wit PCR protocol'. 
Lanes 1-5, genomic M tuberculosis DNA at concentrations of lOOng, !Ong, Ing, 
I OOpg and I Opg, respectively, subjected to an annealing temperature of 6soc. Lanes 
7-11 , 13-17, similar concentrations of DNA subjected to annealing temperatures of 
69oc and 100c respectively. 
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9.4. Inhibitors as a constituent of source material. 
Primary inhibitors are constituents of material which contain the target 
template. Examples are haem components, present in blood cells or blood 
stained material (Higutchi, 1989 and Kaye et al., 1991). The presence of 
protoporhyrin rings or polysaccharides, for example heparin, have been 
described as being capable of inhibiting PCR (Beutler et al., 1990 and Cheyrou 
et al., 1991). 
9 .4 .1. RNA inhibition of PCR. 
Introduction. 
Referring to chapter 11, it is our experience that while the 'De Wit PCR 
protocol' used is specific for M tuberculosis, culture specimens that have been 
identified biochemically as M. tuberculosis (the production of niacin is taken as 
conclusive), do not, on first attempt, always test positive by PCR. The testing 
of repeat samples does sometimes correct this difficulty. It was at first 
supposed that non-amplification was due mainly to the crude DNA extraction 
method (the boiling of culture suspensions). However, the presence of RNA is 
reported to have an effect on amplification. While it has not been established 
whether large amounts of RNA are released during the boiling extraction 
method for M tuberculosis, Pikaart and Villeponteau (1993) do report that the 
absolute and relative amounts of RNA present in a specimen can influence 
target amplification adversely. For this reason a test for RNA inhibition of 
amplification during the M tuberculosis PCR culture identification assay was 
conducted. 
Method. 
Three niacin producing mycobacterial cultures, which tested negative 'by the 
De Wit PCR protocol', were treated with RNase prior to retesting. Crude lysate 
(100µ1) from each of these specimens were incubated at 370c for one hour with 
lµl of lOµg/ml RNase. A positive PCR M tuberculosis culture was treated 
similarly. Amplification followed, using the 'De Wit PCR protocol'. Paired 
specimens of all four cultures were amplified without having been treated with 
RNase to allow for the comparison of results (figure 9.4). An alternative PCR 
assay for the presence of M tuberculosis (Eisenach et al., 1990 and 1991) was 
applied similarly to the four culture specimens. The products of amplification 
116 
(20µ1) were separated by electrophoresis in 3% agarose gel, stained with 
ethidium bromide and photographed with UV trans-illumination. 
Results. 
Using the 'De Wit PCR protocol' (figure 9.4~ lanes 1-3 and 5-7 respectively) the 
results show that all three of the 'niacin' positive, PCR negative test specimens 
gave negative results in the untreated and RNAsed protocols, showing that 
RNAse treatment did not improve amplification in any of the specimens. The 
positive control lanes gave signals of equal strength. 
The results using the Eisenach et al., (1990 and 1991) protocol were not as 
clear. All four specimens treated with RNAse are clearly positive (lanes 13-
16). In the untreated (not RNased) specimens, two of the three 'niacin' positive, 
'De Wit' PCR negative test specimens (lanes 10 and 11 ), were positive and gave 
signals of equal intensity when compared to their RNAsed counterparts (lanes 
14 and 15). The remaining untreated test specimen (lane 9) and the untreated 
positive control specimen (lane 12) gave signals which could indicate that 
RNAse treatment (lanes 13 and 16 respectively) does improve amplification. 
Overall though, RNAse treatment does not improve amplification results. 
Further, if the results of lanes 1-8 and lanes 9-16 are compared, it is clear that 
the Eisenach et al., (1990 and 1991) protocol, although not specific for M 
tuberculosis but rather for the M tuberculosis complex group, 1s a more 
sensitive assay than the 'De Wit PCR protocol' assay. 
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Lane kb 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
.394-+ 
+-· 154 
Figure 9.4. The effect of RNAse treatment on the amplification of niacin positive 
mycobacterial cultures. 
Lanes 1-8 amplification using the 'De Wit PCR protocol'; lanes 1-4, culture lysates 
which were not treated with RNAse; lanes 5-8: the same culture lysates treated with 
RNAse. Lanes 9-16, amplification of the same lysates using the 'Eisenach PCR 
protocol'; lanes 9-12 : culture lysates which were not treated with RNAse; Janes 13-16: 
culture lysates treated with RNAse. 
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9.4.2. Unknown inhibitory constituents of source material. 
Referring to chapter 2, 13 pericardia! fluids gave positive results when cultured 
for M tuberculosis and negative results when tested for the presence of the 
organism by the 'De Wit PCR protocol'. 
Method. 
As inhibitors are one possible reason for this finding, DNA extracted material 
(10µ1) from each of these specimens was retested. However, before PCR, lOpg 
of genomic M tuberculosis DNA was added to each reaction mix. This 
concentration of DNA was used as it is the lowest amount clearly detectable by 
gel electrophoresis using the 'De Wit' protocol. Positive controls, consisting of 
lOpg and lOOpg genomic M tuberculosis DNA and a negative control (water · 
blank) were included. The products of amplification (20µ1) were separated by 
electrophoresis in 3% agarose gel, stained with ethidium bromide and 
photographed with UV trans-illumination. 
Results. 
The positive controls (figure 9.5) showed the expected degree of amplification. 
The negative control gave a negative result. With regard to the test results 
(lanes 1-13), the degree of amplification using lOpg of specific DNA was 
acceptable in the majority of the specimens tested and inhibition is not a factor 
in these particular cases. The specimen result in lane 8 gave a faint band of the 
correct size. Lanes 1 and 2 show non-specific smearing which may have 
masked any faint positive (lOpg) results. 
Clarridge et al., (1993) report that inhibitors were present in 0-20% of the 
specimens in their study ( depending on the type of specimen). However, 
source-material inhibitors do not seem to have played a role in the results 
obtained in the pericardia! fluid pilot trial. Noordhoek et al., (1994) reports 
that poor results might not only be due to inhibitors but to non-lysis of M 
tuberculosis cells and/or loss of DNA during specimen extraction or DNA 
purification procedures. This could be one explanation for the culture positive 
and PCR negative results when the assay on these specimens was done. Even 
the use of a highly sensitive detection sytem (Southern blotting and radio-
labelled hybridisation followed by auto-radiography) did not detect the 
expected amplified product when these specimens were first tested as part of 
the pilot study ( chapter 2). An alternative explanation is that in PCR assays 
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where the specimens contain low numbers of target molecules, non-specific 
amplification products are generated which compete with specific 
mycobacterial DNA present in the specimen and consequently interfere with 
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Figure 9.5. The testing of M tuberculosis PCR negative, culture positive pericardial 
fluids for the presence of inhibitors in the source material. 
Lanes 1-13, M tuberculosis PCR negative, culture positive pericardial fluids with the 
addition of lOpg of genomic M tuberculosis DNA. Lane 14-15, positive controls; 




While a number of potentially inhibitory reagents are used for extraction and 
purification purposes in the 'De Wit' protocol, the design is such that their use 
does not interfere with the amplification procedure. Furthermore, primary 
inhibition does not seem to be a factor in the PCR of mycobacterial cultures 
( chapter 11) or the pericardia! fluid trial ( chapter 2); judging by the the results 
seen in figures 9.4.and 9.5. 
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10 1. Introduction. 
One of the greatest challenges facing the diagnostic application of PCR is the 
elimination of false positive results due to contaminating target DNA (Persing 
et al., 1991). The problem of PCR contamination is pervasive: even Taq 
polymerase has been reported to contain bacterial DNA of unknown origin 
(Rand and Houck, 1990). 
PCR produces vast numbers of potentially amplifiable molecules; it is 
estimated that a standard PCR can contain as many as 1012 molecules of the 
amplicon (Kwok and Higuchi, 1989). Aerosolization can generate small 
droplets that may contain as many as 1 os amplicons each (Persing, 1991 ). 
Repeated amplifications and the handling of the amplification products can 
result in the accumulation of target specific sequences. Ventilation systems 
and even the skin and hair of workers can act as mobile sources of 
contamination (Kitchin et al. , 1990). The subsequent contamination of 
reagents and glassware, for example, can result in spurious positive results 
(Persing, 1991). 
A further consideration is that detection systems are not able to distinguish 
between amplifications of contaminating and true target DNA, especially if the 
clinical source material contains low numbers of the target organism. The 
problem is especially acute in the diagnosis of infectious diseases where assays 
are be able to detect template molecules at the limits of sensitivity (that is 1-10 
molecules ). Where culture is the only comparative gold standard, the burden 
of proof of true positive results rests on the laboratory concerned (Persing, 
1991). Amplicon contamination of clinical PCR has even led to the formal 
retraction of results being reported in the literature (Farrel and Tidy, 1989). 
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10.2. Sources of contamination. 
Contamination, for the purposes of this thesis, can be ascribed to two main 
sources: (i) cross contamination between specimens; (ii) laboratory 
accumulation of PCR amplicons. 
10.3. Measures to avoid or eliminate contamination. 
10. 3 .1. Physical containment. 
One way of eliminating contamination is to institute a strict separation of work 
areas with a distinct direction of work flow, as has been done in the 
Department of Medical Microbiology UCT. This division involves two 
dedicated PCR areas and, in addition, the use of the general laboratory as a 
'dirty' PCR area. The first PCR-clean or 'target-DNA-free' area is used solely 
for the preparation and storage of PCR reagents. It is also a reserve for PCR 
stock, pipettes, glassware and other dedicated materials. Reagents and other 
chemical compounds for PCR are also be prepared here. In addition, the 
cleaning of the area and the general removal of waste material is attended to by 
one operator using dedicated utensils. Use of this room is restricted to a few 
selected and trained persons. A second area, suitably removed from both the 
first dedicated area and the general laboratory, is used for DNA preparation and 
extraction purposes (Williamson, 1992). As before, extraction materials and 
reagents are dedicated to this area. New and disposable plastic-ware is used as 
often as possible (Orrego, 1990) in order to avoid the use of washed glassware . 
The aliquoting and storage of pre-amplification mixes for later use avoids 
excessive handling of PCR stocks (Komer, 1990). 
All work in these two areas takes place, when situations permit this, within the 
confines of a wooden glass-faced inoculation hood with its own UV radiation 
source. Operators involved in PCR activities are trained to avoid the 
inadvertent transfer of specific DNA from DNA extraction and amplification 
areas. Aerosol resistant tips (ART*, Continental Laboratory Products) are also 
used when needed. These pipette tips, fitted with a filter near the attatchment 
end, allow the dispensing of small volumes without the risk of contaminating 
the dispensing pipette with DNA. 
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However, the strategy involving physically separate areas for different aspects 
of PCR, while important as an anti-contamination measure, must be used in 
conjunction with other measures to decrease the risk of DNA contamination. 
To illustrate this point, an experiment was conducted where empty PCR 
reaction tubes (eight in number) were left open (overnight) in an enclosed 
laboratory which had never been used as a location for the culture of M 
tuberculosis. Following this, a PCR master-mix was made up and aliquoted 
into the eight PCR tubes. No DNA was added. The samples were subjected to 
PCR, using the sensitive two-set nested 'De Wit PCR protocol' described in 
chapter 8. Products from the first reaction (10µ1) were transferred to the 
second reaction mixture containing the inner primer set. This transfer took 
place in a PCR-clean area, using PCR-clean equipment. 
In spite of available precautions to avoid false positive results (the use of clean 
tubes and pipettes, vigorous hand washing before all PCR manipulations and 
the use of protective clothing and gloves), specific amplification was detected 
after the products of PCR were separated by electrophoresis on agarose gel, 
stained with ethidium bromide and analysed by UV trans-illumination (figure 
10.1). While entirely speculative, it is possible that the positive result obtained 
was due to the amplification of air-borne contamination. The PCR tubes could 
also have been contaminated with amplicons carried on shed epithelial cells 
and hair from laboratory personnel, including mys_elf (Kitchin et al., 1990). 
Clearly, the avoidance of PCR contamination requires not one but a 
combination of different anti-contamination strategies. 
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Figure 10.1. Nested PCR results obtained using a PCR protocol which specified that 
no target DNA be added to the first-round PCR reaction mixture. 
Lanes 1-8, nested amplifications conducted using the two-set nested protocol 
described in chapter 8. No DNA template was added to the PCR mixture. 
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10.3.2. UV radiation. 
The use of UV radiation to minimize contamination has been reported in the 
literature (Salcar and Sommer, 1990) although there has been some comment on 
its effectiveness and on how it should be employed (Cimino et al., 1990 and 
Fox et al., 1991). In the Department of Medical Microbiology, UCT, all PCR 
tubes are, where practical, exposed to UV radiation before the addition of the 
PCR mixture (Philips TUV 15W for 10 minutes). Hood containment areas and 
items such as Gilson pipettes which are resistant to UV radiation are routinely 
bathed in UV before use. UV light sources are periodically checked for 
effectiveness by exposing newly plated cultures of Staphylococcus aureus 
( oxford strain) to UV radiation before overnight incubation. The presence of 
growth after incubation signifies that the UV source is ineffective as a 
sterilizing agent and needs to be replaced. 
10.3.3. Photo-chemical methods. 
This is a method which utilizes the photo-chemical properties of a psoralen 
derivative and has been described fairly extensively (Cimino et al., 1991 Meier 
et al. , 1993). Psoralen is added to the PCR mixture before amplification as it 
does not substantially interfere with Taq polymerase activity or primer 
annealing and is also the1mally stable. The PCR mixtures are exposed to long 
wave UV radiation directly after amplification. UV activates the psoralen 
which forms adducts with pyrimidine residues that prevent Taq polymerase 
from traversing this region in subsequent amplifications (Persing, 1991). Its 
effectiveness as an anti-contamination measure depends in part on the length 
and nucleotide content of the sequence amplified. The G+C concentration 
should, ideally, be 50% or less, otherwise higher concentrations of psoralen 
have to be used. 
However, increased levels of psoralen have been implicated in the inhibition of 
PCR. A limiting factor in the use of this technique is the G+C rich (80%) 
content of the M tuberculosis sequence targeted in the 'De Wit PCR protocol'; 
the photochemical activities of isopsoralens are more effective where DNA 
sequences are A+T rich (Rys and Persing, 1993). For this reason, this 
technique was not tested. 
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10.3.4. Biochemical methods. 
Several biochemical methods make use of nucleases to overcome 
contamination. 
(a) Exonucleases. 
Muralidhar and Steinman (1992) have published a protocol which uses 
exonuclease T7 as an anti-contamination measure. This protocol exploits the 
geometric differences between amplicons and genomic targets and therefore 
allows the eradication of contaminating amplicons whilst leaving the native 
genomic target relatively intact. This method was not tested because of the 
relative expense involved and because of problems associated with the 
availability of this enzyme. Zhu et al., (1991), report on the use of exonuclease 
III for PCR sterilisation while Rochelle et al., (1992) report on the treatment of 
Taq polymerase for contamination, using DNase. 
(b) Primer hydrolysis. 
Rys and Persing (1993) have suggested the use of a post-PCR alkaline 
hydrolysis step of PCR products synthesized by using primers containing 3' 
ribose residues. In their study, the effectiveness of this system depended on the 
number and position of the 3' ribose residues but amplified DNA sequences 
were still inactivated in the range 104-109 copies. This method appears to be 
highly effective and is cost competitive. However, tubes containing amplified 
DNA must be opened to allow the addition of NaOH. Rhys stated that until 
PCR reaction vessels that allow one-way reagent addition after amplification 
are developed, the opening of tubes may lead to contamination by aerosolized 
amplification products. 
This method was only available in our department during the final stages of the 
writing up of this thesis. Therefore its effectiveness, using the modified PCR 
reaction tube ( chapter 12), has not been tested. 
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(c) Uracil-N-glycosylase. 
Uracil-N-glycosylase (UNG) is the basis for a widely used anti-contamination 
strategy. UNG is capable of cleaving the uracil base from the phosphodiester 
backbone of uracil-containing DNA (Longo et al., 1990), preventing its use as a 
target in amplification. It does not remove uracil from RNA or free 
nucleotides, but only from single or double stranded DNA longer than about 4 
nucleotides (Longo et al., 1990). After treatment with UNG, uracil-containing 
DNA is unstable and subsequent heating breaks the phosphodiester backbone. 
The UNG anti-contamination protocol involves the substitution of dUTP for 
dTTP in the PCR protocol. Therefore, DNA containing dU is produced upon 
amplification. When contaminating strands of dU-target DNA are present in 
pre-amplification PCR mixtures, incubation with UNG cleaves the amplicons. 
Following this, the initial PCR DNA denaturation incubation step (usually 5-10 
minutes) denatures the enzyme (with a subsequent loss of activity). 
Amplification of dU-target DNA can then proceed unhindered. 
Some authors find the UNG protocol useful as an anti-contamination measure. 
We tested dUTP with the 'De Wit PCR protocol' and found no loss in 
sensitivity. The results, after 20µ1 of each aliquot was separated in 3% agarose 
gel, stained with ethidium bromide, and analysed by UV trans-illumination, can 
be seen in figure 10.2. 
However, heating UNG at 950c for 10 minutes (figure 10.3.) or even at 1000c 
for 15 minutes did not fully inactivate the enzyme. Corroborative reports have 
appeared in the literature of incomplete inactivation of UNG at high 
temperatures (Persing,1991). Espy et al. , (1993) also reported that amplicons 
less than/equal to lOObp are not effectively inactivated by UNG. These 
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Figure 10.2. Chromosomal M tuberculosis DNA amplifications substituting dUTP 
for dTTP. 
Lanes 1-3, Ing, lOOpg, lOpg of DNA, respectively, amplified using 200nM dTTP; 
lanes 4-6, Ing , lOOpg lOpg of DNA, respectively, amplified using 200nM dUTP. The 
'De Wit PCR protocol' was used in all amplifications. 
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Figure 10.3. Heat inactivity ofUracil-N-glycosylase. 
M tuberculosis genomic DNA (20pg, heat denatured at 950c for 10 minutes) was 
amplified in the presence or absence of UNG. The effect of heat-inactivation of UNG 
was assessed. Lane 1, amplification in the absence of UNG; M tuberculosis DNA and 
Taq polymerase were added to the PCR reaction mix which had been pre-incubated at 
950c for 10 minutes. Lane 2, amplification in the presence of heat-inactivated UNG; 
UNG (lunit) was pre-incubated at 950c for 10 minutes in PCR reaction mix prior to 
the addition of DNA and Taq polymerase. Lane 3, amplification in the presence of 
UNG; addition of UNG (lunit), M tuberculosis DNA and Taq polymerase 
immediately followed by thermal cycling without pre-incubation at 950c. The 'De Wit 
PCR protocol' was used in all amplifications. 
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( d) Restriction endonuclease. 
Dougherty et al., (1993) reported the use of a restriction endonuclease (Sma I) 
as an anti-contamination measure. An endonuclease is selected that restricts 
the PCR product between, but not within, the primer binding sites. Pre-
treatment of PCR mixtures with endonuclease prior to the addition of the 
sample DNA ensures that any contaminating target amplicons are degraded. 
The restricting enzyme is heat inactivated before sample DNA is added, thus 
preventing the degradation of true-target DNA. 
Avail restriction enzyme is capable of restricting the amplification product 
directed by, and internal to, the primers Kl and S2 used in the 'De Wit PCR 
protocol'. It was also found that this enzyme is active in PCR buffer (results 
not shown). 
Method. 
In order to prove the effectiveness of Avail as an anti-contamination method 
with the 'De Wit PCR protocol', the following digests were constituted: aliquots 
(3 in number) containing Lamda DNA (0.5µg) and PCR buffer (20µ1) . Avail 
was added to each of these at the following concentrations: lunit, 0.5units and 
0.25units respectively. Further aliquots (2 in number), with 0.5µg of 'U' 
containing M tuberculosis DNA in PCR buffer (20µ1), were constituted. Avail 
(lunit) was placed in one of the two aliquots. A last set of aliquots (2 in 
number) with 0.5µg of 'T' containing M tuberculosis DNA in PCR buffer 
(20µ1) was constituted. Avail, lunit, was placed in one of the two aliquots. 
All mixtures were incubated at 370c for 1 hour. Following this, 20µ1 of each 
aliquot was separated in 3% agarose gel, stained with ethidium bromide, and 
analysed by UV trans-illumination. The results can be seen in figure 10.4. 
Results and discussion. 
The results show that Avail enzyme is capable of restricting 0.5µg Lamda DNA 
at concentrations of 1 unit, 0.5units, and 0.25units with almost equal facility 
(figure 10.4). Avail is able to restrict 'U' containing and 'T' containing DNA 
with near-equal efficiency. 
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Figure 10.4. The testing of Avail using various templates, namely Lambda DNA, M 
tuberculosis PCR DNA ('De Wit PCR protocol') and similar M tuberculosis template 
with dUTP substituting for dTTP. 
Lanes 1-3, Lambda DNA O.Sµg, PCR buffer 20µ1 , Avail lunit, O.Sunits and 
0.25units, respectively. Lanes 4-5, O.Sµg of 'U' containing M tuberculosis DNA and 
PCR buffer. Lane 4 also contained Avail, 1 unit. Lanes 6-7, 0. 5 µg of 'T' containing M 
tuberculosis DNA and PCR buffer. Lane 6 also contained Avail, 1 unit. 
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To determine the value of this anti-contamination procedure: (i) the 
concentration of Avail required to digest a specific amount of susceptible DNA 
had to be ascertained. Lambda DNA, at a concentration of 0.5µg, was used in 
this test. This concentration was chosen because it represents an amount 
grossly in excess of that expected during a PCR contamination episode. 
Lambda DNA has the added advantage of possessing several Avail restriction 
sites, whereas the target produced during the 'De Wit PCR protocol' has two 
such restriction sites. Therefore, adequate restriction of Lambda DNA at this 
concentration would ensure effective anti-contamination treatment of the 'De 
Wit PCR' protocol pre-amplification mixes. (ii The Kl-S2 ('De Wit PCR 
protocol') sequence contained the necessary restriction site [GG(A/T)CC] but 
the restriction of the amplicon had to be tested empirically with Avail to ensure 
the effectiveness of the protocol as an anti-contamination measure. (iii) It had 
to be ascertained whether Avail could restrict dU as well as dT containing 
target sequences. This was because dUTP rather than dTTP is routinely used 
in the 'De Wit PCR protocol'. 
In view of these results, it was decided to use Avail to pre-treat PCR reaction 
mixes at a concentration of 1 unit/40µ1 PCR reaction mix. The protocol 
included an Avail incubation step for one hour at 370c , an Avail inactivation 
step at 600C for 10 minutes, followed by the addition of the specimen extract 
for PCR. 
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10.4. The effectiveness of anti- contamination measures. 
10 .4 .1. Introduction 
Despite the use of anti-contamination measures, false positive amplifications 
still confounded the results of assays done in this laboratory. The following 
assay was done on a cerebrospinal fluid from a suspected case of tuberculous 
meningitis, using the 'De Wit PCR protocol'. The results will help to illustrate 
the problems posed by contamination in diagnostic PCR. 
10.4.2. Method. 
Cellular material was concentrated by centrifuging the specimen (3mls CSF) at 
6000xg for 20 minutes (Heraeus Megafuge 1.0), followed by the removal and 
disposal of all but the lower 0.3ml of the supernatant fluid and the centrifuged 
deposit. This smaller volume, together with the deposit, was boiled for 5 
minutes to lyse cells and release cellular DNA. A volume of 10µ1 was added to 
PCR mixtures in triplicate and subjected to amplification. Positive controls 
( lpg and 20pg genomic M tuberculosis DNA) and two water-blank negative 
controls were included. The water used was obtained from a source well 
removed from all 'M tuberculosis' laboratory activity (Dept of Virology: 
Serology section). Anti-contamination measures (physical containment, UV 
irradiation treatment of reaction tubes before loading and the 'Avail' protocol) 
were applied to all specimens and controls. The products of amplification were 
separated by electrophoresis in agarose gel, stained with ethidium bromide and 
analysed by UV trans-illumination. The gel was Southern blotted, subjected to 
hybridization using a radio-labelled probe (32p) and autoradiographed, as 
decribed in chapter 2. 
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10.4.3 Results and discussion: autoradiography. 
The positive controls gave the expected positive signals. One of the test 
specimens (lane 5) gave a false-positive result due to 'spill-over' from the lpg 
positive control (lane 6). One of the two negative controls gave a positive 
signal, despite the use of anti-contamination procedures (figure 10.5). This 
invalidated this particular test-run. It is difficult to speculate at which point 
during the PCR protocol the contamination of the negative control took place. 
The stock water used as a negative control source could have been 
contaminated during the PCR preparative stage. Alternatively, contamination 
could have occurred after amplification but before hybridisation ( chapter 8) as 
a result of agarose gel 'slot' spill-over (Noordhoek et al., 1994). 
Noordhoek et al., (1994) also reported on a high false positive rate among 3 of 
the 7 laboratories which took part in a WHO sponsored, blinded PCR study of 
200 samples for the presence of BCG. Of the 110 non-BCG containing 
samples, the percentages of false positives in the results obtained by these 
laboratories were 77, 20 and 17. This represents an unacceptably high rate for 
laboratories engaged in the clinical evaluation of specimens for the presence of 
M tuberculosis. As regards the pericardia! fluid pilot trial (table 2.2.), it will 
be seen that 5 fluids tested culture negative and PCR positive; an anomalous 
result considering that out of 20 cultw·e positive specimens only 5 were PCR 
positive. Thus a factor to be considered as important as regards the problem of 
contamination in this laboratory is the number of persons who have become 
involved in a) the culture of M tuberculosis, b) manipulations involving the 
extraction and amplification of DNA from cultw·e sources of M tuberculosis. 
All of these activities pose an obvious contamination risk to activities involving 
TB DNA extraction from clinical specimens, even if the latter are treated with 
special care and are handled in dedicated areas. Therefore, the implications of 
the CSF result above do raise questions as to the reliability of any positive 
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Figure 10.5. Amplification results illustrating the problem of target contamination. 
Lanes 1 and 2, water blank negative controls; lanes 3, 4 and 5, CSF specimen in 
triplicate; lanes 6 and 7, genomic M tuberculosis DNA, 1 pg and 20pg respectively. 
Amplification products were separated by electrophoresis in 3% agarose gel, Southern 
blotted, hybridised using a radio-labelled 32p probe and auto-radiographed. 
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10.5. Conclusion. 
Rys and Persing (1993) state that the ultimate long term success of all nucleic 
acid amplification methods catalysed by enzymes depends on whether the 
products of amplification are contained or inactivated. Contamination control 
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CHAPTERll. 
IDENTIFICATION OF M. tuberculosis CULTURES BY PCR. 
11.1. Introduction. 
Current laboratory diagnosis of suspected cases of tuberculosis depends on the 
culture and subsequent biochemical identification of M tuberculosis. This 
approach has two main disadvantages: 
(i) The process is lengthy. Current speciation techniques are based on the 
ability of M tuberculosis, unlike M bovis and BCG, to produce niacin in 
cultures. The niacin testing protocol, however, requires large amounts of slow-
growing mycobacterial primary culture ( about 3 weeks growth of a large 
loopful: Laidlaw et al., 1989 ). 
(ii) With the increase in mycobacterial infections in immuno-compromised 
patients (notably HIV-related illnesses), reports of M kansasii being implicated 
are not uncommon. More disturbing are incidents of infection involving 
niacin-producing strains of M. kansasii (Nachamkin, 1992). 
The specificity of the primers used in the 'De Wit PCR protocol' for M 
tuberculosis (De Wit et al, 1990 and 1992) and the relative speed of the 
procedure suggested that PCR might have a role to play in the more reliable 
differentiation of M tuberculosis from other members of the genus, namely, by 
amplification from culture. To test this, PCR assays were carried out on 846 
mycobacterial cultures from clinical specimens and the results of these were 
compared with those of the niacin test on the same specimens. 
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11.2. Materials and Methods. 
Mycobacterial processing and culture techniques for clinical specimens were 
followed (section 1.8). On sub-culture of the primary colonies, the cotton swab 
used to seed L&J slopes was placed in a screw-capped, 15ml polypropylene 
tube (Evergreen) containing 1ml of sterile Tris-EDTA buffer (lOmM Tris, 
lmMEDTA). 
To lyse the bacteria, the cell suspensions were heated in boiling water for 10 
minutes, cooled to ambient temperature and vortexed. Centrifugation in a 
Beckman GS-6 centrifuge ( 1 OOOxg for 3 minutes) was used to recover the 
condensate that had formed in the top of the tube. The suspensions were boiled 
for a further five minutes, cooled and re-centrifuged. This was to ensure 
inactivation of viable organisms that might not have been inactivated during the 
first heating procedure. 
The 'De Wit PCR protocol', using the primers Kl and S2 to prime a 336bp 
amplification product, was adjusted as follows: an initial denaturing step of 
950c for 8 minutes followed by 38 cycles consisting of 950c for 10 seconds 
and 680C for 60 seconds. This adjusted thermocycle profile was determined to 
be the profile giving the best results with the DNA extraction and PCR-product 
detection ( electrophoresis in agarose gels) methods used. 
Assays were performed without prior knowledge of the culture and biochemical 
test results. Swabs from non-M tuberculosis cultures and from uninoculated 
culture media were included in every batch of tests to monitor specimen 
contamination with M tuberculosis DNA. All PCR negative and ZN positive 
specimens were identified further using biochemical tests (section 1.8). 
Amplification reaction products (20µ1) were separated by agarose gel 
electrophoresis. The presence of an amplification product of 336bp was 
considered positive for M. tuberculosis (figure 11.1). 
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Figure 11.1. Mycobacterial cultures identified asM tuberculosis using the 'De Wit 
amplification assay'. 
Lane 1, M kansasii control; lane 2, uninoculated L&J slope control; lanes 3-8, 
cultures identified as M tuberculosis using the 'De Wit PCR protocol' and confirmed 
using the 'niacin production' test. 
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11.3. Results and Discussion. 
To date 846 assays have been done. Of these, 99 were on non-mycobacterial 
cultures or bacteria-free specimens used as negative controls; none of these 
were PCR positive. Of the 747 Ziehl-Neelsen positive cultures, 650 (87%) 
have been identified as M tuberculosis by the niacin assay while 571 (76%) 
were positive using the PCR assay. Thirty two of the 79 PCR negative, niacin 
positive cultures were PCR positive when an additional swab or the original 
lysate was reamplified. While the test did not identify all of the niacin positive 
specimens, the protocol is not designed to be highly sensitive. With the present 
sensitivity level, contaminating DNA, which could confound the results of a 
more sensitive assay, is not detected using this protocol. This feature avoids the 
issuing of false positive results. Since the protocol includes the biochemical 
identification of PCR negative cultures, no M tuberculosis isolates should be 
subject to misclassification. Of the 747 Ziehl-Neelsen positive cultures, 97 
were non-M tuberculosis isolates consisting of M kansasii (39), M 
scrofulaceum (9) and M smegmatis (5). These were PCR negative. The 
remaining 44 isolates were not identified and were reported as being 
'environmental mycobacteria'. These also gave negative PCR results. 
The PCR assay takes 1 day to pe1form. In contrast, niacin production and other 
biochemical tests for M tuberculosis can take as long as three weeks. 
Several authors have described the use of probes or PCR protocols for the early 
detection of mycobacterial isolates in BACTEC cultures. Using a non-
radioactive probe, Evans et al., (1992) obtained 77% sensitivity and 100% 
specificity for M. tuberculosis in primruy BACTEC cultures. Generally 
probes, although highly specific, do present with problems in the direct 
detection of M tuberculosis in clinical specimens (Steyn, 1993). Cormican et 
al., (1992) were able to identify the presence of 15 M tuberculosis complex 
organisms by PCR 7-10 days earlier than achieved by standard growth 
inhibition tests. In this study a sensitivity of 88% and a specificity of 100% 
was obtained. 
The 'De Wit amplification assay' represents a different yet highly reliable 
approach to the early identification of M. tuberculosis from cultures and 
indicates a more practical application of PCR for the laboratory diagnosis of 
tuberculosis than the direct detection of the organism in clinical specimens. 
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CHAPTER12 
MODIFIED REACTION TUBES; 
for the sequential addition of reagents in PCR assays. 
12.1. Introduction. 
12.2. Reaction tube modification. 
12.3. Application of the modified tubes in the PCR detection of Hepatitis 
C virus. 





MODIFIED REACTION TUBES; 
for the sequential addition of reagents in PCR assays. 
12.1. Introduction. 
PCR protocols such as nested primer amplifications (Plikaytis et al., 1990), re-
amplification protocols (Pierre et al., 1991) and PCR on reverse transciption 
cDNA (Boddinghaus et al., 1990) require additional opening and closing of the 
reaction tubes. As shown in chapter 8, the risk of contamination during this 
procedure is considerable. The number of times a reaction tube is opened can 
be limited by storing the additional reagents required for sequential reactions in 
the same tube. These are then added to the reaction mixture at the appropriate 
time during the amplification procedure. An original method of accomplishing 
this was devised in the Medical Microbiology department, UCT (Allan et al., 
1994). 
12.2. Reaction tube modification. 
Modified Eppendorf 'safe-lock' reaction tubes (0.75ml) were constructed as 
follows: a Gilson p20/p200 pipette tip (Elkay Lab System) was cut in two with 
a scalpel blade 10-12mm from the narrow end. The tip of the smaller piece 
was melted using a Bunsen burner and pressed onto the centre of the inner 
surface of the lid of a reaction tube at an angle of 900. The pressure applied 
shortened the tip to 7-8mm. This attachment formed a reservoir for a second 
set of reagents. 
12.3. Application of the modified tubes in the PCR detection of Hepatitis 
C virus. 
145 
The modified tubes were used in the detection of hepatitis C, an RNA virus, in 
the serum of infected patients. Viral RNA was extracted from 200µ1 of serum 
using the guanidinium-thiocyanate/phenol-chloroform method of Chomczynski 
and Sacchi (1987) and was dissolved in 15µ1 of DEPC water with 40U RNasin 
(Promega). RNA (5µ1) was incubated at 950c for 5 minutes in the presence of 
the outer primers (0.2µM of each) in PCR buffer. These primers are 
complimentary to the conserved 5' non-coding region of the HCV genome 
(Brown et al., 1992). This mixture was added, after cooling, to a modified 
reaction tube containing 200µM of each dNTP, 1.25units Taq polymerase 
(Boehringer Mannheim), 200units MMLTV reverse transcriptase (BRL) and 
lOunits RNasin in a final volume of 50µ1. Liquid paraffin (2 drops) was then 
added. The reservoir contained 5µ1 of PCR buffer, 4µM inner primers (Brown 
et al., 1992), 1.25units Taq polymerase and 0.01% bromphenol blue. This mix 
was placed as far as possible within the reservoir using a Gilson ClO tip. 
Vaseline was used to seal the orifice of the reservoir (figure 12.1). The tube 
was handled with reasonable care to avoid premature release of the mix. 
Reverse transcription was carried out at 420c for 30 minutes followed by the 
inactivation of the reverse transcriptase at 950c for 90 seconds. Thirty cycles 
of PCR were used to amplify the outer PCR product from the cDNA 
(denaturation 92.50C for 45 seconds, annealing 500c fpr 60 seconds, extension 
at 100c for 90 seconds). The closed tube was centrifuged for 10 seconds at 
6000xg in an Eppendorf centrifuge to add the contents of the reservoir to that in 
the tube. The reaction tube was tapped a few times to ensure mixing of the 
reaction mixes, which turned uniformly blue due to the presence of the 
bromphenol blue dye. A further 30 PCR cycles were performed. Aliquots 
(10µ1) of the products of amplification were separated by electrophoresis in 3% 
agarose gel, stained with ethidium bromide and analysed by UV trans-
illumination (figure 12.2.a). Subsequent Southern blots were hybridised with a 
digoxigenin labelled, HCV-specific DNA probe to confirm the identity of the 
PCR products (figure 12.2.b). 
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Figure 12.2 a and b. Detection of HCV amplification products. 
a) Agarose gel stained with ethidium bromide, lanes 2-5, HCV antibody positive 
patients; lanes 6-7, HCV antibody negative patients; lanes 8-9, negative reagent 
controls; lanes 1 and 10, molecular-weight marker VI, digoxigenin labelled 
(Boehringer Mannheim). The arrow indicates the position of the 202bp HCV band. 
b) Hybridisation analysis after Southern blotting of PCR products using a digoxigenin-
labelled HCV-specific probe. 
12.4. Application of the modified tubes to add extra Taq polymerase 
during PCR. 
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The addition of extra Taq polymerase during PCR can have a marked effect on 
the sensitivity of PCR. The validity of assay results will not be compromised if 
this can be achieved without the need to open the reaction tube (thereby risking 
contamination). 
To show the effect that the addition of a further quantity of Taq polymerase can 
have, dilutions of genomic M tuberculosis DNA were subjected to a modified 
'De Wit PCR protocol' (primers Kl, Sl, K2 and S2 added to the pre-
amplification mix). Similar dilutions, but in modified tubes, were subjected to 
the same protocol. The modified tubes contained extra Taq polymerase in PCR 
buffer (0.75units in 4.5µ1 of lx PCR buffer). This mixture was sequestered in 
the upper compartment of the modified reaction tube. After 30 PCR cycles, all 
tubes were cooled on ice, followed by the addition of the sequestered enzyme. 
PCR was again carried out for 30 cycles. The amplification products (20µ1) 
were separated in 3% agarose gel and analysed by UV trans-illumination. The 
visual results under UV trans-illumination showed that considerably more 
amplification product was present in the lanes of the specimens which received 
additional enzyme, using the modified tube. These results are shown 
photographically in figure 12.3 (lanes 4-8) where the increase in product could 
be interpreted (incorrectly) as high background and non-specific amplification 
only. Lanes 5-7 also show that as the concentration of amplifiable DNA drops, 
the internal primer product (K2 and S2) is favoured over that of the external 
primers (Kl and Sl). This phenomenon has been noted in other experiments 





1 2 3 4 5 6 7 
Figure 12.3. The addition of extra Taq polymerase using the modified tube. 
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Lanes 1-4, 450pg, 45pg, 4.5 pg and 450 fg genomic M tuberculosis DNA 
respectively; lanes 5-8, similar concentrations of M tuberculosis DNA in modified 
reaction tubes. All tubes were subjected to a modified 'De Wit PCR protocol' for 60 
cycles. After 30 cycles, Taq polymerase, internally sequestered in the upper 
compartment of the modified tubes, was added to each of the reaction mixes 
represented by lanes 5-8. 
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12.5. Discussion. 
The modified reaction tubes, used here in the PCR detection of Hepatitis C 
virus and in the addition of extra Taq polymerase, were originally devised to 
overcome the problem of having to open the reaction tubes during nested 
primer PCR. Other components, however, such as NaOH (for a primer 
hydrolysis step, section 10.3.4.b.), labelled primers and even template ('hot-
start' protocol, D'Aquila et al., 1991) can be added at any stage during the 
amplification reaction using the modified tube. Components can be added to 
the reservoir under clean 'containment' conditions and because the reaction tube 
does not have to be re-opened after the amplification protocol has commenced, 




The work presented in this thesis details attempts to adapt the PCR assay, 
developed by De Wit et al., (1990) for use in a routine clinical laboratory. Its 
role as an aid in the diagnosis of M tuberculosis pericarditis is evaluated. 
Clinical PCR involves 3 basic steps: DNA extraction, PCR amplification and 
the detection of the amplified product. 
(i) DNA extraction usually involves toxic organic chemicals. The use of 
phenol and organic solvents ( chapters 2 3 and 4) are common to many 
extraction methods. There is also the risk of contamination of the sample with 
DNA from other specimens (chapter 10) or from amplified products from 
previous reactions (chapters 8 and 10). This is an ubiquitous problem in 
diagnostic PCR. 
(ii) PCR amplification requires expensive reagents and manual dexterity in 
handling very small volumes without introducing contaminants (Walker et al., 
1992). Amplification protocols rely on machines which do not always provide 
adequate thermal profiles (Hoezel, 1990). The findings in chapter 7 as regards 
the accuracy and reliability of therrnocyclers confirm this observation. 
Optimization of PCR is predicated on a variety of known and unknown factors 
(chapters 7 and 9). More will therefore have to be discovered about the 
physical and chemical foundations of PCR to ensure optimisation of all facets 
of the technique (Bloch, 1991 ). 
(iii) Detection methods are either rapid but insensitive (gel electrophoresis 
detection protocols; chapter 11) or sensitive but time consuming and expensive 
(Southern blotting, hybridization and autoradiography). 
Certain requirements need to be met before the diagnostic PCR procedure, 
based on the direct examination of clinical specimens, becomes more useful. In 
summary, and based on the findings in this thesis, these can be listed as 
follows: 
a) A simple ·and effective extraction procedure is needed. The choice of 
method will depend on the type of specimen and on the amount of infecting 
organisms expected to be present in the specimen. In pericardia! fluids from 
cases of tuberculous pericarditis, the method will have to be rapid yet simple 
enough to conserve the (sometimes crucially) minute amounts of target DNA 
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present in the untreated specimen. Yet, the in toto extraction of DNA from M 
tuberculosis, which is an organism which is physically resistant to many DNA 
extraction procedures, requires the use of elaborate ('De Wit PCR protocol', 
chapters 2 and 3) rather than simple extraction procedures. Extraction, using 
the 'De Wit PCR protocol', does provide DNA that is unsheared, but lru:ge 
amounts of DNA are lost during the procedure (chapter 3). The simple 
extraction procedures, while having the advantages of ease-of-use and speed, 
do not extract and isolate enough target DNA from its bacterial ( chapter 11) or 
clinical ( chapter 6) origins. 
b) A further requirement is a strategy that is able to i) negate the effects of all 
forms of inhibition ii) remove inhibition ( chapter 9). 
c) Especially necessary are PCR protocols that are able to avoid or neutralise 
the influence of both sporadic and systematic contamination originating from 
the PCR macro- and-micro-environment. Anti-contamination strategies will 
have to be evaluated beforehand to establish their efficacy: the use of the UDG 
protocol, though theoretically attractive, proved impractical because of the heat 
resistance of the enzyme. The use of psoralen derivatives are not suitable 
where high G+C content DNA is involved (chapter 10). Various other systems 
were tested namely: physical containment, the use of UV radiation and 
restriction enzymes. Yet no one anti-contamination method is all-
encompassing in its effectiveness; a protocol based on various strategies used 
in concert is the most practical. 
d) Reliable, safe, practical, accurate, rapid and accessible methods for the 
detection of amplification product are needed. The use of hybridizing 
techniques involving 32p are not practicable in a routine laboratory situation 
and simpler methods, such as those involving gel electrophoresis, have a 
limited application because of a relative lack of sensitivity. 
e) Interpretative strategies that provide facilitative support for the clinician 
are required. Of relevance in this regard is the clinical as opposed to the 
statistical significance of the presence of M tuberculosis DNA in a clinical 
specimen. Brisson-Noel et al., (1989) reports that mycobacteria can still be 
present in treated patients some time after the culture for mycobacteria is 
negative. M tuberculosis DNA has been detected in samples that were 'acid-
fast' and 'culture' negative and that were obtained from patients who had been 
on treatment for tuberculosis for 2 months (Folgueira et al., 1993). As put by 
Clewley et al., ( 1989), the significance of 'minute quantities of selected regions 
of a viral genome in a healthy person will be difficult to assess'. The 
significance, where a similar situation exists in i), persons who, as regards M 
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tuberculosis infections, are to all intents and purposes 'healthy', or ii), in 
persons who have been treated at length for M tuberculosis related infections, 
will also be difficult to assess. 
The difficulties experienced with the extraction of mycobacterial DNA from 
certain clinical specimens and the unwanted amplification of contaminating 
DNA are well referenced in the literature and are by no means peculiar to this 
study. This has led to the retraction of published results (Farrell and Tidy, 
1989). One author states that it is debatable whether PCR in its present limited 
form is suitable as a routine clinical test (Persing, 1990). While this statement 
has some credence with regard to the direct PCR examination of pericardia! 
fluid specimens for the presence of M tuberculosis DNA, we have found the 
modified 'De Wit amplification and detection protocol' eminently suitable for 
the rapid identification of M tuberculosis cultured from clinical specimens. 
It is my view that, as is the case with many novel diagnostic techniques, an 
objective evaluation of the PCR technique does not always allow initial 
subjective expectations to be fulfilled. The obvious potential implications of 
false positive and false negative 'clinical PCR' results do not have to be 
elaborated upon. Podzorski and Persing (1993), state that we will have to 
advance cautiously into the new diagnostic era. 
Nevertheless, there is no doubt that many of the present problems concerning 
the application of the PCR technique will be overcome as new developments in 
the field take place. And these inevitably will. However, because of the 
clinical nature of many infectious diseases and the consequences of laboratory 
misdiagnosis, the real challenge is to assign contemporary PCR techniques a 
useful, practical and relevant role with regard to the diagnosis of infectious 
diseases in general and tuberculosis in particular. 
Appendix 1 
PCR Protocol: M. bovis primer sequences from M. bovis 
-thermocycle parameters. 
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DNA molecular weight marker VI; Boehringer Mannheim. 
The mixture contains 15 fragments with the following number of base pairs: 
2176/1766/1230/1033/653/517/453/394/298/298/234/234/220/154/154 
Appendix 4 
Fast Magnetic Purification (FMP) for 
M13 single-stranded DNA minipreps 
RPN 1690 
For the rapid Isolation of M13 alngle·stranded DNA templates for use 
In dldeoxy DNA sequencing 
Warning: For research use only. Not r~ommended or Intended for 
diagnosis of disease In humans or animals. Do not use lntemally or 
externally In humana or anlmala. 
Amersham 
roductlon 
sequencing by the Sanger dideoxy nucleotide method ,·1 has ergone significant refinement in recent years . including the elopment of add itional vectors 111, the use of base analogues ,i • . mes that are thermostable ,s, or have high process1v1ty rates ·~ and uments for the partial automat ion of sequence ana lysis ., ' 
growth and extraction of sing le-stranded M13 recombinant templates ~nsidered to be one of the rate limiting steps w1th1n many seouenc,ng ects . For th is reason. Amersham International has developed a nove: arat,on technology (patent pending) wh,ch both s,mpli f,es and shortens extract ion of ssDNA from M 13 or phagem,d recomb,nants 
> is a novel technique for the rapid separation of prec1p1tates from 9rnatants. which harnesses the power of magnetism rather than rifugat1on . The small. dispersed. superparamagnet,c FMP part ,c ies ac t solid phase around which the prec1p1tate can form . On applicat ion of gnet,c field grad ient . the part icles become magnet ized and migrate 10 ole of the magnet . taking the precipitate with them. Th,s permits the removal of supernatant. Only when the magnet ,s removed do th,; cles red,sperse enabl ing the trapped precipitate to be washed or vered in a suitable solvent . 
M1~ minlprep procedure involves the following steps: 
aratlon of M13 su~matants:• Plaques are picked and grown as 1n ndix 1. Host cells are removed by centrifugation. and the resulting rnatants are then extracted by FMP. 
e precipitation: The addition of the FMP/PEG/NaCI suspension es the phage to aggregate around the FMP part icles. On appllcat,on e magnetic field. the part icles are rapidly attracted to the ooies of the et .carrying the phage with them. The supernatant can theri be eas ily ved . On removing the magnetic field. the part icles lose the•r magnet ic ents which enables resuspension of the FMP/phage pellet 
tocols 
ents of the kit ,-
t contains the following components: 
ml of FMP phage precipitant 
I of ly~ buffer containing buffered chaotrope 
I of recove/7~er containing Tris/EDT A 
ovides sufficient material for the extraction of 100 templates from hage supernatant samples. 
ed~e ,!2r extr~ctjoc. of .single·!l!!'and.J._d M 13 DNA 
e the required number of 1.5ml microcentrifuge tubes i;;the able ra, k of •he l'MP separator. (1 tube/ template) . 
• 0.5ml of clanf,ed pnage supernatant (prepared as on page ~/ ano to each 1.5ml microcentrifuge tube. 
<e and swirl the bottle containing FMP beads to ensure a 
eneous suspens ion. Add 200µ1 of the suspension to each of the supernatants . Mix by inverting the rack 3 or 4 times. Alternat ively , 
5 
g up and down or vortexing may be used for mixing individual tubes ge 9) . Incubate at room temperature, away from the magnet. for 5 s. 
a the rack on to the FMP magnet and allow the suspension to e for at least 1 minute. 
the rack still in place, slowly and carefu lly remove the supernatant e tube using a paste~r pipette, 200µ1 pipette tip or vacuum )r. Discard the supernatant. 
ove the rack from the magnet and add 100µ1 of lysing buffer to each se this 100µ1 to wash the pellet from the side of the tube. This may by inverting the rack, or using a pipette . 
• 50µ1 of 100% ethanol, mix by inversion or pipetting and incubate at mperature for 10 minutes. 
,, 
lysls of phage coat and concentration of ONA: The phage/FMP pellet 1· resuspended in the lysis buffer which breaks open the protein coat of the phage, thus releasing the DNA into solution. The addition of ethanol will • cause the DNA to precipitate around the FMP particles . Reapplying the magnetic field results in the separation of the FMP part icles and DNA from the supernatant. A 70% ethanol wash of the pellet minimizes sal1 carry-over to the DNA recovery stage. 
ONA recovery: The magnetic field is removed, and the pellet is resuspended in the recovery buffer. DNA is soluble in this buffer, and the FMP particles can be removed from the DNA solution using the magnetic separator. 
The FMP particles used in this procedure have been specialty formulated by Amersham to ensure minimum non-specific binding and maximum yielo of DNA. Use of the FMP separator enables fast. convenient and efficient separation of part icles from solution. The DNA extracted using th,s technology is an ideal template for Sanger sequencing using a DNA polymerase. radioactively labelled nucleotides and dideoxy nucleotide chain terminators. 
7 
' 
\ 8) Place the rack over the magnet and allow the suspension to separati \ at least 1 minute. 
9) Remove and discard the supernatant . 
' 
10) Remove the rack from the magnet, add 0.5ml of 70% ethanol to ea tube and resuspend the pellet by inversion or pipett ing. 
11) Return the rack to the magnet and allow the suspension to separat< \ at least 1 minute. 
12) Very carefully remove and discard the supernatant Ensure th at NC I ethanol remains in the bottom of the tut),. 
~3) Remov1; the rack from the magnet ano add an appropriate volume c;_ recovery buffer (typically 25µ1 for use with the Amersham Multiwel l microtltre plate sequencing system, (page 30) or 1 OµI for Sequenase"-'/ Use this volume of buffer to wash the pellet from the wall of the tube . Leave at room temperature away from the magnet for 5 minutes . 
14) Place the rack over the magnet and allow the suspension to separai for at least 1 minute. 
15) Remove the supernatant. and transfer to fresh tubes in a second rac 
16) Store at -200C in a freezer until use. DO NOT STORE IN A FROST· FREE FREEZER. 




?ERKIN ELMER CETUS 
Distributed by: 
Perkin-Eimer Ltd., Maxwell Road . Beaconsfield, Bucks. HP9 1 QA 
lsogene Kit L228-0440 
For the extraction and purification of DNA 
ISOGENE INFORMATION SHEET 
lsogene 
RESEARCH USE ONLY 
Recommendations for the extraction of ONA bands from agarose electrophoresis gels. The following procedure 
should give optimal recovery from 1 % agarose. 
1. Weigh a 1.5 ml mlcrocentrifuge tube. Cut out the desired band of ONA from the agarose gel, place it In the 
microcentrifuge tube, and weigh again. Calculate the weight of the ONA band and estimate tts volume, assuming a density of 1 gml·' . 
2. Add twice the gel volume of Sodium Iodide reagent. Incubate in a water bath at 60 °C for 10 min to solubllize the agarose. 
3. Vortex briefly then cool In iced water for 5 min. 
4. Thoroughly vortex the DNA Binder vial , taking care to resuspend all the sediment that may have formed 
during storage and ensure a completely uniform suspension before pipetting. According to the volume of 
agarose, add the following amounts of DNA Binder suspension: 
Volumeof 













5. Rotate at room temperature for 10 min on an end-over-end rotatory mixer or by hand. 6. Spin for 1 O s In a microcentrifuge (typically about 5 s acceleration followed by 5 s at maximum speed of about 13,000 rpm). 
7. Remove the supernatant but do not discard it until the entire procedure has been completed satisfactorily: if 
the binding in Step 5 has been non-optimal for any reason, the supernatant may contain unextracted ONA 
which can still be recovered by re-extraction. perhaps with a larger volume of DNA Binder. 8. Wash the pellet two to three times with Wash Buffer. If the volume of ONA Binder used was 30 µl or less, 
use 200 µl of Wash Buffer each time; if the volume used was more than 30 µL. use 400 µl of Wash Buffer 
each time. To carry out each wash step, add Wash Buffer, resuspend the pellet by vortexing two to three times for up to 5 s each time, centrifuge for 10 s as above, and discard the supernatant . 9. After the last wash, add 20 µl of distilled water, resuspend the pellet by vortexing , and centrifuge for 1 Os as above. Collect the supernatant containing the eluted ONA and transfer tt to a suitable container (such as 0.5 ml mlcrocentrifuge tube). 




?ERKIN ELMER CETUS lsogene Distributed by: 
Perkin-Elmer Ltd., Maxwell Road, 
Beaconsfield, Bucks. HP9 1 QA 
lsogene Kit L228-0440 
For the extraction and purification of DNA 
RESEARCH USE ONLY 
PRINCIPLE 
The lsoGene Kit can be used to purify ONA following the princi
ples of Vogelstein and Gillespie (Proc. Nat. Acad. Sci. 
1979: 76:615). ONA is ex1racted onto a finely particulate binde
r in the presence of sodium iodide. These are conditior1!; 
that favor the solubilization of agarose and protein, thereby fac
ilitating the isolation of ONA from agarose gels or cell 
lysates. Bound ONA is recovered by elution with distilled water
. 
lsoGene ex1raction from electrophoresis gels may be used in th
e isolation of the specific product ONA following 
amplification by the patented· GeneAmp™ Polymerase Chain 
Reaction (PC~M) technique. The lsoGene procedure 
may also be applied to the desalting and/or concentration of O
NA solutions aircl may replace alcohol-precipitation or 
column-based methods for ONA purification. The method will s
eparate ONA from enzyme-inhibiting impurities, and 
from phenol or other organic solvents. Another application is th
e removal of small unreacied molecules, including 
radioactive nucleotides, following processes such as end-label
ing or nick translation. 
The ONA Binder reagent of the lsoGene Kit has a higher bindin
g capacity and will eXlract ONA from larger sample 
volumes than binders of the "glass milk" type. In addition, the l
soGene ONA Binder is more easily resuspended 
during the wash and elution steps of the procedure than are "g
lass milk" binders. 
REAGENTS 
ONA Binder slurry in water. One vial (1 ml) per kit. 
Store at 2·8 "C 
Immediately before use, vortex-mix thoroughly so as to ensure
 that a uniform suspension of DNA Binder reagent is 
pipetted. 
Sodium Iodide solution (6 M) in waler contain ing sodium sulphi
le (5 gl' ') and kept in a light-proof bottle . 
One bottle (60 ml) per kit. 
Store at 2-8 •c. 
Wash Buffer Concentrate. (x100) Trls-HCI butter (1 M pH 7.5) co
ntaining NaCl (1 M) and EOTA (100 mM). 
One bottle (10 ml) per kit . 
Store at 2·8 "C. 
To prepare Wash Butter, dilute the concentrate 100 fold with 7







Place the sample (20-500 µL) In a 1.5 ml microcentriluge tube
. Add two volumes of sodium iodide reagent 
(so as to give 4 M sodium iodide concentration) then cool in ice
d water for 5 min. 
Add DNA Binder reagent. Immediately before each pipetting o
f lhe DNA Binder. thoroughly vortex mix the 
slurry to ensure a uniform suspension. If there is 5 µg or less of s
ample DNA and lhe sample volume is 
200 µLor less. use 1 O µL of ONA Binder: ii the sample volume
 is more than 200 µl. use 20 µl of ONA 
Binder. For larger quantities of DNA, use 10 µl of DNA Binder
 for each 5 µg of ONA in the sample. 
After adding the ONA Binder, mix gently by end-over-end rotat
ion for 10 min at room temperature to ensure 
optimal binding of the DNA. 
(Although DNA binds to the same extent at any temperature be
tween O and 60 °, DNA bound at the lower end 
of this temperature range Is eluted more easily in Step 5.) 
Pellet the bound ONA in a microcentrifuge (5 min) . 
(The refractive indices of the ONA binder and sodium iodide so
lution are very similar, so careful examination 
is necessary as the pellet may be almost transparent.) 
Wash the pellet two or three times with 200 µL volumes of Was
h Buffer, gently resuspending the ONA Binder 
each time by vortexing two to three times for up to 5 s each tim
e. --
(Resuspend ahd mix carefully to avoid possible shearing of lon
g DNA molecules.) 
Remove all the supernatant from the last wash. then release th
e DNA by eluting with distilled water. Add 
20 µL of distilled water, vortex and centrifuge as above. Collec
t the supernatant containing the eluted DNA 
and repeat the elution step using another 20 µL of distilled wat
er. 
(After washing in Step 4, there is a small amount of elhanol in t
he pellet. This Impedes the solubilizatlon of 
DNA by water . It Is essential to treat the pellet twice with water 
to obtain high elution recoveries of DNA. 
Typically 10 to 15% of bound DNA is eluted Into the first 20 µL




Recovery of DNA from agarose gela: 
The informallon and complete protocol for the ex1ractlon of ONA bands from agarose electrophoretlc gels is given in the lsogene Information sheet. The table in paragraph four gives the volume of ONA binder to add to the samples. The best recoveries of ONA from agarose are obtained when the electrophoresis buffer is TAE (40 mM Tris-acetate. pH 8, 1 mM EOTA). The presence of borate in electrophoresis buffers reduces ONA recoveries . 
Plasmtd preparation: Plasmids may be prepared by the alkaline lysis method of lsh-Horowicz and Burke (Nucl. Acids Res. 1981 ; 9:2989). After acidifying the lysate and discarding the Insoluble residue. the ONA can be further purified by applying tha lsoGena Procedure as abova. 
Separation of ONA from aalta, phenol, or other small molecules: Apply the lsoGene Procedure as above. 
L228-o440 
ORDERING INFORMATION 
lsoGene Kit for the ex1ractlon and purification of ONA. Sufficient for 100 assays. Each kit contains one vial (1 ml) of ONA binder, one bottle (60 ml) of sodium Iodide solution and one bottle (10 ml) of Wash Buffer concentrate. Store at 2-8 •c. 
"PCA Is covered by US Patent No. 4,683,202 ls.sued to Cetus Corporation. Patents pending on ONA Polymerase and its use. G-AtnpN la a trademark of the Ce1u1 Corporation 
?EnKIN ELMEn CETUS P9ricln-Elm« Corp .• Anelytlcat lnstrvmenta, 761 Main Ave .. Norwalk. c· 06851HJ012 U.S.A. Toi: (2031762· 1000. Telex 965·95" Bod..,-~ Pori<ln·EI.- , Co .• OmbH. Posttach 1120. n10 
Uee>erhngen. Federal Reput>Oc of Germany, Tel : (07551) 810 
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Revised EnZap na PROTOCOL 
(for Research Use Only) 
Introduction: 
EnZap•• is a proprietary resin centrifuge tube based 
nucleic add purification system. The device consists of two 
components: a tube insert containing a support membrane 
(upper compartment), and a standard 1.5 ml centrifuge tube 
(lower compartment). The EnZap polymer exhibits high affinity 
and capacity for proteins and has low affinity and capacity for 
nucleic acids. These characteristics permit the devices to be 
employed for the removal of proteins from nudeic adds by 
applying the sample to the resin containing upper compartment, 
centrifuging and recovering the eluted nudelc adds in the filtrate 
contained in the lower compartment. The recovered nucleic 
adds can be stored as the filtrate or recovered by conventional 
precipitation techniques. The devices offer a rapid, efficient 
method of protein removal from nudeic adds and avoids the 
difficulties of phenol/chloroform extractions. 
Materials and Equipment: 
EnZap Components: 
1. EnZap devices consist of two components: a tube Insert 
containing 0.45µ support membrane (upper compartment), ancl 
a standard 1.5 ml centrifuge tube Oower compartment). 
2. Tube(s), each containing 1.25 mis of EnZap resin 
Other Equipment and Materials: 
3. 1 M sodium acetate buffer pH 4.5 
4. A centrifuge which accommodates 1.5 ml centrifuge 
tubes capable of at least 10,000 x g. 
5. Reagents for nudeic acid precipitation 
Storage: 
EnZap tubes and resin should be stored at either roor, 
temperature or 4 • C. Do Not Freeze/ 
General: 
EnZap devices are designed to be employed in 
centrifuges common to most molecular biology laboratories. 
Sample is combined with resin and the pH is adjusted to 4.5.This 
mixture is then loaded into the upper chamber of the device. Tile 
device is centrifuged for two to five minutes. Nudeic acids pasf; 
through in the filtrate and are collected in the centrifuge tube. 
Proteins are retained in the resin bed of the upper insert. The 
nucleic acids can be recovered by conventional precipitation 
methods. 
Procedure: 
I. Sample Preparation: 
1. Resuspend the EnZap polymer by vigorous mixing until 
appearance is homogeneous, i.e. no visible layering of resin 
and buffer. 
2. Using either the tube insert provided or a suitable tube and iii 
the following order, add EnZap resin according to the following 
schedule: 
a SO µI Resin tor protein levels of 1oc>,Jg. 
b. 1oc>,JI Resin for protein levels of 100-SOOµg. 
c. 150µ1 Resin for protein 18Yels of 1-3mgs. 
Schedule b. applies In most cases. 
3. Add your samole in a volume of _not less than 25µ1 or create · 
than 300µ1 to the tube evntainmg the aliquot of the 
EnZap resin. 
4. Add 1/10 volume(sample+ resin) of 1 M acetate buffer 
pH 4.5 and mix thoroughly. 
II. Spedmen Procedure: 
1. If you employed your own tube, pipet the sample/resin mix 
into the tube insert(upper chamber) provided. 
2. Insert the upper chamber into the 1.5ml centrifuge prov,ded 
3. Close the device. 
4. Centrifuge the EnZap cartridge for 2-5 minutes to completely 
elute the buffer from the resin bed of the upper chamber into 
the lower centrifuge tube. Note: For optimal results the relatJv 
centrtfugll force should not exceed 14,000 x g. How8V8r, bnc 
spins ot 2-S minutes or less at 14,000 x g will not damage the 
support bed. 
5. Proteins are retained in the resin of the filter cup which can b, 
discarded. 
6. Nudelc acids are contained in the filtrate. 
7. In some Instances a further wash of 100µ1 of o. 1 M acetate 
buffer may be required to fully elute the nudeic acids. 
For example, ONA concentrations of less than 1JJ.g,_ __ 
8. Recover the nucleic adds by precipitation according to the 
following example, reference or your preferred technique. 
Example ethanol precipitation r8COY8ry of ONA: 
1. Adjust the sodium acetate concentration of the nitrate 
to 0.3M by the addition of 3M sodium acetate stock 
pH5.2 
2 Add 25 volumes of absolute ethanol chilled to 
-20·c. 
3. Place mixture at ~ • C tor 30 minutes. 
4. Centrifuge 15 minutes at 14,000 x g at 4 • C. 
5. Carefully remove the liquid phase. 
6. Wash with 300µ1 70% ethanol. 
7. Centrifuge 15 minutes at 14,000 x g. 
8. Carefully remove the ethanol phase. 
9. Invert the tube and air dry to remove the residual ethanol. 
10. Dissolve the DNA in appropriate buffer. 
Nudelc Add Precipitation Reference: Volume 3, pp. E.1 O·E., 5. 
Molecular Cloning A Laboratory Manual, 2nd edition, J. 
Sambrook, E. F. Fritsch, T. Maniatis, editors, Cold Spring Harbc 
Laboratory Press, 1989. 
Performance Characteristics: 
The protein binding capacity of the resin is such that 3 mgs 
BSA in 1~1 applied to the EnZap ii 98% retained, 20 Units of Alkaline 
phosPlltlatue is 99% retained on the resin. Less than 2% of protein or 
enzym". 'actillity is found in the fittrate at iheae extreme loadings. When 
1 mg BSA or 10 units of AP were applied virtually 100% was retained anc 
vir1ually no protein or AP actillity was found in the filtrate. Protein capac,• 
is diminished by detergents and higher pH; however, chaotropic agents 
have minimal effects. 
The DNA binding characteristics are such that 1µg of 1000bp 
dsONA is 90% recovered in the filtrate. Similar behaviof' for RNA is 
obaerwd. Up to ~g nucleic acid hu no adverse effect on the protein 
binding capacity of the EnZap. 
BioVenture$, ~rv::, Phooe: 615-896-7353 













a ENZYMES/ PROTEINS RETAINED 
•No PhenoVChloroform •>90% D·NA Recovery •>98% Protein Removal 
•>99% Enzyme Removal• High Protein Capacity• Low DNA Affinity 
Trial Size 5 Tubes 
Regular Size 25 Tubes 
Economy Size 100 Tubes 
Cat. No. EZ-5 
Cat. No. EZ-25 
Cat. No. EZ-100 
Bio Ventures, Inc. 
P.O . .Box 2561 
848 Sc:ott Street 




1-800-235-8938 615-896-7353 FAX: 615-896-4837 
Literature cited 
Allan, B., Smuts, H. and Steyn, L. (1994). Modified reaction tubes for the 
sequential addition of reagents in PCR assays. Nucleic Acids Research 22, 109-
110. 
Barnes, P.F., Bloch, A.B., Davidson, P.T. and Snider, D. (1991). Tuberculosis in 
patients with human immunodeficiency virus infection. New England Journal 
Medicine 324, 1644-1650. 
Berman, S., Kibel, M.A., Fourie, P.B, and Stebe!, P.M. (1992). Childhood 
tuberculosis and tuberculous meningitis: high incidence rates in the Western Cape 
of South Africa. Tubercle and Lung Disease 73, 349-355. 
Best, M., Sattar, S.A., Springthorpe, V.S. and Kennedy, M.E. (1991). Efficacies of 
selected disinfectants against mycobacterium tuberculosis. Journal of Clinical 
Microbiology 28, 2234-2239. 
Beutler, E., Gelbart, T. and Kuhl, W. (1990). Interference of heparin with the 
polyn1erase chain reaction. BioTechniques 9, 166. 
Bishberg, E., Sunderam, G., Reichman, L.B. and Kapila, R. (1986). Central 
nervous system tuberculosis with the acquired immune deficiency syndrome and 
its related complex. Annals of Internal Medicine 105, 210-213. 
Bloch, W. (1991). A biochemical perspective of the polymerase chain reaction. 
Biochemistry 30, 2735-2747. 
Boddinghaus, B., Rogall, T., Flohr, T., Blocker, H. and Bottger E. (1990). 
Detection and identification of mycobacteria by amplification of rRNA. Journal 
of Clinical Microbiology 28, 1751-1759. 
Boehringer Mannheim Catalogue. (1994), 503. 
Brisson-Noel, A., Gicquel, B., Le Cossier, D., Levy-Fribault, V., Nassif, X. and 
Hance, A. (1989). Rapid diagnosis of tuberculosis by amplification of 
mycobacterial DNA in clinical samples. Lancet ii, 1069-1071. 
Brisson-Noel, A. , Aznar, C., Chureau, C., Nguyen, S., Pierre, C., Bartoli, M., 
Bonete, R. , Pialoux, G., Gicquel, B. and Garrigue, G. (1991). Diagnosis of 
tuberculosis by DNA amplification in clinical practice evaluation. Lancet 338, 
364-366. 
Brown, D., Powell, L. , Morris, A., Rassam, S., Sherlock, S., McIntyre, N., 
Zuckerman, A. and Dusheiko, G.M. (1992). Improved diagnosis of chronic 
hepatitis C virus infection by detection of antibodies to multiple epitopes, 
confirmation by antibody to synthetic oligopeptides. Journal of Medical Virology 
38, 167-171. 
Buck, G.E., O'Hara, L.C. and Summersgill, J.T. (1992). Rapid, simple method for 
treating clinical specimens containing Mycobacterium tuberculosis to remove 
DNA for polymerase chain reaction. Journal of Clinical Microbiology 30, 1331-
1334. 
Cheyrou, A., Guyomarc'h, C., Jasserand, P. and Blouin, P. (1991). Improved 
detection of HBV DNA by PCR after microwave treatment of serum. Nucleic 
Acids Research 19, 4006. 
Chomczynski, P. and Sacchi, N. (1987). Single-step method of RNA isolation by 
acid quanidinium thiocyanate-phenol-chloroform extraction. Analytical 
Biochemistry 162, 156-159. 
Cimino, G.D., Metchette, K., Isaacs, S.T. and Yu Sheng, Zhu. (1990) More false-
positive problems. Nature 345, 773-774. 
Cimino, G.D., Metchette, K.C., Tessman, J,W., Hearst, J.E. and Isaacs, S.T. 
(1991). Post- PCR sterilization: a method to control carryover contamination for 
the polymerase chain reaction. Nucleic. Acids Research 19, 99-108. 
Clarridge, J.E., Shawar, RM., Shinnick, T.M. and Plikaytis, B.B. (1993). Large-
scale use of polymerase chain reaction for detection of Mycobacterium 
tuberculosis in a routine mycobacteriology laboratory. Journal of Clinical 
Microbiology 31, 2049-2056. 
Clewey, J.P. (1989). The polymerase chain reaction; a reveiw of the practical 
limitations for human immunodeficiency virus diagnosis. Journal of Virological 
Methods 25, 179-188. 
Chou, Q., Russell, M., Birch, D., Raymond, J. and Block, W. (1992). Prevention 
of pre-PCR priming and primer dimerization improves low copy number 
amplification. Nucleic Acids Research 20, 1717-1723. 
Collins (1984) In Mycobacteria and Human disease, 49-61. Edited by Grange, 
J.M. Edward Arnold, London. 
Collins, F.M. (1989). Mycobacterial disease, immunosuppression, and acquired 
immunodeficiency syndrome. Clinical Microbiological Reveiws 2, 360-377. 
Collins, F.M. (1991). Antituberculous immunity: new solutions to an old problem. 
Reveiws of Infectious Diseases 13, 940-50. 
Cormican, M.G., Barry, T., Gannon, F. and Flynn, J. (1992). Use of polymerase 
chain reaction for early identification of Mycobacterium tuberculosis in positive 
cultures. Journal of Clinical Pathology 45, 601-604. 
Cousins, D.V., Wilton, F.D., Francis, B.R. and Gow, B.L. (1992). Use of 
polymerase chain reaction for rapid diagnosis of tuberculosis. Journal of Clinical 
Microbiology 30, 255-258. 
Cruikshank, R. (1969). Mycobacterium In Medical Microbiology, 194-212. Edited 
by Cruikshank. E&S Livingstone Ltd., Edinburgh and London. 
Daniel, T.M. (1989). Rapid diagnosis of tuberculosis : laboratory techniques 
applicable in developing countries. Review of Infectious Diseases ll(S2), S471-
S478. 
Daniel, T.M. (1990). The rapid diagnosis of tuberculosis: a selective reve1w. 
Journal of Laboratory and Clinical Medicine 116, 277-282. 
D'Aquila, R., Bechtal, L., Videler, J., Eron, J., Gorczyca, P and Kaplan, J. (1991). 
Maximizing sensitivity and specificity of PCR by pre-amplification heating. 
Nucleic Acids Research 19, 3749. 
de Lassence, A., Lecossier, D., Pierre, C., Cadranel, J., Stem, M. and Hance, A.J. 
(1992). Detection of mycobacterial DNA in pleural fluid from patients with 
tuberculous pleurisy by means of the polymerase chain reaction: comparison of 
two protocols. Thorax 41, 265-269. 
De Wit, D., Steyn, L., Shoemaker, S. and Sogin, M. (1990). Direct detection of 
Mycobacterium tuberculosis in clinical specimens by DNA amplification. Journal 
of Clinical Microbiology 28, 2437-2441. 
De Wit, D., Maartens, G. and Steyn, L. (1992). A comparative study of the 
polymerase chain reaction and conventional procedures for the diagnosis of 
tuberculous pleural effusion. Tubercle and Lung Disease 73, 262-267. 
Dougherty, R.M., Philips, P.E., Gibson, S. and Young, L. (1993). Restriction 
endonuclease digestion eliminates product contamination in reverse transcribed 
polymerase chain reaction. Journal of Virological. Methods 41, 235-238. 
Eisenach, K.D., Cave, M.D., Bates, J.H. and Crawford, J.T. (1990). Polymerase 
chain reaction amplification of a repetitive DNA sequence specific for 
Mycobacterium tuberculosis. Journal of Infectious Diseases 161, 977-981. 
Eisenach, K.D., Sifford, M.D., Bates, J.H. and Crawford, J.T. (1991). Detection 
of Mycobacterium tuberculosis in sputum samples using a polymerase chain 
reaction. American review of Respiratory Disease 144, 1160-1163. 
Engelberg, N.C. (1991). Nucleic acid probe tests for clinical diagnosis - where do 
we stand? ASM News 51, 183-186. 
Erlich, H.A., Gelfand, D.H. and Saiki, R.K. (1989). Specific DNA amplification. 
Nature 331, 461-462. 
Espy, M.J., Smith, T.F. and Persing, D.H. (1993). Dependence of polymerase 
chain reaction product inactivation protocols on amplicon length and sequence 
composition. Journal of Clinical Microbiology 31, 2361-2365. 
Evans, K.D., Nakasone, A.S., Sutherland, P.A., de la Maza, L.M. and Petersen, 
E.M. (1992). Identification of Mycobacterium tuberculosis and Mycobacterium 
avium-Mycobacterium intracel/ulare directly from primary BACTEC cultures by 
using acridinium ester-labelled DNA probes. Journal of Clinical Microbiology 30, 
2427-2451. 
Farrell, P.J. and Tidy, J. (1989). Retraction: human papilloma-virus subtype 16b. 
Lancet ii, 1535. 
Feinstein, A.R. (1972). The need for humanised science in evaluating medication. 
Lancet 2, 421-423 . 
Folgueira, L., Delgado, R., Palenque, E. and Noriega A.R. (1993). Detection of 
Mycobacterium tuberculosis DNA in clinical samples by using a simple lysis 
method and polymerase chain reaction. Journal of Clinical Microbiology 31, 
1019-1021. 
Forbes, B.A., and Hicks, K.E.S. (1993). Direct detection of Mycobacterium 
tuberculosis in respiratmy specimens in a clinical laboratmy by polymerase chain 
reaction. Journal Of Clinical Microbiology 31, 1688-1694. 
Fox, J.C., Ait-Khaled, M., Webster, A. and Emery, V.C. (1991). Eliminating PCR 
contamination: is UV iITadiation the answer? Journal of Virological M ethods 33, 
375-382. 
Fries, J., Patel, R. , Piessens, W. and Wirth, D. (1991). Detection of untreated 
mycobacteria by using polymerase chain reaction and specific DNA probes. 
Journal of Clinical Microbiology 29, 1744-1747. 
Gelfand, D. (1989). Taq DNA polymerase In PCR Technology, a guide to 
principles and applications, 31-38. Edited by Erlich. H. Stockton Press, New 
York. 
Gelfand, D. and White J.J. (1990). Thermostable DNA polymerases In PCR 
Protocols, a guide to methods and applications, 129-141. Edited by Innis, M.A., 
Gelfand, D.H., Sninsky, J.J. and White, T.J. Academic Press, Inc.,San Diego, 
California, USA. 
Girling, DJ., Darbyshire, J.H., Humphries, M.J. and Mahoney, G.O. (1988). 
Extra-pulmonary tuberculosis In British Medical Bulletin, 44: 736-756. Edited by 
Rees, R.J.W. Churchill Livingstone, London. 
Gow and Barbos (1984) In Mycobacteria and Human disease, 119-137. Edited by 
Grange, J. M. Edward Arnold, London. 
Grange, J.M. (1988a). The genus Mycobacterium In Mycobacteria and Human 
disease, 9-30. Edward Arnold, London. 
Grange, J.M. (1988c). The species of Mycobacteria In Mycobacteria and Human 
disease, 31-48. Edward Arnold, London. 
Grange, J.M. (1988b). Diagnostic Mycobacteriology In Mycobacteria and Human 
disease, 49-61. Edward Arnold, London. 
Grange, J.M. (1988d). Epidemiology and control of mycobacterial disease In 
· Mycobacteria and Human disease, 90-101. Edward Arnold, London. 
Grange, J.M. (1988e). Tuberculosis In Mycobacteria and Human disease, 119-
13 7. Edward Arnold, London. 
Grange, J.M. (1989). Mycobacterial disease in the world: yesterday, today and 
tomorrow In The Biology of the Mycobacteria vol 3, 3-36. Edited by Ratledge C. , 
Stanford, J. and Grange, J.M. Academic Press Ltd., London, UK. 
Hance, A.J., Grandchamp, B., Levy-Fribault, B., Lecossier, D., Rauzier, J., 
Bocart, D. and Gicquel, B. (1989). Detection and identification of mycobacteria 
by amplification of mycobacterial DNA. Molecular Microbiology 3, 843-849. 
Harries, A.D. (1990). Review article: Tuberculosis and human immunodeficiency 
virus infection in developing countries. Lancet 335, 390. 
Hermans, P.W.M., Schuitema, A.R.J., Van Soolingen, D., Verstynen C.P.H.J., 
Bik, E.M., Thole, J.E.R., Kolk, A.HJ. and van Embden, J.D.A. (1990). Specific 
detection of Mycobacterium tuberculosis complex strains by polymerase chain 
reaction. Journal of Clinical Microbiology 28, 1204-1213. 
Higutchi, R. (1989). Simple and rapid preparation of samples for PCR In PCR 
Technology, a guide to principles and applications, 31-38. Edited by Erlich, H. 
Stockton Press, New York, USA. 
Hoezel, R. (1990). The trouble with PCR machines. Trends in Genetics 6, 237-
238. 
Holodniy, M., Kim, S., Katzenstein, D., Konrad, M., Groves, E. and Merigan, 
T.C. (1991). Inhibition of human immunodeficiency virus gene amplification by 
heparin. Journal of Clinical Microbiology 29, 676-679. 
Innis, M.A. and Gelfand, D.H. (1990). Optimization of PCR In PCR Protocols: A 
guide to methods and applications, 3-12. Edited by Innis, M.A., Gelfand, D.H., 
Sninsky, J.J. and White, T.J. Academic Press, Inc.,San Diego, California, USA. 
lvanyi, J. , Bottomley, G.H. and Jackett, P.S. (1988). lmmunodiagnostic assays for 
tuberculosis and leprosy In British Medical Bulletin 44, 635-649. Edited by Rees, 
R.J.W. Churchill Livingstone, London, UK. 
Jawetz, E., Melnick, J.L. and Adelberg, E.A. (1972). Mycobacteria In Review of 
Medical Microbiology, 188-194. Lange Medical Publications, Los Altos, 
California, USA. 
Kaye, S., Loveday, C. and Tedder, R.S. (1991). Storage and preservation of whole 
blood samples for use in detection of human immunodeficiency virus type- I by the 
polymerase chain reaction Journal ofVirological Methods 35, 217-226. 
Kennedy, D.H. (1989). Extrapulmonary tuberculosis In The Biology of the 
Mycobacteria vol 3, 245-284. Edited by Ratledge et al; Academic Press Ltd., 
London, UK. 
Kitchin, P.A., Szotyori, Z., Fromhole, C. and Almond, N. (1990). Avoidance of 
false positives. Nature 344, 201 . 
Kiyotoshi Kaneko, Osamu Onodera, Tadashi Miyatake and Shoji Tsuji. (1990). 
Rapid diagnosis of tuberculous meningitis by polymerase chain reaction (PCR). 
Neurology 40, 1617-1618. 
Kornher, J. (1990). The Nuts and Bolts of PCR: notes from PCR Workshop held 
April 3-7, Keystone Colorado, USA. 
Ktistner, H.G.V. (1993). Epidemiological Comments 20, 4. 
Kwok,S. and Higuchi, R. (1989). Avoiding false positives with PCR. Nature 339, 
237-238. 
Laidlaw, M. (1989). Mycobacterium: tubercle bacilli In Practical Medical 
Microbiology, 399-416. Edited by Collee, J.G., Duguid, J.P., Fraser, A. G. and 
Marmion, B.P. Churchill Livingstone, London. 
Larzul, D., Guige, F., Sninsky, J.J., Mack, D.H., Brechot, C. and Guesdon, J.L. 
(1988). Detection of hepatitis B virus sequences in serum by using in vitro 
enzymatic amplification. Nucleic Acids Research 16, 81-91. 
Li, H., Gyllensten, U.B., Cui, X. Saiki, R.K., Erlich, H.A. and Arnheim, N. 
(1988). Amplification and analysis of DNA sequences in single human sperm and 
diploid cells. Nature 335, 414-417. 
Loche, M. and Mach, B. (1988). Identification of HIV-infected seronegative 
individuals by a direct diagnostic test based on hybridisation to amplified viral 
DNA. Lancet ii, 418-421. 
Longo, M.C., Berninger, M.S. and Hartley, J.L. (1990). Use of uracil DNA 
glycosylase to control c~-over contamination in polymerase chain reactions. 
Gene 93, 125-128. 
Lou, Y.K., Han Qin, Molodysky, E. and Morris, B. (1993). Simple microwave 
and thermal cycler boiling methods for preparation of cercvico-vaginal lavage cell 
samples prior to PCR for human papilloma virus detection. Journal of Virologica/ 
Methods 44, 77-82. 
Lucas, S.B. (1989). Mycobacteria and the tissues of man In The Biology of the 
Mycobacteria vol 3, 107-176. Edited by Ratledge C., Stanford, J. and Grange, 
J.M. Academic Press Ltd., London, UK. 
Maher (1929) In The Biology of the Mycobacteria vol 3, 3-36. Edited by Ratledge 
C., Stanford, J. and Grange, J.M. Academic Press Ltd., London, UK. 
Maniatis, T. (1982). Appendix A: Biochemical techniques In Molecular Cloning, 
a laboratory manual, 436-478. Edited by Maniatis, T., Fritsch, E.F. and 
Sambrook, J. Cold Spring Harbour Laboratory Publications, Cold Spring Harbour, 
New York, USA. 
Manjunath, N., Shankar, P., Rajan, L. , Bhargava, A., Saluja, S. and Shriniwas. 
(1991). Evaluation of a polymerase chain reaction for the diagnosis of 
tuberculosis. Tubercle 12, 21-27. 
Mausner, and Kramer, (1985a) Morbidity and mortality In Epidemiology, An 
Introductory Text, 43-65. W.B. Saunders Company, Philadelphia, USA. 
Mausner, and Kramer, (1985b) Epidemiologic aspects of infectious diseases, In 
Epidemiology, An Introductory Text, 263-301. W.B. Saunders Company, 
Philadelphia, USA. 
McDonough, K.A., Kress, Y. and Bloom, B.R. (1993). Pathogenesis of 
tuberculosis: interaction of Mycobacterium tuberculosis with macrophages. 
Infection and Immunity 61, 2763-2773. 
Meier, A., Persing D.H., Finken, M. and Bottger, E. (1993). Elimination of 
contaminating DNA within polymerase chain reaction reagents: implications for a 
general approach to detection of uncultured pathogens. Journal of Clinical 
Microbiology 31, 646-652. 
Minnikin, 1982 In The Biology of the Mycobacteria vol 1, 95--185. Edited by 
Ratledge C., Stanford, J. and Grange, J.M. Academic Press Ltd., London, UK. 
Miyazaki, Y., Koga, H., Kohno, S. and Kaku, M. (1993). Nested polymerase 
chain reaction for detection of Mycobacterium tuberculosis in clinical samples. 
Journal of Clinical Microbiology 31, 2228-2232. 
Morse et al (1964) In The Biology of the Mycobacteria vol 3, 3-36. Edited by 
Ratledge C., Stanford, J. and Grange, J.M. Academic Press Ltd., London, UK. 
Morse et al (1961) In The Biology of the Mycobacteria vol 3, 3-36. Edited by 
Ratledge C., Stanford, J. and Grange, J.M. Academic Press Ltd., London, UK. 
Muralidhar, B. and Steinman, C.R. (1992) Geometric differences allow 
differential enzymatic inactivation of PCR product and genomic targets. Gene 
117, 107-112. 
Nachamkin, I., MacGregor, R.R., Staneck, J.L., Tsang, A.Y., Denner, J C., 
Willner, M. and Barbagallo, S. (1992). Niacin-positive Mycobacterium kansasii 
isolated from immunocompromised patients. Journal of Clinical Microbiology 30, 
1344-1346. 
Narain, J.P., Raviglione, M.C. and Kochi, A. (1992). HIV-associated tuberculosis 
in developing countries: epidemiology and strategies for prevention. Tubercle and 
Lung Disease 73, 311-321. 
Noordhoek, G.T., Kolk, A.HJ., Bjune, B., Catty, D., Dale, J.W., Fine, P.E.M., 
Godfrey-Faussett, P., Cho, S., Shinnick, T., Svenson, S.B., Wilson, S. and van 
Embden, J.D.A. (1994). Sensitivity and specificity of PCR for detection of 
Mycobacterium tuberculosis: a blind comparison study among seven laboratories. 
Journal of Clinical Micribiology 32, 277-284. 
Nunn, P.P. and McAdam, K.P.W.J. (1988). Mycobacterial infections and AIDS 
In British Medical Bulletin 44, 801-813. Edited by Rees, R.J.W. Churchill 
Livingstone, London. 
Oste, C. (1989). PCR automation In PCR Technology, a guide to principles and 
applications, 23-30. Edited by Erlich, H. Stockton Press, New York. 
Orrego, (1990). Organizing a laboratory for PCR work In PCR Protocols, a guide 
to methods and applications, 447-454. Edited by Innis, M.A., Gelfand, D.H., 
Sninsky, J.J. and White, T.J. Academic Press, Inc.,San Diego, California, USA. 
Panaccio, M., Georgesz, M. and Lew, A.M. (1993) FOLT PCR: A simple 
protocol for amplifying DNA directly from whole blood. BioTechniques 14, 238-
243 . 
Pao, C.C., Lin, S.S., Wu, S.Y., Juang, W.M., Chang, C.H., and Lin, J.Y. (1988). 
The detection of mycobacterial DNA sequences in uncultured clinical specimens 
with cloned Mycobacterium tuberculosis DNA as probes. Tubercle 69, 27-36. 
Pao, C.C., Benedict Yen, T.S., You, J-B., Maa, J-S., Fiss, E.H. and Chang, C-H. 
(1990). Detection and identification of Mycobacterium tuberculosis by DNA 
amplification. Journal of Clinical Microbiology 28, 1877-1880. 
Patel, R.J., Fries, J.W.U., Piessens, W.F. and Wirth, D.F. (1990). Sequence 
analysis and amplification by polymerase chain reaction of a cloned DNA 
fragment for identification of Mycobacterium tuberculosis. Journal of Clinical 
Microbiology 28, 513-518. 
Persing, D.H. (1991). Polymerase chain reaction: trenches to benches. Journal of 
Clinical Microbiology 29, 1281-1285. 
Petersen, E.M., Lu, R., Floyd, C., Nakasone, A., Friedly, G. and De La Maza, 
L.M. (1989). Direct identification of Mycobacterium tuberculosis, Mycobacterium 
avium and Mycobacterium intracellulare from amplified primary cultures in 
BACTEC media using DNA probes. Journal Of Clinical Microbiology 27, 1543-
1547. 
Pierre, C., Lecossier, D., Boussougant, Y., Bocart, D., Joly, V., Yeni, P, and 
Hance, A.J. (1991). Use of a reamplification protocol improves sensitivity of 
detection of Mycobacterium tuberculosis in clinical samples by amplification of 
DNA. Journal of Clinical Microbiology 29, 712-717. 
Pikaart, M.J. and Villeponteau, B. (1993). Suppression of PCR amplification by 
high levels of RNA. BioTechniques 14, 132-133. 
Plikaytis, B.B., Gelber, R.H. and Shinnick, T.M. (1990). Rapid and sensitive 
detection of Mycobacterium leprae using a nested-primer gene amplification 
assay. Journal of Clinical Microbiology 28, 1913-1917. 
Podzorski, R.P. and Persing, D.H. (1993). PCR: the next decade. Clinical 
Microbiology Newsletter 15 (18), 137-144. 
Prescott, L.M., Harley, J.P. and Klein, D.A. (1990a). Control of microorganisms 
by physical and chemical agents In Microbiology, 234-249. Edited by Kane, K. 
Wm.C. Brown Publishers, Dubuque, Iowa, USA. 
Prescott, L.M., Harley, J.P. and Klein, D.A. (1990b). The bacteria In 
Microbiology, 464-488. Edited by Kane, K,. Wm.C. Brown Publishers, Dubuque, 
Iowa, USA. 
Ramesar, R. (1992). Introduction In EBG-PCR Workshop, 2-3. Edited by 
Ramesar, R. Roche, Cape Town, South Africa. 
Rand, K.H. and Houck, H. (1990). Taq polymerase contains bacteria of unknown 
origin. Molecular and Cellular Probes 4, 445-450. 
Reed (1957) In Mycobacteria and Human disease, 49-61. Edited by Grange, J.M. 
Edward Arnold, London. 
Ribicki, E. (1991). Standard PCR protocol EBG-PCR Workshop, 10-12. Edited 
by Ramesar, R. Roche, Cape Town, South Africa 
Richards, E. (1989). Preparation of genomic DNA from plant tissue In Current 
Protocols in Molecular Biology, 2.3 . Edited by Ausubel, F., Brent, R., Kingston, 
R.E. , Moore, D.D., Seidman, J.G., Smith, J.A. and Struhl, K. Green Publishing 
and Wiley lnterscience, New York, USA. 
Rochelle, P.A., Weightman, A.J. and Fry, J.C. (1992). DNase 1 treatment of Taq 
DNA polymerase for complete PCR decontamination. Biotechniques 13, 520. 
Rogall, T. , Flohr, T. and Bottger, E.C. (1990a). Differentiation of Mycobacterium 
species by direct sequencing of amplified DNA. Journal of General Microbiology 
136, 1915-1920. 
Rogall, T., Wolters, J. , Flohr, T. and Bottger, E.C. (1990b). Towards a phylogeny 
and definition of species at the molecular level within the genus Mycobacterium. 
International Journal Systematic Bacteriology 40, 323-330. 
Rowley, A.H., Whitley, R.J. , Lakeman, F.D. and Wolinsky S.M. (1990). Rapid 
detection of herpes simplex virus DNA in cerebrospinal fluid of patients with 
herpes simplex encephalitis. Lancet 1, 1440-441. 
Ryan, F. (1992a). Reign of terror In Tuberculosis: The Greatest Story Never Told, 
3-15. Swift Publishers, Worcestershire, England. 
Ryan, F. (1992b). An alliance of terror In Tuberculosis: The Greatest Story Never 
Told, 389-405. Swift Publishers, Worcestershire, England. 
Rys, P.N. and Persing, D.H. (1993) Preventing false positives: quantitative 
evaluation of three protocols for inactivation of polymerase chain reaction 
amplification products. Journal of Clinical. Microbiology 31, 2356-2360. 
Saiki, R.K. (1989). The design and optimization of the PCR In PCR Technology, a 
guide to principles and applications, 7-16. Edited by Erlich H. Stockton Press, 
New York, USA. 
Sambrook, J. , Fritsch, E.F. and Maniatis, T. (1989). Molecular Cloning; a 
laboratory manual, books 9-10, volume 2. Edited by Nolan, C. Cold Spring 
Harbour Laboratory Press, Cold Spring Harbour, New York, USA. 
Sarkar, G., Kapelner, S. and Sommer, S. (1990). Formamide can dramatically 
improve the specificity of PCR. Nucleic. Acids Research 18, 7465. 
Sakar, G. and Sommer, S. (1990). Shedding light on PCR contamination. Nature 
343, 27. 
Sarniak, RM., Sharma, M., Kate, S.M. and Jindal, S.K. (1993). Serodiagnosis of 
tuberculosis: assessment of kaolin agglutination test. Tubercle and Lung Disease 
74, 405-406. 
Samsarrica (1982) In The Biology of the Mycobacteria vol 3, 3-36. Edited by 
Ratledge C., Stanford, J. and Grange, J.M. Academic Press Ltd., London, UK. 
Savic, B., Sjobring, U., Alugupalli, S. and Larsson, L. (1992). Evaluation of 
polymerase chain reaction, tuberculostearic acid analysis, and direct microscopy 
for the detection of Mycobacterium tuberculosis in sputum. Journal of Infectious 
Diseases 166, 1177-1180. 
Schulzer, M., Fitzgerald, J.M., Enarson, D.A. and Grzybowski, S. (1992). An 
estimate of the future size of the tuberculosis problem in sub-saharan Africa 
resulting from HIV infection. Tubercle and Lung Disease 73, 52-58. 
Shankar, P., Manjunath, N., Lakshmi,R., Aditi, A., Seth, P. and Shriniwas. (1990). 
Identification of Mycobacterium tuberculosis by polymerase chain reaction. 
Lancet 335, 423. 
Sharwar, R.M., El-Zaatari, F.A.K., Nataraj, A. and Clarridge, J.E. (1993). 
Detection of Mycobacterium tuberculosis in clinical samples by two-step 
polymerase chain reaction and nonisotopic hybridization Methods. Journal of 
Clinical Microbiology 31, 61-65. 
Sjobring, U., Mecklenburg, M., Andersen, A.S. and Miomer, H. (1990). 
Polymerase chain reaction for detection of Mycobacterium tuberculosis. Journal 
of Clinical Microbiology 28, 2200-2204. 
Smith, P.G. (1988). Epidemiological methods to evaluate vaccine efficacy In 
British Medical Bulletin, 44, 679-690. Edited by Rees; R.W.J. Churchill 
Livingstone, London. 
Sompolinsky (1978) In Mycobacteria and Human disease, 49-61. Edited by 
Grange, J.M. Edward Arnold, London. 
Steyn, L M. (1992). 'Towards Eliminating the Captain of all of the Men of Death'. 
Motivation for a Mycobacterium tuberculosis Research Unit, the Department of 
Medical Microbiology, University of Cape Town. 
Steyn, L., Allan, B., Roditi, D., Chojnacki, M. and Barlow, D. To be submitted 
for publication, 1994. Identification of Mycobacterium tuberculosis in primary 
bacterial cultures by a highly specific PCR assay: a modified protocol for the 
laboratory diagnosis of tuberculosis. 
Steyn, L.M. (1993). The rapid laboratory diagnosis of tuberculosis. South African 
Medical Journal 83, 379-380. 
St.Pierre, B., Neustock, P., Schramm, U. , Wilhelm, D., Kirchner, H. and Bein, G. 
(1994). Seasonal breakdown of polymerase chain reaction. Lancet 343, 673 . 
Stryer, L. (1988a). Exploring proteins In Biochemistry, 43-70. W. H. Freeman and 
Company, New York, USA. 
Stryer, L. (1988b). Introduction to biological membranes In Biochemistry, 283-
314. W. H. Freeman and Company, New York, USA. 
Sunderam, G., McDonald, R.J., Maniatis, T., Oleske, J., Kapila, R. & Reichman, 
L.B. (1988). Tuberculosis as a manifestation of the aquired immunodeficiency 
syndrome (AIDS). Journal of the American Medical Association 256, 362-366. 
Sutherland (1981) In Mycobacteria and Human disease, 119-137. Edited by 
Grange J.M. Edward Arnold, London. 
Sutherland, I. (1988). Research into the control of tuberculosis and leprosy in the 
community In British Medical Bulletin 44, 665-678. Edited by Rees, R.J.W. 
Churchill Livingstone, London. 
Tandon, P.N. and Bhargava, S. (1985). Effect of medical treatment on intracranial 
tuberculoma-a CT study. Tubercle 66, 85-89. 
Thierry, D., Brisson-Noel, A., Vincent-Levy-Frebault, V., Nguyen, S., Guesdon, J-
L. and Gicquel, B. (1990). Characterization of a Mycobacterium tuberculosis 
sequence, IS 61 JO, and its application in diagnosis. Journal of Clinical 
Microbiology 28, 2668-2673. 
Thomas K.R. and Olivera B.M. (1978). T7 Gene 6 Exonuclease. Journal of 
Biological Chemistry 253, 424-429. 
Tidy J A, Farrell P J. Retraction: human papillomavirus subtype 16b. Lancet 
(1989); 2: 1535. 
Treco, D.A. (1989). Preparation of genomic DNA In Current Protocols in 
Molecular Biology, 2.1.1.-2.1. 7. Edited by Ausubel, F., Brent, R., Kingston, R.E., 
Moore, D.D., Seidman, J.G., Smith, J.A. and Struhl, K. Green Publishing and 
Wiley Interscience, New York, USA. 
Vandenvelde C, Verstraete M, Van Beers D. Fast multiplex polymerase chain 
reaction on boiled clinical samples for rapid viral diagnosis. J. Viral. Methods 
(1990), 30: 215-228. 
Velan, B. (1989). Immunoscreening after hybrid selection and translation In 
Current Protocols in Molecular Biology, 6.8.1-6.8.5. Edited by Ausubel, F., 
Brunt, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A. and Struhl, K. 
Green Publishing and Wiley lnterscience, New York, USA. 
Villemin (1868) In The Biology of the Mycobacteria vol 3, 3-36. Edited by 
Ratledge C., Stanford, J. and Grange, J.M. Academic Press Ltd., London, UK. 
Walgren (1948) In The Biology of the Mycobacteria vol 3, 107-176. Edited by 
Ratledge C., Stanford, J. and Grange, J.M. Academic Press Ltd., London, UK. 
Walker, D.A., Taylor, I.K., Mitchell, D.M. and Shaw, R.J. (1992). Comparison of 
polymerase chain reaction amplification of two mycobacterial DNA sequences, 
IS6110 and the 65kDa antigen gene, in the diagnosis of tuberculosis. Thorax 47, 
690-694. 
Wang, X., Chen, T., Kim, D. & Piomelli, S. (1992) Prevention of Carryover 
Contamination in the Detection of fiS and fiC Genes by Polymerase Chain 
Reaction. American Journal of Haematology 40, 146-148. 
Watson, R. (1990). PCR in a Teacup In PCR Protocols, a Guide to methods and 
Applications, 429-434. Edited by Innis, M.A., Gelfand, D.H., Sninsky, J.J. and 
White, T .J. Academic Press Limited, London, UK. 
Williamson, A. (1992). Detection and typing of mucosa! human papilloma viruses 
by PCR In EBG-PCR Protocols for PCR workshop, 67-69. Edited by Ramesar, R. 
Roche Magazine Reprint, Cape Town South Africa. 
Wilson, K. (1987). Preparation of genomic DNA from bacteria In Current 
Protocols in Molecular Biology, 2.4.1-2.4.5. Edited by Ausubel, F., Brunt, R., 
Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A. and Struhl, K. Green 
Publishing and Wiley Interscience, New York, USA. 
Wilson, S.M., McNerney, R., Nye, P.M., Godfrey-Fausset, P.D., Stoker, N.G. and 
Voller, A. (1993). Progress toward a simplified polymerase chain reaction and its 
application to diagnosis of tuberculosis. Journal of Clinical Microbiology 31, 
776-782. 
Zhu, Y., Isaacs, S., Cimino, G. and Hearst, J. (1991). The use of exonuclease III 
for polymerase chain reaction sterilization. Nucleic Acids Research 19, 2511. 
